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ABSTRACT 
In the United States (US), diabetes affects an estimated 13% of adults (25.8 million people).2, 3 A 
disproportionate burden of the disease is borne by US minority populations.4 Black and Hispanic 
Americans have higher prevalence of type 2 diabetes mellitus (T2DM),5 achieve poorer disease 
control,6, 7 and have more T2DM complications than their White counterparts.8, 9 Efforts to 
reduce these disparities are hindered by the fact that patients typically have T2DM for 4-7 years 
prior to diagnosis.10  There is a confluence of disadvantages: behavioural risk factors, genetic 
predisposition, lack of access to adequate health care, and local environmental disadvantages, 
all are likely to contribute to these increased burdens in a synergistic fashion. A comprehensive 
understanding of “upstream” factors contributing to racial/ethnic differences in T2DM therefore 
offers the greatest potential to reduce the “downstream” costs of T2DM faced by disadvantaged 
populations.11 
This research investigated the roles of certain risk factors in racial/ethnic variation in T2DM using 
the Boston Area Community Health (BACH) Survey. The BACH Survey is a community-based, 
stratified random sample, epidemiologic cohort of 5,502 Boston, Massachusetts residents. 
Follow-up surveys were conducted approximately five (BACH II, 2008-2010, N=4,144) and seven 
(BACH III, 2010-2012, N=3,155) years later. The BACH III survey was designed to assess the 
relative contributions of (1) genetic, (2) lifestyle/behavioural, (3) psychosocial, (4) biophysiologic, 
(5) contextual/neighbourhood, and (6) social/economic determinants to racial/ethnic disparities 
in diabetes. Therefore, my analyses focused on the 3,155 participants of the third wave of the 
BACH survey. 
First, I examined the role of biogeographic ancestry (BGA) versus socioeconomic factors in 
racial/ethnic disparities in the incidence of T2DM over roughly seven years of follow-up. I used 
the excess relative risk method, the risk difference method, and g-computation to examine the 
direct and indirect effects of race/ethnicity on T2DM incidence. Using the g-computation 
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method, I found that socioeconomic factors accounted for 44.7% of the excess risk of T2DM 
among Blacks and 54.9% among Hispanics. The findings indicated that BGA had almost no direct 
association with T2DM and was almost entirely mediated by self-identified race/ethnicity and 
socioeconomic factors.  
Second, I examined the role of neighbourhood contextual factors in racial/ethnic disparities. 
Two-level random intercepts logistic regression was applied to assess the associations between 
race/ethnicity, neighbourhood characteristics (census tract socioeconomic status, racial 
composition, property and violent crime, open space, geographic proximity to grocery stores, 
convenience stores, and fast food, and neighbourhood disorder) and prevalent T2DM (BACH III 
diabetes status). Multilevel models indicated a significant between-neighbourhood variance 
estimate of 0.943, providing evidence of neighbourhood variation. Individual-level demographic 
factors (race/ethnicity, age and gender) explained 22.3% of the neighbourhood variability in 
T2DM. However, the addition of neighbourhood-level variables to the model had very little 
effect on the magnitude of the racial/ethnic disparities and on the between-neighbourhood 
variability.  
Finally, I assessed the relative contributions of six domains of influence to racial/ethnic 
disparities in T2DM: (1) socioeconomic, (2), local environmental, (3) psychosocial, (4) 
lifestyle/behavioural, (5) biophysiologic, and (6) genetic/ancestral. I constructed risk scores for 
each domain of influence and used structural equation models (SEM) to evaluate the direct 
effects of each conceptual domain of influence on T2DM prevalence as well as the indirect effect 
of each conceptual domain on the magnitude of the racial/ethnic disparities in T2DM. The final 
models indicated that 38.9% of the total effect of Black race on T2DM prevalence was mediated 
by the socioeconomic, environmental, psychosocial, lifestyle/behavioural risk scores with 21.8% 
of the total effect of Black race being explained by socioeconomic risk. 45.7% of total effect of 
Hispanic ethnicity was mediated. Again, the largest mediator was the socioeconomic risk score 
with 26.2% of the total association explained. 
6 
My analyses consistently demonstrated that social determinants contributed to racial/ethnic 
disparities in T2DM. My results suggest that socioeconomic factors are the largest contributors 
to the causation and/or amplification of these disparities. Biogeographic ancestry (an individual’s 
genetic race/ethnicity) had no direct effect on T2DM prevalence or incidence. Neighbourhood 
factors did not contribute to racial/ethnic disparities once individual socioeconomic factors were 
taken into account. Finally, while lifestyle/behavioural and biophysiologic characteristics had 
significant direct effects on T2DM prevalence, they did not appear to substantially contribute to 
disparities in T2DM once socioeconomic factors were taken into account.  
These results have national and local policy implications as they suggest that in order to reduce 
disparities, either wide-scale social and economic policy shifts need to occur, or interventions 
need to be targeted toward racial/ethnic minorities and the socially and economically 
disadvantaged. 
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1 Introduction 
1.1 Introduction 
Achieving health equity, eliminating disparities, and improving the health of all population 
groups has been identified as a national priority in the United States (US)12 and worldwide.13 The 
term ‘disparities’ refers to group differences in the burden of mortality and morbidity that are 
distributed inequitably by: race/ethnicity, gender, sexual identity, age, disability, or 
socioeconomic status. Effectively combating disparities requires addressing multiple potential 
influences on the health status of specific populations.11 These include variations in 
individual/proximate causes (lifestyles and behaviours and biological influences), as well as 
population/upstream causes (socio-demographic influences and/or local environment).14 
Complex factors—genetic, physiological, psychological, familial, cultural, social, political and 
economic may coalesce to determine these disparities.15  
The burden of type 2 diabetes mellitus (T2DM) disproportionately affects US minority 
populations. Black and Hispanic Americans have a higher T2DM prevalence,2 greater diabetes 
risk factors, poorer control of their diabetes,6, 7 and a greater number of diabetes-related 
complications than White Americans.8, 9, 16  Diabetes is the seventh and fourth leading cause of 
death among White and Black Americans, respectively17  and diabetes accounts for a loss of 
0.332 years of life among Black versus White Americans.18 
Many factors have been identified as contributing  to these disparities, including variations 
in lifestyles and behaviours,19-21 biophysiological, 22-25, 26 psychosocial,27-29 sociodemographic,30-32 
environmental factors,33-35 and underlying genetic/ancestral factors,36, 37 and events occurring 
during foetal life including maternal physiology and life context. Several studies have attempted 
to evaluate whether racial/ethnic disparities can be attributed to factors other than 
race/ethnicity.30, 38-43 However, research to date has largely focussed on individual risk factors in 
16 
isolation and the relative contribution of these multiple competing factors has not been 
identified.   
 
1.2 Overall Aim and Objectives 
This research aimed to explore racial/ethnic disparities in T2DM using a novel multilevel, 
multisystem conceptual model of the creation and/or amplification of racial/ethnic disparities in 
T2DM. I tested this conceptual model using data from the Boston Area Community Health 
(BACH) Survey which was specifically designed with the goal of understanding racial/ethnic 
differences in the prevalence and incidence of diabetic illness. The specific objectives of the 
research papers are: 
1. to quantify the contribution of genetic biogeographic ancestry versus socioeconomic 
factors to racial/ethnic disparities in T2DM incidence, 
2. to identify and estimate the contribution of specific aspects of contextual 
environments/neighbourhoods to racial/ethnic disparities in T2DM prevalence, and 
3. to quantify the relative contribution of (1) social and economic, (2) 
contextual/neighbourhood, (3) psychosocial, (4) lifestyle/behavioural, (5) 
biophysiologic, and (6) genetic/ancestral factors to racial/ethnic disparities in 
prevalent T2DM. 
1.3 Structure of the Thesis 
This thesis incorporates four published papers as chapters; three of which have been submitted 
and published in peer-reviewed journals. These papers comprise Chapters 5-8. These chapters 
are prefaced by the required cover sheet and evidence of copyright retention. The accepted, un-
copyedited text of the manuscripts is presented. However, for consistency the journal 
submission formatting has not been used (e.g. tables and figures are in-line with text). Additional 
17 
analyses and details that could not be included due the journal’s word limits are included 
following the reproduced paper. 
This initial chapter provides a framework for the thesis including my role in the research, 
collaborating institutions, ethical clearances and funding. The second chapter is a literature 
review that focuses on genetic/ancestral, lifestyle/behavioural, psychosocial, biophysiologic, 
contextual/neighbourhood, and socioeconomic determinants of T2DM as well as their potential 
roles in creating and/or amplifying racial/ethnic disparities in T2DM.  This literature review is not 
intended to be comprehensive; rather it is intended to identify and categorize the major 
determinants of T2DM that are potential contributors to disparities. The third chapter provides a 
description of the methodologies used in the study and the study’s conceptual framework. 
The first paper is a cohort profile of the Boston Area Community Health (BACH) Survey. This 
constitutes Chapter 0 and provides details on the BACH study which was used to address this 
thesis’s main objectives. 
There are three main chapters addressing the study’s objectives analysing the BACH study data. 
Chapter 5 focuses on the contribution of biogeographic ancestry to racial/ethnic disparities in 
T2DM. Chapter 6 examines the contributions of neighbourhood characteristics to racial/ethnic 
disparities. Chapter 7 examines the relative contributions of socioeconomic, neighbourhood, 
psychosocial, lifestyle/behavioural, biophysiologic, and biogeographic ancestral factors to 
racial/ethnic disparities in T2DM. 
Chapter 8 is a discussion section that synthesizes the findings from each of the chapters 
including discussion of the strengths and limitations of this work. Chapter 0 discusses the 
implications of the study findings for policy and practice. 
The appendices provide additional material relevant to this work including ethics approval, data 
collection instruments, and publications and presentations relevant to this work. 
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1.4 Role of the Candidate 
The BACH III study was conceptualised, proposed, and awarded to the Principal Investigator of 
the BACH study, John B. McKinlay. I served as the project manager, lead scientist, and lead 
statistician on the project. I designed the study questionnaires, secured the necessary ethics 
approval, assisted with the development of the data management system, assisted with the 
recruitment and training of staff, and managed all day-to-day aspects of the study.  
I conceptualized the papers for publication included in the body of this thesis, conducted all 
statistical analyses, and wrote the initial draft of all four papers. I then incorporated feedback 
from co-authors in an iterative process. 
1.5 Collaborating Institutions 
The institutions collaborating on this research were New England Research Institutes, Inc. 
(Watertown, MA), Massachusetts General Hospital (Boston, MA), and the London School of 
Hygiene and Tropical Medicine (London, UK). 
1.6 Ethical Clearance 
Ethical approval for this work was provided by the New England Research Institutes Institutional 
Review Board and the London School of Hygiene and Tropical Medicine Ethics Committee (see 
Appendix A). 
1.7 Funding  
Funding to support this research was received from the National Institute of Diabetes and 
Digestive and Kidney Diseases, U.S. Department of Health and Human Services Grant Number 
DK080786. 
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2 Background 
National survey data from National Health and Nutrition Examination Survey (NHANES) estimate 
that approximately 40% of the US population has some hyperglycaemic condition.2 It is 
estimated that 12.9% of US adults have diabetes and another 29.5% have prediabetes.3 
According to a fact sheet released in 2014 by the CDC, T2DM is a growing public health problem 
that  affects 29.1 million US adults.2  Diabetes is implicated in kidney failure, lower-limb 
amputations, blindness, heart disease, and stroke, and is the seventh leading cause of death in 
the US.2 A disproportionate burden of T2DM is experienced by minorities in the US.  US national 
survey data indicate that 12.8% of Hispanics, and 13.2% of non-Hispanic Blacks have diagnosed 
diabetes compared to 7.6% of non-Hispanic Whites.2 When including both undiagnosed and 
diagnosed diabetes in these estimates, 18.7% of all Blacks have diabetes compared to only 
10.2% of Whites.2 The incidence of diabetes is estimated to be 66% higher among Hispanics and 
77% higher among Black adults than among White adults.2 Further research shows that Black 
and Hispanic Americans have poorer control of their diabetes6, 7 and a greater number of 
diabetes-related complications than Whites.8, 9, 16   
The contributors to racial/ethnic disparities in T2DM are complex. Individual characteristics and 
behaviours are often the focus of epidemiologic studies.15 However, these ubiquitous risk factors 
do not appear to explain the widespread racial/ethnic disparities in population health which are 
produced by multiple reinforcing risk factors.15 Underlying the problem are a complex interplay 
of factors including: (i) social, political and economic structure and policy, (ii) 
contextual/neighbourhood environments, (iii) psychosocial stressors, (iv) lifestyle/behavioural 
factors and their driving forces (e.g. cultural, familial), (v) biophysiologic factors, and (vi) 
genetics, ancestry, and foetal programming. While many risk factors for T2DM have been 
identified and implicated in the aetiology of racial/ethnic disparities in T2DM, most research has 
viewed these risk factors in isolation or explored one particular category of explanation (i.e. 
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lifestyle characteristics associated with T2DM). The relative contributions of these identified risk 
factors to T2DM overall, and to racial/ethnic disparities in T2DM, are unknown.  
The purpose of the following review of the literature is two-fold: (1) identify and categorize the 
major determinants of T2DM to ensure that the measures included in this thesis research are as 
inclusive as possible, (2) elucidate how these independent risk factors for T2DM may contribute 
to racial/ethnic disparities.  Furthermore, this literature review helps to identify and quantify the 
major measured and unmeasured influences in the models considered in this research. 
Given these aims, this literature review places an emphasis on large, multi-ethnic or multi-racial, 
observational research projects conducted among adults.  The strengths and limitations of some 
of the research projects mentioned frequently in this background are described below. 
The National Health and Nutrition Examination Survey (NHANES) is the largest program of 
studies designed to assess health in the US. The survey combines data from individual interviews 
and physical examinations. Nearly 5,000 individual participants, representative of the US 
population, participate each year. Despite the strengths in sample size, survey design, breadth of 
measures, and representativeness, there are nonetheless limitations to the NHANES data. 
Specifically, each yearly instalment is cross-sectional in nature and there are small numbers of 
participants within certain racial/ethnic subgroups, including non-Mexican Hispanic adults. 
The Atherosclerosis Risk in Communities (ARIC) study is a prospective population study initiated 
in 1987.44 Conducted in four cities in the US, 15,792 subjects were enrolled and followed three 
times through 1995. The strengths of the ARIC study, particularly to informing this research, are 
the extensive measures collected (including social, lifestyle/behavioural, and extensive genetic 
markers), the large sample size, the varied study locations (both rural and urban with differing 
social, economic, and geographic profiles), the prospective design, and the large sample of Black 
and White participants. Limitations relevant to evaluating potential determinants in this 
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research are that the study lacks adequate numbers of Hispanic participants to evaluate 
determinants relevant to Hispanic populations. 
The Multiethnic Study of Atherosclerosis (MESA) study is a prospective cohort study initiated in 
2000.45 Conducted in six geographically and compositionally diverse areas in the US, the study 
enrolled 6,814 racially/ethnically diverse participants (White, Black, and Hispanic). Five follow-up 
examinations have occurred through 2012. The strengths of the MESA study are the prospective 
design, the varied study locations, the racially/ethnically diverse participants, and the inclusion 
of markers identifying pre- and undiagnosed- diabetes. While both the ARIC and the MESA 
studies provide a wealth of prospectively captured data elements from racially/ethnically diverse 
cohorts, there is an emphasis in both of these studies’ publications on biophysiologic and genetic 
determinants. Although there are several publications from both that focus on neighbourhood 
determinants of disease. 
The Whitehall II study, in contrast, was specifically designed to investigate social and economic 
influences on health. Initiated in 1985 (N=10,308), the prospective cohort study’s sample base 
was all civil servants working in London – Whitehall departments. The Whitehall II study provides 
an excellent opportunity to examine long-term exposures including childhood and life-course 
measures. However, there are limitations in generalizing information gathered from the UK 
based sample to the US. Notably, the socioeconomic diversity of individuals employed as civil 
servants cannot be extrapolated to the full spectrum of socioeconomic diversity in the US. 
Additionally, there is limited racial/ethnic diversity in the sample. 
2.1 Genetic/Ancestral Factors 
2.1.1 Family History 
First-degree relatives of individuals with T2DM are at increased risk of developing 
hyperglycaemic conditions including insulin resistance,46-49 decreased beta cell function,50, 51 
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metabolic syndrome,51, 52 and have a 4-to 5- fold higher risk of developing this disease than those 
without a family history.53 This association is consistent across generations of research studies, 
across cultures,54 and across study designs from classical experimental designs55, 56 to population 
studies. In addition to the genetic risk associated with a family history of T2DM, it has been 
suggested that genetic predisposition to T2DM is related to ethnicity.47,48,57 For example, Jensen 
et al state that “it is apparent that genetic predisposition related to ethnicity is a major 
determinant of diabetes risk.”57 However, the authors’ findings suggest that that the 
pathogenesis of T2DM is similar among racial/ethnic groups.  
2.1.2 Biogeographic Ancestry 
Despite considerable discussion of the roles of genetics versus environmental factors in health 
disparities,58-60 considerable uncertainty remains regarding the importance of genetic variation. 
The concepts of genetics, race, and ethnicity are often confused.61-63 The term ‘race’ is 
commonly defined in terms of biological differences between groups assumed to have different 
biogeographical ancestries.64 However, the genes associated with ‘race’ represent only a small 
fraction of the estimated 30,000 total genes in our genomes.65, 66 It is important to note that 
there is substantially less genetic variation between than within commonly defined racial/ethnic 
groups.67 Analysis of variance of genetic variation has indicated that approximately 75% of 
genetic variance is found ‘within’ racial/ethnic groups, while 10% of the variance is found 
‘between’ races.64 Furthermore, the US Census categorizations (White, Black, Asian, etc.) are 
largely social constructs, as is the concept of biological race itself.63, 68 In contrast, ethnicity is a 
complex multidimensional construct that reflects biological factors, geographical origins, 
historical influences, as well as social, cultural, economic factors.69 
A genetic basis for racial/ethnic differences in diabetes risk, the ‘thrifty gene’ hypothesis, was 
first proposed over 40 years ago.70 The thrifty gene hypothesis proposed that the high 
prevalence of obesity and T2DM in African Americans, Native Americans and admixed Hispanics 
was due to a metabolic efficiency rendered detrimental by Western society’s abundance 
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coupled with a shift towards a sedentary lifestyle in both occupation and leisure activities.70-72 
The hypothesis has been heavily criticized from several different perspectives,61 but has 
nevertheless been revived in recent years as the rapid evolution of science and technologies 
have facilitated an expansion in genetic research.  
Since T2DM has a complex genetic aetiology, it may be important to account for the substantial 
heterogeneity in genetic heritage that exists in admixed populations.73-76 Individual proportions 
of European, African, and Native American ancestry can vary substantially among the commonly-
used categories of Black 73, Hispanic 75, and White.77 Several studies have suggested that the 
biologic mechanisms leading to increased T2DM risk in Black and Hispanic Americans may be 
related to genes associated with BGA47,4857 since certain genetic markers tend to cluster by 
BGA.78 Although these genes constitute only a very small portion of genetic variation, their 
presence suggests that genetic differences across racial/ethnic groups could have some 
implications for racial/ethnic disparities.  
Ancestry Informative Markers (AIMs) are a method of genotyping an individual’s genetic 
race/ethnicity. Several studies have examined the role of BGA in T2DM by utilizing these 
markers. These studies have produced mixed results to date. Cross-sectional analysis from ARIC 
Study found that BGA was not associated with HbA1c among African Americans and found that 
the contributions of demographic and metabolic factors outweighed the contributions of BGA.79 
However, an analysis of ARIC/Jackson Heart data, found that BGA was associated with T2DM 
among African Americans, a finding that changed little after adjustment for lifestyle and 
socioeconomic factors.80 The latter study was also cross-section in nature, which may 
overestimate the contribution of genetic (immutable) factors and underestimate the 
contribution of socioeconomic and/or lifestyle behavioural (mutable) factors. 
Studies among Hispanic populations have also produced mixed results. In a study of Columbian 
and Mexican participants, the association between ancestry and T2DM was attenuated when 
socioeconomic factors were taken to account.36 However, SES was measured based on 
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residential location, rather than individually reported. In a study of Puerto Rican participants 
living in the continental US demonstrated a negative association between West African BGA and 
T2DM, meaning participants with a greater percentage of West African ancestry actually had a 
lower prevalence of T2DM.81 While this study was cross-sectional, on the spot diabetes testing 
(fasting glucose ≥ 126 mg/dl), allowed for both diagnosed and undiagnosed disease to be 
captured. 
Prior to BACH, only one study had examined the effects of ancestry among both African and 
Hispanic Americans. The Women’s Health Initiative (WHI) found that ancestry was significantly 
associated with diabetes risk, but that socioeconomic factors attenuated the effects among 
Hispanic but not African American women.37 The WHI is a prospective clinical trial/cohort study 
and included 16,476 in this analysis using time-to-diabetes diagnosis. However, the WHI used 
geocoded addresses to obtain individual-level socioeconomic information which may attenuate 
diabetes risk attributable to SES due to measurement error. The BACH III study examined the 
effect of West African and Native American ancestry on fasting glucose and HbA1c among non-
diabetic individuals. In these analyses we found that West African but not Native American 
ancestry had a small, but significant, effect on fasting glucose and HbA1c. These findings were 
not affected by adjustment for socioeconomic factors.82  
These studies highlight the complexity of the relationship between biogeographic ancestry and 
socioeconomic status. Specifically, in several studies among admixed Hispanic populations, 
country of origin, individual genetic ancestry, and socioeconomic status were intertwined. 
Martinez-Marignac et al suggest among Hispanic populations, individual genetic ancestry may 
be, in part, affected by socioeconomic stratification (segregation) and country of origin.36, 83 At 
the very least, these arguments underscore the need for comprehensive measures of socio-
demographic factors when examining the role of genetic determinants in T2DM.  
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2.1.3 Other Genetic Factors 
Genetic studies have identified and confirmed approximately 70 loci that are associated with 
T2DM risk and over 30 loci associated with variations in fasting glucose.84-87 Early studies focused 
primarily on people of European descent. However, recent studies have extended this research 
to Black and Hispanic populations.88-90 The findings from these studies indicate substantial 
overlap in the T2DM susceptibility loci across racial/ethnic groups. This indicates that genetic 
variants contribute similarly to diabetes risk across races/ethnicities,80, 85, 90-93 meaning that it is 
unlikely that these identified loci explain racial/ethnic differences in diabetes risk. A recent study 
which recruited a large sample of African Americans and European Americans found that African 
Americans have a greater overall T2DM risk allele load. However, they found that cumulative risk 
allele load was associated with risk of T2DM in European Americans, but only marginally in 
African Americans.94 This result suggests that total risk allele load may differentially affect 
people of different race/ethnicities. 
2.2 Lifestyle/Behavioural Determinants 
2.2.1 Physical Activity 
Physical activity is an important risk factor for the development of diabetes.19 Individuals who 
participate in regular physical activity demonstrate a reduced risk of developing T2DM.19 
Subjectively95 (self-report) and objectively96 (accelerometry) measured physical activity data 
demonstrate that light to moderate physical activity is beneficial to glucose tolerance whereas 
sedentary time is detrimental glucose tolerance. Research has repeatedly suggested that 
substituting light-intensity activity for television viewing or other sedentary time may be a 
practical and achievable preventive strategy to reduce the risk of T2DM. This observation 
evidence is further bolstered by data from a randomized study of overweight/obese adults. This 
trial indicated that interrupting sitting time with short bouts of light- or moderate-intensity 
walking lowers post meal glucose and insulin levels thereby improving glucose metabolism.97 
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According to self-report data, White Americans have significantly more leisure-time physical 
activity than Black and Hispanic Americans.98 However, accelerometry data, which may be less 
prone to self-report measurement and recall error, indicate that Hispanics may have overall 
higher physical activity levels than Blacks and Whites. This may be due, in part, to physically 
demanding occupational or domestic activities.99  
Indirectly, physical activity affects T2DM risk through its effect on BMI/obesity. Regular physical 
activity, in addition to helping to maintain a healthy weight, is associated with short-term up-
regulation and long-term down-regulation of inflammatory markers, a key biophysiologic 
pathway to insulin resistance, pre-diabetes, and T2DM.100, 101  Clinical studies have shown that 
exercise improves skeletal muscle glucose uptake and increases insulin sensitivity.102 Physical 
activity affects several components in the insulin signalling pathway simultaneously, which 
facilitate glucose uptake into skeletal muscle.103  
2.2.2 Dietary Patterns 
Like physical activity, healthy dietary patterns have been linked to a reduced risk of developing 
diabetes in a number of research studies.20  Long-term data from NHANES have indicated 
differences in dietary patterns between White and Black participants (1971-2002).104  These data 
indicated that Black participants tend to consume foods higher in energy density (i.e. fat and 
sugar) and consume fewer vegetables than their White counterparts.104 In particular, diets that 
are high in refined sugars, high in saturated fat, and low in fibre are associated with pro-
inflammatory responses that may be in the causal pathway towards T2DM. For example, a diet 
high in refined sugars (e.g. sugar sweetened beverages, candy, white bread) is associated with 
increased levels of pro-inflammatory markers like C-reactive protein (CRP).105 The consumption 
of saturated fatty acids is associated with deficient insulin signalling through several molecular 
pathways,106-108 and also with pro-inflammatory responses.109, 110 
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2.2.3 Alcohol Consumption 
Alcohol abuse is considered as a risk factor for several adverse public health outcomes. A 
systematic review of the literature111  indicated that low-to-moderate alcohol intake (1-3 
drinks/day) may result in a lower incidence of T2DM versus teetotallers (33% to 56% lower 
incidence) whereas heavy alcohol consumption (> 3 drinks/day) may increase the risk for 
incident T2DM (43% increased incidence of diabetes). Moderate alcohol consumption appears to 
augment insulin sensitivity and may decrease the incidence of non-alcoholic fatty liver disease, 
which is closely related to metabolic diseases including insulin resistance and obesity.112-114  Most 
research indicates a J- or U-shaped relationship between alcohol consumption and the 
development of T2DM,111, 115 but the relationship between alcohol consumption and T2DM is not 
fully explained. Furthermore, the mechanisms involved in the augmentation of insulin sensitivity 
by modest alcohol consumption are not clearly understood.  
2.2.4 Obesity and Fat Distribution 
Being overweight (body mass index (BMI) ≥ 25 kg/m2 or obese (BMI ≥ 30 kg/m2)  is a well-
established risk factor for insulin resistance and diabetes.21, 116, 117 Obesity confers a 20-50 fold 
increased risk for developing T2DM.21, 118, 119 In the US, only about a third of adults are 
considered to be of “normal” weight,120 and similar trends are being observed worldwide.121 The 
prevalence of obesity is increasing and, in the US, varies by race/ethnicity.122 Data from NHANES 
found that 49.5% of Blacks, 39.1% of Hispanics, and 34.3% of Whites are obese.123 African-
Americans and Hispanics are more likely to be obese at the time of T2DM diagnosis than their 
White counterparts.124, 125  
The relationship between race and diabetes risk may be modified by body mass index (BMI). 
Black and White Americans with higher BMIs appear to have a similar risk for diabetes, whereas 
Blacks with lower BMIs have a higher risk of diabetes (OR of 1.87 and 1.76 for men and women, 
respectively) than their White counterparts.41 This data comes from the NHANES, Epidemiologic 
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Follow-up Study (1971-1992) which included over 1,000 incident cases of diabetes during 20 
years of follow-up.  
In contrast cross-sectional data from NHANES indicate that Hispanic men and women appear to 
have greater risk for diabetes than White adults across the BMI spectrum.125, 126 Black and 
Hispanic adults appear to have higher insulin resistance than White adults even after adjustment 
for BMI.116, 127, 128 Trends in the prevalence of diabetes by race/ethnicity over time demonstrate 
that ethnic disparities are worsening among normal and overweight groups but not among the 
obese.129  
One hypothesized reason for these differential effects may be differences in fat distribution, 
particularly central adiposity. Central adiposity is highly correlated with increased insulin 
resistance which in turn increases risk for T2DM.130, 131 Waist circumference appears to be a 
stronger predictor of T2DM risk than BMI with the relationship between waist circumference 
and T2DM risk being found even among people within the “normal range” of BMI (BMI < 25 
kg/m2).132 The ARIC study found that central adiposity accounted for nearly 50% of the excess 
risk of T2DM in Black women vs. White women. However, the results in men were not 
consistent.22 The anthropometric indices of waist circumference (WC) and waist-to-height ratio 
(WHR) are associated with insulin resistance.23-25 Results from a cross-national study using 
NHANES data from England and the US demonstrated ethnic differences in the prevalence of 
diabetes, even among those characterized as normal weight and suggested that differences in 
WC or WHR may account for some of these differences.133  
2.2.4.1 Mechanisms 
Most obese individuals, even those who are insulin resistant, do not develop hyperglycaemia. 
Among most individuals, the pancreatic islet beta cells (the cells that store and release insulin) 
increase insulin release to compensate for the reduced efficiency of insulin action, thereby 
maintaining normal glucose tolerance.134 For obesity and insulin resistance to be associated with 
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T2DM, beta cells must be unable to offset decreased insulin sensitivity.135, 136 Adipose tissue also 
affects metabolism by releasing non-esterified fatty acids (NEFAs) and glycerol, hormones 
(including leptin and adiponectin), and pro-inflammatory cytokines.137-139 It has been suggested 
that the release of NEFAs “may be the single most critical factor in modulating insulin 
sensitivity.”140 Increased NEFA levels are observed in obesity and T2DM, and are associated with 
the insulin resistance observed in both.140 Insulin resistance develops within hours of an acute 
increase in plasma NEFA levels.141 
The distribution of body fat is also a significant determinant of insulin sensitivity. Most obese 
individuals are insulin resistant. However, among lean individuals with different body fat 
distributions, insulin sensitivity can vary markedly. Lean individuals with more peripheral fat are 
more insulin sensitive than lean individuals with more centrally distributed fat (i.e. the 
abdominal and chest areas).135, 142 There are differences in the characteristics of peripheral and 
central adipose tissue that may explain, in part, why the metabolic effects differ. For example, 
intra-abdominal fat expresses more secretory protein encoding genes and proteins responsible 
for energy production.143  
Recent decades have seen major advances in our understanding of the mechanisms underlying 
obesity, insulin resistance and T2DM. However, despite these advances in understanding there is 
still much to be explored regarding racial/ethnic disparities in these conditions and the 
mechanisms underlying these disparities.  
2.3 Psychosocial  
Psychosocial factors may also play an important role in the development of T2DM. Specifically, 
increases in the prevalence of short sleep duration and depressive symptoms have been 
implicated as risk factors for T2DM.144, 145 Studies have also demonstrated the association of 
various psychosocial stressors with diabetes, including adverse life events28 and a low sense of 
coherence.29  
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2.3.1 Sleep 
Scientists are now beginning to recognize the downstream health consequences of sleep-related 
problems, including increased risk for obesity146, 147 which in turn increases risk for T2DM.148-151 
Data from NHANES indicate that sleeping fewer than five hours a night more than doubles the 
risk of pre-diabetes.152 Recent research indicates that sleep restriction results in physiological 
changes that may have profound implications for T2DM related diseases.153  There are several 
mechanisms by which sleep disturbances and/or deprivation may contribute to weight gain and 
incident obesity conferring increased T2DM risk. Short sleep increases cortisol and insulin 
secretion thereby promoting fat storage. Increases in ghrelin and reductions in leptin which 
stimulate appetite and inhibit satiety regulating signals to the brain, respectively, can lead to 
increased intake of high fat and high carbohydrate foods.147 Sleep loss also leads to increased 
systemic inflammation as measured by CRP concentrations.154 In addition, insufficient or 
inadequate sleep may lead to decreased energy expenditure, further increasing the risk for 
weight gain and incident obesity.155, 156 Increased insulin production coupled with impaired 
glucose metabolism, greatly increase the risk for T2DM.157 Short sleep increases blood pressure 
and sympathetic hyperactivity.158 Sleep restriction and poor sleep quality are now being seen as 
major risk factors for obesity and obesity-related disease, right along with the two of the most 
commonly identified risk factors: lack of exercise and overeating.147, 159 
Sleep problems appear to differentially affect racial/ethnic minorities,160-162 with most studies 
documenting worse sleep among minority groups, including several smaller cross-sectional 
studies and the  National Health Interview Survey (N=32,749 adults).161-167 For example, Patel et 
al,  found that African-Americans were 65% more likely than Whites to report poor sleep quality 
and Hispanics were 59% more likely.168 Research suggests that the racial disparities in sleep are 
partially explained by (mediated by) SES and other related factors (e.g. occupation and financial 
strain).162, 169-173 Low income, education, and overall SES were frequently associated with 
reduced opportunities to obtain sufficient sleep and with adverse environmental conditions that 
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compromise sleep quality.170, 174 The BACH study examined the effect of self-reported short sleep 
duration and poor quality of sleep on racial/ethnic disparities in the development of obesity and 
T2DM.175 However, we did not find that sleep quantity or quality mediated the effect of 
race/ethnicity on these conditions. While we utilized longitudinal data to examine the incidence 
of disease, our measures of sleep were subject to considerable measurement error. 
Nonetheless, research to date appears to suggest that sleep could play a role in racial/ethnic 
disparities in obesity and T2DM.175  
2.3.2 Depressive Symptoms 
Depressive symptoms can potentially contribute to lifestyle changes which may in turn confer 
T2DM risk. While it has been suggested that depression and T2DM may be associated in a bi-
directional manner, a meta-analysis of nine longitudinal studies indicated that depression 
confers a 25% to 37% increased risk of developing T2DM.145 These findings were consistent in 
sensitivity analyses attempting to control for undiagnosed diabetes at baseline. The 
pathophysiological mechanisms underlying this relationship are unclear. One potential 
mechanism is that depressive symptoms are associated with increased levels of pro-
inflammatory markers and declining insulin sensitivity.176, 177 
2.3.3 Chronic stress 
Psychosocial stress, including adverse life events,28 job strain,178 low sense of coherence,29 
appears to be associated with T2DM. While one pooled analysis of over 100,000 participants 
indicated work-related stress was associated with an increased risk of T2DM178 another meta-
analysis of nine studies did not.179 The biological pathways of the stress—diabetes association 
are not fully understood, however several theories have been proposed. For example, perceived 
psychological stress coupled with a reduced sense of control/increased helplessness leads to an 
activation of the hypothalamic-pituitary-adrenal (HPA) axis. This in turn results in abnormal 
endocrine function including increased cortisol and decreased sex steroid levels. This endocrine 
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dysregulation antagonizes the effects of insulin.180 These imbalances also can lead to obesity, 
particularly visceral adiposity, which plays an important role in insulin resistance and T2DM (see 
Section 2.4.1). Cross-sectional findings have found an association between stressful life events 
with visceral adiposity and T2DM.28, 181 Internal versus external sense of control is also thought 
to be a key mediator between stressful events and health, as individuals with a low internal 
sense of control are less likely to deal successfully with stressors.29, 182 
2.4 Biophysiologic  
2.4.1 Low-grade inflammation 
There is increasing clinical and observational evidence that low-grade inflammation may be an 
important pathway through which socioeconomic, lifestyle, and psychosocial factors influence 
T2DM risk (Figure 2-1). Low-grade chronic inflammation affects insulin signalling and increases 
beta-cell death.26, 183, 184 Markers of inflammation, such as interleukin-6 and c-reactive protein 
are associated with insulin resistance and diabetes incidence.185-187 As noted previously, certain 
dietary patterns (e.g. high in refined sugars, high in saturated fat) are associated with increased 
inflammatory responses.105 Regular physical activity is associated with lower systemic 
inflammation.101 The adipose tissue associated with obesity, a key risk factor for T2DM, may be a 
source of local inflammation and lead to the activation of immune cells.188-190 Over-nutrition and 
obesity increase insulin requirements and impose stress on beta cells. It is noteworthy that 
patients with pre-diabetes and T2DM appear to demonstrate a greater inflammatory response 
to dietary glucose.191 This suggests that early in the progression towards T2DM, the ability to 
contain inflammation induced by diet may be compromised.  
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Figure 2-1. Lifestyle and psychosocial factors cause decreased beta cell function, insulin 
resistance, and T2DM via low-grade inflammation 
 
2.4.2 Glucose Metabolism and Insulin Resistance 
It has been suggested that the higher prevalence of T2DM in minority US populations is partially 
attributable to differences in glucose metabolism.192 In several studies among non-diabetics, 
including longitudinal data from ARIC,193 Blacks and Hispanics had higher fasting insulin and 
greater insulin resistance than Whites across various levels of BMI.127, 193-196 An experiment 
conducted among Black and White Americans indicated that while glucose levels and C-peptide 
responses were identical in oral glucose tolerance testing, serum insulin levels (before and 
during) were greater (2-3 fold) among Blacks and hepatic insulin extraction was lower.197 These 
results suggest that greater insulin resistance may be partially responsible for the higher 
prevalence of T2DM among Blacks and Hispanics. Several researchers have suggested that there 
is a biologic or genetic basis for these racial/ethnic differences in insulin resistance. However, 
more recent research with broader inclusion of ethnic groups and greater numbers of subjects 
found that Black, Asian, Caucasian and Hispanic Americans all became insulin resistant and had 
reduced beta cell function as glucose tolerance declined.57 Although Black and Hispanic 
Americans had a greater degree of insulin resistance than Caucasians even after adjustment for 
BMI, the change in resistance observed in each group suggested that insulin resistance and 
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decreased beta cell function is a characteristic feature in the pathogenesis of T2DM in all 
racial/ethnic groups.57 
2.4.3 Βeta cell dysfunction 
As mentioned in Section 2.2.4, for obesity and insulin resistance to be associated with T2DM, 
beta cells must be unable to offset decreased insulin sensitivity.135, 136 In healthy individuals, 
there is a feedback loop between the insulin-sensitive tissues and the beta cells, with beta cells 
increasing insulin supply in response to demand from the liver, muscles and adipose tissue.198 In 
order for glucose tolerance to remain unchanged, changes in insulin sensitivity must be matched 
by a proportionate yet opposite change in circulating insulin levels. For example, as Figure 2-2 
demonstrates, in individuals with marked insulin resistance, additional small changes in insulin 
sensitivity produce large changes in insulin levels, whereas in very insulin sensitive individuals, 
large changes in insulin sensitivity would be associated with small changes in insulin 
concentrations. Failure of this feedback loop results in a deviation from normal glucose 
tolerance and underlies the development of T2DM.  
Figure 2-2. Relationship between insulin sensitivity and fasting insulin. Adapted from Kahn, 
1993198  
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In T2DM, beta cell function is reduced, in that the cell fails to release insulin rapidly in response 
to glucose stimulation even though it clearly contains insulin.198 In T2DM the numbers of beta 
cells are reduced by about 50%.199-201 However, the degree of beta cell loss cannot fully account 
for the change in secretory response and function, because by the time the diagnostic level for 
diabetes occurs, beta cells are operating at 25% or less of its functional capacity.202 There is a 
continual decline in beta cell function as T2DM progresses.198 The extremely high blood glucose 
levels often observed in T2DM are a likely contributor to further disease progression through 
glucotoxic effects on the beta cell and harmful effects on insulin sensitivity.203 In contrast, among 
healthy individuals exposure to high blood glucose levels has exactly the opposite effect; it 
improves insulin sensitivity and enhances beta cell function.204 This suggests a pre-existing 
abnormality or risk, that is perhaps genetically determined, that is an important mechanism by 
which beta cell dysfunction occurs.205  
Providing further evidence for the hypothesis of a pre-existing risk, groups of individuals at 
increased risk of T2DM exhibit beta cell dysfunction well before they would be considered to 
have reduced glucose tolerance.57, 206-208 Longitudinal studies examining the progression from 
insulin resistance to T2DM with data collected from Whites, African Americans, Hispanics, and 
Pima Indians have found that those who did not progress to T2DM simply increased their insulin 
output as insulin sensitivity declines. However, among individuals who progressed to T2DM, the 
presence of a defect in insulin release was already present at baseline.208, 209  
Racial/ethnic disparities in insulin resistance and beta cell function have been suggested in a 
number of studies,127, 195-197, 210 whereas others have found no differences among racial/ethnic 
groups.57 In a large cohort with adequate numbers of African American, Asian American, 
Caucasian, and Hispanic American participants, all were found to have similarly progressing 
insulin resistance and decreasing beta cell function as glucose tolerance declines.57 The nature of 
the change in these two parameters was similar in all racial/ethnic groups studied.57 These 
results suggest that the pathogenesis of insulin sensitivity and beta cell function are similar 
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among different racial/ethnic groups and therefore unlikely to explain disparities in risk between 
racial/ethnic groups.57 
2.5 Contextual/Neighbourhood Influences 
The literature discussed above focuses on the role of individual-level factors (genetic, 
lifestyle/behavioural, and biophysiologic). Epidemiologic literature, particularly in the US, tends 
to focus on these proximate risk factors for several reasons: (1) they are potentially controllable 
at the individual level and (2) they resonate with the value and belief systems of Western culture 
that emphasizes “personal responsibility”—the idea that individuals control their personal fate 
and responsible for their own actions.15, 211, 212 While this research is important, interventions 
focusing on reducing diabetes risk factors at the individual-level (e.g. diet and exercise 
programmes, behaviour modification, medication, and surgical treatment) have met with limited 
success.213-216 Individually-based determinants may fail to capture the entire causal pathway 
between race/ethnicity and T2DM. More recently, researchers have identified a number of 
environmental-level factors associated with obesity, diabetes, and other chronic diseases.217 
Neighbourhoods have emerged as a potential context in which disparities are fostered as they 
possess both physical and social attributes which can affect the health of individuals. The 
influence of neighbourhood context on health has been the focus of quite a body of research 
over the past decade, although most of the studies to date have focused on risk factors 
upstream to T2DM (i.e. dietary patterns,218-220 physical activity,219, 221 and body mass 
index/obesity219, 220, 222). However, studies linking neighbourhood characteristics directly with 
T2DM are limited.31, 223-225  
Research has documented important differences in neighbourhood physical and social 
environments and health outcomes. However, the extent to which contextual factors contribute 
to disparities has remained elusive. This may be due, in part, to limitations inherent to 
neighbourhood and macro-environmental research. Residential selection refers to the fact that 
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individuals do not select residential environments at random and that race/ethnicity, culture, 
and familial influences all affect where individuals live.226, 227 Reverse causation refers to the 
notion that lifestyles and behaviours may influence the choice of residential location, rather than 
the reverse. For example, individuals with better diets may seek out neighbourhoods with a 
healthier food environment.228 These issues highlight the fundamental complexity in separating 
individual factors from contextual factors in research. 
2.5.1 Built environment 
Recently, the influence of built environment has received considerable attention, particularly in 
the US. The term ‘built environment’ typically refers to the man-made surroundings (e.g. density 
of fast food restaurants, distance to nearest park, and sidewalk completeness) that may or may 
not provide the setting for healthy behaviours, including healthy eating and physical activity. The 
domains and measures of the built environment used in scientific research vary considerably, in 
part, because of the large number of features that could potentially influence health 
behaviour.229 Some aspects of the built environment, such as access to grocery stores, 
convenience stores, and restaurants, are highlighted as a target for research in large part 
because they are potentially modifiable features of neighbourhood environments.230 Access to 
supermarkets and grocery stores were positively associated with healthy food behaviours and 
lower BMI in a number of studies including ARIC and the Women’s Health Intiative,33, 34, 231-234 
while a high density of fast food restaurants has shown to have detrimental effects on BMI.233-237 
Differential rates of food store types by neighbourhood characteristics (i.e. neighbourhood 
deprivation, racial composition) may contribute to the differential prevalence of obesity, and 
subsequent T2DM, by race/ethnicity.238, 239  
The nearby availability of parks and other “green spaces” (i.e. walking/biking trails) is 
increasingly viewed as a target for policymakers and urban planners for promoting healthier, 
more active lifestyles in disadvantaged communities.  Proximity to parks has been linked to an 
increased frequency of, and the intensity of, physical activity,240, 241 lower BMI,242, 243and lower 
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risk of T2DM in population-based studies and large cross-sectional investigations.244   These 
health benefits are manifested even among people living in deprived neighbourhoods.245 These 
findings indicate that increased access to parks and green space may potentially reduce obesity 
and T2DM disparities.  
Walkability, a popular measure of a neighbourhood’s conduciveness to walking for both 
transportation and recreation, has been associated with attaining the daily recommended 
physical activity246, 247 and therefore, reduced rates of obesity.248-250 In addition, some research 
suggests that neighbourhood walkability improves mental health251, 252 which may also be a 
pathway by which neighbourhood determinants impact T2DM risk. Improved neighbourhood 
walkability may also increase social capital and collective efficacy.253-255  
Research on the contextual environment presents many limitations. Many of the research 
studies cited above examine residential location (where an individual lives). However, other 
locations (i.e. work) may influence individual behaviour and therefore one’s diabetes risk. 
Additionally, self-selection into neighbourhoods, also referred to as residential selection bias, 
can attenuate associations.256  
These findings underscore the importance of several measures of built environment on healthy 
behaviours, body mass index/obesity, and subsequent diabetes risk. However, not all 
racial/ethnic and/or socioeconomic groups experience the same neighbourhood environments. 
Residential segregation often results in disparate neighbourhood environments, including the 
built physical environment.257 Specifically, historical disinvestment in racially and/or 
socioeconomically segregated neighbourhoods may shape accessibility and the availability of 
neighbourhood services and amenities.258 Therefore, the location of neighbourhood amenities 
(e.g. location of food stores, recreational areas) may contribute to socioeconomic and 
racial/ethnic disparities.259   
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2.5.2 Neighbourhood deprivation 
It has previously been suggested that most of the racial/ethnic variation in T2DM is explained by 
social and economic factors at the neighbourhood-level.260 Neighbourhood socioeconomic status 
(SES) appears to be a contributor to obesity,234, 261, 262 cardiovascular disease risk factors ,263-267 
metabolic syndrome among women,264 as well as T2DM prevalence35 and incidence.31, 223 The 
neighbourhood socioeconomic environment can influence the availability of grocery stores, 
recreational facilities, and educational resources which may influence diet, physical activity and 
subsequent T2DM.  In addition, economically deprived neighbourhoods may increase exposure 
to chronic stress (i.e. noise, violence, and poverty) which is a potential risk factor for negative 
health outcomes including T2DM.268, 269 These results suggest that neighbourhood-level SES may 
modify the relationship between individual-level SES and negative health outcomes. This 
underscores the potential importance of accounting for indicators of neighbourhood deprivation 
in studies examining health disparities. 270, 271 
A landmark experimental study, the Moving to Opportunity for Fair Housing Demonstration 
(MTO) study, offered housing vouchers to low-income families living in public housing projects in 
high-poverty neighbourhoods. The experimental group were offered the vouchers to move to 
low-poverty neighbourhoods. The MTO evaluated the impact of neighbourhood poverty and 
housing mobility on physical and mental health, economic self-sufficiency, criminal behaviour, 
and educational outcomes.272 The significant finding was that the experimental group, who were 
offered the vouchers, had a reduced prevalence of obesity, morbid obesity, and diabetes 
(defined as an HbA1c ≥ 6.5). More than 90% of the households in the MTO experiment were 
headed by black or Hispanic women. This finding has powerful implications for the impact of 
neighbourhood mobility and neighbourhood poverty on racial/ethnic disparities in obesity and 
diabetes.273  
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2.5.3 Racial Segregation 
Racial residential segregation, which refers to the physical separation of racial subgroups in 
space, is widespread in the Unites States and was previously supported by the federal 
government as well as economic and social institutions.257 Although discrimination in housing 
and mortgage lending has been illegal for 50 years, explicit and implicit discrimination sustains 
high levels of segregation.274 These continuing patterns of segregation have implications for the 
social, economic and health-related well-being of the segregated minority group275-279 and are 
considered a fundamental cause of racial/ethnic health disparities.280, 281 Segregation is 
hypothesized to influence health by perpetuating disparities in education and employment 
opportunities, clustering poverty spatially, shaping the social and physical neighbourhood 
context, and the availability of healthy resources.277, 280 A few studies have examined the 
association between racial segregation and neighbourhood amenities. While some studies have 
indicated that high levels of residential segregation are associated with obesogenic 
characteristics (less access to healthy food options,231, 282, 283 greater access to unhealthy food,284 
and less open spaces for recreational activities285, 286) other studies have found that spatial 
inequalities in racial/ethnic composition and socioeconomic disadvantage do not always result in 
disparate access to physical resources.258, 287 Another potential mechanism by which segregation 
could impact health is stress. Stress related to disadvantage and discrimination can lead to 
coping behaviours such as increased sugar288 and fat intake289, 290 that may help reduce stress, 
but have adverse physical health effects. 
Much of the current diabetes disparities literature fails to account for the fact that the US is 
largely segregated both racially and economically. The strong association of race with 
socioeconomic status both on the individual- and neighbourhood- level may lead to residual 
confounding in many studies.291 One study, which examined an economically deprived but 
racially integrated neighbourhood in comparison to national data, suggested that when Blacks 
and Whites live under similar conditions, racial/ethnic disparities in many diseases, including 
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T2DM, disappear or are reduced.270 Data from NHANES examined whether racial/ethnic 
segregation was associated with obesity and found that this association only held among women 
and was not mediated by neighbourhood socioeconomic factors.292 However, data from national 
samples may be particularly susceptible to residual confounding due to overwhelming 
racial/ethnic stratification nationally.270  
While neighbourhood disadvantage and segregation may be important mediators of 
racial/ethnic disparities in T2DM there are a number of limitations in measuring these 
constructs. Measurements of neighbourhood exposures rely heavily upon the definition of 
“neighbourhood” being used.293 US Census tracts are one of the most frequently used measures 
of neighbourhood. While census tracts, when first delineated, were designed to be homogenous  
with respect to population characteristics, economic status, and living conditions,294 they may 
not correlate with an individual’s neighbourhood identification. New methods in neighbourhood 
research may alleviate some spatial misclassification. For example, the use of circulate or 
network buffers for an individual’s residential address may be less prone to this bias.293   
2.5.4 Crime, Safety and Perceived Neighbourhood Disorder 
Racial/ethnic minorities, specifically African Americans and Hispanics, are more likely to live in 
neighbourhoods with higher levels of social, physical and economic disorder, which include 
crime, graffiti, lack of trust among neighbours, abandoned buildings, and concentrated poverty 
that contribute to social instability.295, 296 Residents of neighbourhoods with high crime rates are 
less likely to walk and be physically active, particularly women and young children.259, 297-299 This 
physical inactivity likely contributes to greater risk for obesity and T2DM. There is also evidence 
that residents’ beliefs, or perceptions, about the safety of their neighbourhood may influence 
their behaviour thus influencing mediating the neighbourhood safety—T2DM risk association.300 
There are several studies that demonstrate evidence for this mediating effect. In two cross-
sectional studies, perceived neighbourhood disorder potentially mediated the associations 
between neighbourhood disadvantage and self-rated health, physical function, adolescent 
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obesity and several chronic conditions.301, 302 Reports of physical disorder (abandoned buildings, 
vacant lots, graffiti, etc.) have been shown to partly mediate the association between racial 
isolation and BMI, while incident crime was not associated with BMI.303  
2.5.5 Summary 
While there is a compelling body of research linking neighbourhood determinants to diet, 
physical activity, weight change, and obesity, the subsequent causal links towards T2DM risk 
have largely been assumed. Research detailing the complex pathways between specific aspects 
of neighbourhoods, obesity, and T2DM risk are needed.  
Our research aims to address specific limitations in contextual research thus far. To date, most 
multilevel studies of neighbourhood effects on T2DM have been limited to aggregate census 
characteristics.304 While census-derived measures, such as area poverty or racial segregation 
indices have shown important effects that persist despite adjustment for individual risk factors, 
they remain proxies for the actual physical and social characteristics of the actual 
neighbourhood. A further limitation to the use of these measures in the literature is that they 
are often used as a proxy for individual-level socioeconomic factors. Because of these 
limitations, there is still considerable debate regarding whether the associations between 
neighbourhood and T2DM reflect causal processes, and if they do, what specific aspects of 
neighbourhoods affect individual risk of T2DM. 
2.6 Social and Economic Determinants 
In this thesis, social determinants are defined as factors that involve a person’s relationships to 
other people. These include social and economic structures of society (i.e. socioeconomic status) 
as well as social supports. 
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2.6.1 Socioeconomic Status 
It is well established that health follows a social gradient—better health with increasing 
socioeconomic position.305-308 In the past three decades the socioeconomic disparity in morbidity 
and mortality has grown.309  Multiple inter-related pathways have been proposed to explain 
social inequalities in health, the most prominent mechanisms being health behaviours, 
psychosocial factors and access to material health promoting factors (i.e. healthy food, adequate 
health care).306, 307, 310-312  
A social gradient in diabetes risk has been well documented in the US313, 314 and in other 
developed nations.35, 315-317 There are many pathways and mechanisms by which race/ethnicity 
and SES can combine to affect the development of diabetes.318 Early in life, foetal exposures, 
such as poor maternal nutrition, may contribute to adult T2DM risk. Childhood socioeconomic 
circumstances may influence childhood nutrition, physical activity and illness (see Section 2.6.2). 
Later in life, adult socioeconomic position may influence T2DM risk through a range of 
mechanisms including health behaviours (i.e. physical activity and diet) and psychosocial 
conditions (i.e. increased stress) (see Section 2.6.3). Differences in access to and use of health 
care services may further contribute to socioeconomic disparities in T2DM risk as opportunities 
for early prevention (i.e. behavioural risk factor modification) may be missed.  
Studies of SES and diabetes have reported strong inverse associations between socioeconomic 
position and diabetes prevalence319, 320 and incidence,321, 322 and the US CDC has noted that these 
socioeconomic disparities in the incidence of diabetes appear to be worsening over time.323  
Several longitudinal studies have noted that socioeconomic disparities persist even after 
adjustment for lifestyle and behavioural covariates (unhealthy behaviours, obesity, and 
psychosocial factors).322 Lower education and/or low income are also associated with several 
biomarkers of T2DM including higher levels of fasting insulin, fasting glucose, waist 
circumference and poorer glucose tolerance.324  
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Socioeconomic status (SES) is highly correlated with race in the US with African Americans and 
Hispanics tending to be poorer and less educated.291, 325 Therefore, there is the potential for 
mediation by SES in research examining racial/ethnic disparities in diabetes. A few studies have 
postulated that SES explains racial/ethnic disparities in diabetes entirely.13, 30, 32  
2.6.2 Childhood Socioeconomic Status 
There is accumulating evidence that early-life socioeconomic circumstances have an effect on 
adult health outcomes. Observational studies and systematic reviews have demonstrated 
associations between childhood socioeconomic status and increased risk for obesity, coronary 
heart disease, stroke, all-cause-mortality, and T2DM.326-333 Childhood socioeconomic status has 
also been linked to several T2DM precursors including the metabolic syndrome,334, 335 insulin 
resistance,336 and elevated blood glucose.337   
2.6.2.1 Mechanisms 
There are three major mechanisms by which childhood socioeconomic status can affect health 
status in adulthood. First, early-life circumstances may have a latent effect on adult health, 
independent of socioeconomic status later in life. Second, exposure to socioeconomic adversity 
may have a cumulative (or dose-response) effect through the life-course. Third, early-life 
socioeconomic status may affect adult socioeconomic status creating a pathway effect.  
Maternal socioeconomic disadvantage is consistently associated with low birth weight, likely due 
to a clustering of risk factors including: access to prenatal care, malnutrition, smoking, alcohol 
consumption, drug use, and psychosocial stress.338-345  Low birth weight is associated with adult 
T2DM in long-term longitudinal analyses even after considering ethnicity, childhood 
socioeconomic status, adult lifestyle factors346 and adult BMI.347 Low birth weight is associated 
with “catch-up” growth in early childhood which predisposes individuals to increased incidence 
of obesity.348  
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Childhood SES is also hypothesized to “program” a vulnerable phenotype with exaggerated 
inflammatory responses, thereby increasing the risk of developing T2DM as an adult.349 Adverse 
socioeconomic circumstances have demonstrated an epigenetic effect on glucocorticoid 
signalling, which regulates the secretion of cortisol, and in turn exaggerates inflammatory 
responses.350-352 Epigenetic changes refer to modification in the patterns of gene expression 
without changing the nucleotide sequence of its DNA.353 Yet another pathway is through chronic 
psychosocial stress which is also related to alterations in inflammatory and immune activity.354 
SES differences in gene regulation of response to stress could be due to environmental and/or 
dietary influences over the life course or perhaps a direct consequence of early life 
developmental “programming.”  
The effect of lifetime socioeconomic circumstances on T2DM is partially mediated by traditional 
risk factors such as long-term obesity, physical activity, and diet.332, 355, 356 Unhealthy behaviours, 
like lack of physical activity and poor dietary patterns tend to be more prevalent among adults 
with lower SES (see Section 2.6.3). Adult family members’ health behaviours may be modelled as 
normative behaviours by children.357 Early childhood is a critical period for the ability to self-
regulate food consumption and in the development of food and flavour preferences.358  
Parent socioeconomic circumstances may also affect both the health and education 
achievement of the child which has implications for adult socioeconomic status.359 Childhood 
health also has implications for educational achievement and socioeconomic circumstances later 
in life.360 Therefore adult SES may be an important explanatory mechanism for the association 
between childhood SES and adult T2DM. While many studies demonstrate that disparities by 
childhood socioeconomic status were independent of current socioeconomic status, lifestyle 
factors, and perceived stress, it is clear the effect of social adversity is not limited to early life 
experiences. 
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2.6.3 Adult Socioeconomic Indicators 
2.6.3.1 Income, Education, and Occupation 
As mentioned previously, there is a well-documented socioeconomic gradient in T2DM. Diabetes 
incidence data show a strong inverse relationship with income, education, and occupational 
status.361 
Education is a major determinant of health and health inequalities. Education has traditionally 
been an important route out of poverty for disadvantaged groups. Education is also one of the 
most commonly used measures of SES, and a systematic review and meta-analysis indicated it 
was also the most consistently associated with T2DM.362 Higher educational attainment is 
associated with a decreased risk of T2DM363 and decreased T2DM attributed mortality.308 There 
is some evidence that educational attainment may have a greater impact on diabetes risk among 
women than among men. Data from the NHANES I Epidemiologic Follow-up Study (1971-1992), 
demonstrated that women who had more than 16 years of education had a much lower risk for 
incident T2DM compared with women who had less than 9 years of education. Among men, 
these trends were evident, but not as strong.361  
Evidence from high-income nations overwhelmingly indicates that lower education, occupation, 
and income are all associated with an increased risk of incident T2DM.362 However, even though 
education generally leads to occupations that influence level of income, it has been argued that 
these measures of SES cannot be used interchangeably as they represent different causal 
processes and pathways.364, 365  
2.6.3.2 Mechanisms 
SES likely contributes to the development of T2DM through complex processes involving access 
to health-care services and information, availability of healthy foods and places to exercise, 
economic and occupational opportunities, as well as individual behaviours.366  
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Unhealthy behaviours including lack of physical activity and unhealthy dietary patterns tend to 
be higher in adults with lower SES.367-372 The Whitehall II cohort demonstrated that modifiable 
risk factors such as health behaviours and obesity, could explain almost half of the social 
inequalities in T2DM.373 The Australian Diabetes, Obesity and Lifestyle (AusDiab) study, found 
that behavioural risk factors attenuated the associations between socioeconomic measures and 
fasting glucose by 11-70% depending on gender and the specific socioeconomic measure of 
interest (education or income).324 Unhealthy behaviours are often strongly social patterned. 
Material constraints, limited knowledge, and limited opportunities to act upon health promoting 
messages may act as barriers for lower SES populations to adopt healthier lifestyles.374-376 
However, in a meta-analysis of 21 studies on SES and T2DM, most of the included studies 
concluded that unhealthy behaviours could not fully explain the SES differences in T2DM.362 
Therefore, it is highly likely that other mechanisms are involved.  
Education may capture the transition from childhood SES to adult SES. The skills and knowledge 
attained through education may shape T2DM risk through its influence on an individual’s 
capacity to access and interpret health information including the importance of a healthy 
lifestyle.324  
Adult socioeconomic status may also affect inflammation-related gene regulation. Several 
studies, including Whitehall II and NHANES, have demonstrated greater inflammation in people 
exposed to socioeconomic adversity.377-379 Systemic inflammation is a potential mediator 
between socioeconomic status and T2DM. Biologically, inflammation affects insulin signalling 
and increases beta-cell death, and markers of chronic inflammation have been shown to be 
associated with T2DM prevalence and incidence (see Section 2.4.1). Linking together evidence 
that relates socioeconomic status to inflammation and inflammation to T2DM, research from 
the Whitehall II Cohort demonstrated that chronic inflammation explained a substantial portion 
of the association between socioeconomic status and T2DM.349 
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Psychosocial stress may also be a pathway by which SES impacts T2DM risk. Lower SES is related 
to higher stress levels380 and psychosocial stress affects the adrenal system which in turn may 
lead to T2DM (see Section 2.3.3). Allostatic load is negatively associated with education and 
income independent of race, sex, and lifestyle/behavioural factors. This suggests yet another 
potential mechanism through which SES, and SES-related stress in particular, may increase 
T2DM risk.381  
2.6.4 Health Literacy 
Low health literacy, the inability to obtain, process, and understand health information needed 
to make appropriate health decisions, is a significant challenge worldwide. Most health-related 
reading materials are written at the high school level. Whereas most US adults comprehend at 
the 7th or 8th grade level.382 The relationship between health literacy and diabetes outcomes has 
been studied in several cross-sectional studies383,384 and a randomized intervention indicated 
that improving literacy could improve T2DM outcomes.384, 385 
Limited health literacy differentially affects racial and ethnic minority groups with the proportion 
of adults with basic or below basic health literacy ranging from 28% of White adults to 65% of 
Hispanics adults.386 Health literacy may play a role in the racial/ethnic disparities observed in 
health outcomes among patients already diagnosed with diabetes.387-389 Disadvantaged 
populations are likely more vulnerable to the challenges posed by low health literacy given the 
inherent limitations posed by socioeconomic determinants and lower access to health care.  
2.6.5 Access to health care/quality of care 
Access to health care, as measured by health insurance status (insured versus uninsured) and 
visits to a healthcare provider in the past year, has been linked to a significantly higher odds 
(70%) of having undiagnosed diabetes.390 While the number of undiagnosed cases was moderate 
(N=110), this data comes from a large, nationwide, health survey (NHANES). This evidence may, 
in part, explain why racial/ethnic minorities tend to have more advanced disease at the time of 
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diabetes diagnosis, which in turn leads to adverse outcomes.391 Unequal access to health care, 
and poorer quality of care, are common explanations for racial/ethnic disparities in the 
complications of T2DM.13 Racial/ethnic minorities are more likely to lack health insurance or 
have less comprehensive health insurance coverage.13, 392-394 Minorities are disproportionately 
enrolled in health plans with poorer performance395 and there is some evidence that they 
receive inferior medical care even when they have equivalent health care coverage.395-398  
2.6.6 Acculturation 
There are 40 million foreign-born residents in the U.S., accounting for 12.9% of the current U.S. 
population.399 There has been significant research documenting differences in health status of 
immigrants versus native-born Americans in recent decades. Hispanics are the largest minority 
group in the US and experience a disproportionate burden of poverty and poor health outcomes 
including T2DM.400  
Understanding risk factors and health outcomes among Hispanics can be challenging since 
health behaviours and therefore health outcomes vary as a function of acculturation.401 
Acculturation is a multidimensional process of the adoption of host country cultural norms, 
values and lifestyles and is shaped by the cumulative experience of the interaction of individuals 
with their environments across the life cycle.402, 403  
Current research indicates that recent Hispanic immigrants tend to report healthier behaviours 
and better health than do native-born Americans, but this health advantage erodes over time.404-
407 Acculturation is associated with several negative health behaviours including: poorer 
nutrition, greater tobacco use, and substance abuse.402, 408 Specifically, higher acculturation is 
associated with lower dietary quality in terms of higher total fat and saturated fat and lower 
consumption of fruit, vegetables, grains and legumes.409, 410 This is despite the fact that 
acculturation among Hispanics is positively associated with higher socioeconomic status, greater 
access to health care, and some positive health behaviours (i.e. leisure-time physical activity).408, 
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409 Overall, the evidence suggests that acculturation may increase obesity408, 411 disparities 
among Hispanics because it is consistently associated with less-healthy dietary patterns. 
However, studies examining the association between acculturation and T2DM have shown 
mixed results,408 and results from NHANES noted that the association appeared to be modified 
by country of origin.412 The reason for this disconnect between acculturation and disparities in 
obesity versus T2DM is not known. However, several theories have been articulated. It is 
possible that higher health care access associated with acculturation among Hispanics facilitates 
access to preventive metabolic control screenings and improved prevention efforts.400 
Acculturated Hispanics also tend to have higher socioeconomic status and greater leisure-time 
physical activity, which may both in turn reduce exposure to chronic stress (Section 2.3.3) and 
therefore low-grade inflammation (Section 2.4.1), two important T2DM pathways. 
2.6.7 Discrimination 
Racism, the system of beliefs that members of specific racial/ethnic groups possess 
characteristics regarded as inferior or superior to another racial/ethnic group(s), is an added 
burden for Black and Hispanic Americans. Racism often leads toward the development of 
negative attitudes and beliefs towards racial groups (prejudice) and differential treatment of 
members of these groups by individuals and social institutions (discrimination).413 Racism and 
discrimination can adversely affect health by restricting socioeconomic opportunities and social 
mobility.318 Further, targets of discrimination often experience stress from overt discriminatory 
acts, micro-aggressions, as well as the perceptions of unfair treatment. Experiencing 
discrimination may promote distressing views of human nature, social relations, and result in a 
lower sense of control.182 
In seeking to understand why racial/ethnic disparities in health are not entirely explained by 
socioeconomic factors, social epidemiologists have pursued three major lines of inquiry: (1) that 
the measures of SES are not equivalent across race,291, 365 (2) that childhood SES and early life 
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psychosocial and economic adversity are not fully captured (Section 2.6.2), and (3) that racial 
discrimination can adversely affect health.413, 414 
Chronic racial discrimination may be a factor in racial health disparities.413 Racial discrimination 
may also exacerbate certain health conditions, in part, due to psychological stress.415 Section 
2.3.3 discusses the links between psychosocial stress and diabetes and it follows that if racial 
discrimination is causally associated with psychosocial stress416 then disparities in the experience 
of racial discrimination could amplify health disparities.  
Evidence examining the effect of racial discrimination on diabetes prevalence or incidence is 
limited. However, discrimination has been linked to poorer health outcomes among diabetics, 
including higher HbA1c levels, greater physical burden, and poorer physical function.417 
Discrimination is also associated with greater nutritional risk among Black adults418 which may 
lead to downstream health problems like diabetes. 
2.7 Conclusion 
There is an epidemic increase in obesity and diabetes in the US and around the world. While 
lifestyle and behavioural factors such as diet and exercise may play a large role in the 
creation/amplification of racial/ethnic disparities in T2DM, these explanations appear 
inadequate to explain these disparities. Racial/ethnic disparities in T2DM are a complex and 
widespread phenomenon that may be reinforced by genetics, lifestyles/behaviours, 
psychological factors, physiology, familial structure and history, as well as social, economic, and 
political factors. A greater understanding of the complexity of this causation may frame future 
research and subsequent interventions.  
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3 Methods 
3.1 Conceptual Model 
My conceptual framework, adapted from McKinlay and Marceau,419 combines a population 
health framework with a causal modelling framework to elucidate the causes of racial/ethnic 
disparities in T2DM. This model (Figure 3-1) identifies distal, intermediate, and proximate factors 
that influence T2DM. Distal factors, which may be population-level determinants, include 
population-level and individual-level social conditions (i.e. socioeconomic factors, racial/ethnic 
discrimination). The intermediate determinants of T2DM include neighbourhood- or community- 
level physical and social environments. Proximate determinants of T2DM include 
biophysiological and genetic factors as well as individual health behaviours. 
This conceptual model attempts to overcome two major constraints of modern epidemiologic 
research into T2DM disparities.14 First, rather than focusing on proximate risk factors, it moves 
the focus upstream for a more comprehensive analysis of the causes of T2DM disparities within 
the population. In Figure 3-1 distal factors are identified on the left-hand side, while more 
proximal factors are on identified on the right-hand side. Second, rather than focus exclusively 
on the individual as the site of etiologic action,14 we focus individuals in the context of their 
neighbourhood and social environments. In Figure 3-1 individual-level determinants are 
identified on the top-half of the figure, while neighbourhood-level determinants are identified 
on the lower-half of the figure. The conceptual framework can be represented as a Directed 
Acyclic Graph (DAG) which informs the development of multilevel structural equation models of 
contributors to racial/ethnic disparities in T2DM.291  
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Figure 3-1. Conceptual Model 
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3.2 The Boston Area Community Health (BACH) Survey 
The Boston Area Community Health (BACH) Survey is an epidemiologic cohort study involving a 
community-based, stratified random sample of 5,502 Boston, Massachusetts, residents. The 
baseline BACH Survey (2002-2005) was designed to explore the mechanisms conferring 
increased health risks on minority populations. To this end, the cohort was designed to include 
adequate numbers of racially/ethnically diverse (Black, Hispanic, White) men and women across 
a broad age distribution (30-79). Follow-up surveys were conducted approximately 5 (BACH II, 
2008) and 7 (BACH III, 2010) years later. The BACH Survey’s measures were designed to cover 
seven broad categories: sociodemographics, health care access/utilization, lifestyles, 
psychosocial factors, health status, physical measures, and biochemical parameters. BACH III 
(2010-2012) was designed and conducted with the aim of quantifying the relative contributions 
of these influences to racial/ethnic disparities in prediabetes. To this end, the BACH III survey 
incorporated additional measures assessing type 2 diabetes and its precursors including insulin 
resistance, beta cell function, impaired fasting glucose, prediabetes, and metabolic syndrome. 
Section 4 describes the BACH III survey design and collection in additional detail. Additional 
details regarding the specific measures used follow in Section 3.3. 
3.3 Measures 
3.3.1 Race/Ethnicity 
As discussed in chapter 3, race and ethnicity are interrelated concepts that have a long history in 
the fields of human biology and public health.420  Although the terms are often used 
interchangeably in the literature and there are no definitive definitions, race and ethnicity tend 
to have distinct meanings. Race is typically used to refer to groups that share biological 
similarities that are thought to be genetic in origin,64 whereas ethnicity refers to shared cultural 
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similarities.69 In many cases, race and ethnic groups may overlap considerably. Nonetheless, 
several researchers have argued that race and ethnicity are useful concepts when attempting to 
elucidate health disparities.421, 422   
The racial/ethnic labels used in this research are 1) non-Hispanic Black, 2) Hispanic, and 3) non-
Hispanic White. Race/ethnicity was self-reported by survey participants according to two 
separate survey questions: “Do you consider yourself to be Spanish, Hispanic, or Latino 
(Latina)?” and “What do you consider yourself to be? Select one or more of the following” with 
response categories of American Indian or Alaska Native, Asian, Black or African American, 
Native Hawaiian or other Pacific Islander, White or Caucasian, and Other (Specify). These 
questions are the standard ones used in the United States as recommended by the Office of 
Management and Budget.423 “Non-Hispanic Black” (hereafter referred to as Black) is used to 
categorize people who self-identify as “Black or African-American” and identified as “not 
Hispanic or Latino.” Hispanic is used to categorize people with Spanish or Latin American descent 
who identify as Hispanic irrespective of racial identification. White is used to categorize people 
who self-identify as “White or Caucasian” and identified as “not Hispanic or Latino.”  
Numerous authors have critiqued the reliance on race/ethnicity in the biomedical and 
epidemiologic literature as an etiologic quantity.291, 422, 424 “Race” largely represents a complex 
mixture of behavioural, environmental, and social exposures. 69, 425 For example, Black Americans 
often are poorer, have less education, are more likely to live in disadvantaged communities, and 
have less access to health care.69, 426 Because socioeconomic differences between racial groups 
are so ubiquitous, attempts to separate a “racial” effect often suffer from residual 
confounding.291 This may make it difficult to validly estimate the relative contributions of the 
“genetic” versus “other” components of race.  
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The BACH study attempted to overcome these challenges in several ways. First, the stratified, 
two-stage cluster sampling design ensured that there were sufficient numbers of Black, Hispanic, 
and White participants in the study to permit examination of conditions across the population 
subgroups of interest. Further, the sampling design resulted in a study population of Black, 
Hispanic, and White participants with overlapping socioeconomic circumstances which allows for 
better control of confounding related to socioeconomic factors. Details on the distribution of 
socioeconomic factors by race/ethnicity are given in Table 3-1. Finally, we included several non-
standard indicators of social and economic position including: neighbourhood socioeconomic 
indicators, language, country of birth, acculturation,427 discrimination,428 sense of control,429 
alienation,430 and biogeographic ancestry.  
Table 3-1. Socioeconomic Characteristics by Self-Reported Race/Ethnicity at BACH III 
 
 Black 
N=1026 
Hispanic 
N=1036 
White 
N=1093 
Total 
N=3155 
Income     
<$20,000 413 (33.7%) 621 (43.4%) 304 (20.7%) 27.0% 
$20,000 - $49,999 360 (35.3%) 307 (35.3%) 247 (18.5%) 25.1% 
≥ $50,000 252 (31.0% 108 (21.3%) 542 (60.8%) 47.9% 
Education     
Less than High School 160 (10.2%) 389 (28.0%) 69 (2.9%) 7.9% 
High school or equivalent 378 (37.0%) 346 (36.2%) 225 (16.4%) 24.4% 
Some college 28.7 (32.1%) 180 (18.8%) 204 (15.8%) 20.6% 
College or advanced 
degree 
201 (20.7%) 121 (17.1%) 595 (65.0%) 47.1% 
Census Tract SES431     
Low 448 (43.3%) 373 (37.8%) 141 (7.1%) 21.6% 
Middle 393 (45.5%) 415 (44.9%) 384 (44.7%) 45.0% 
High 90 (11.2%) 150 (17.3%) 374 (48.3%) 33.5% 
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3.3.2 Type 2 Diabetes 
3.3.2.1 Incident Type 2 Diabetes 
Most diabetes surveillance data depends on self-report.432 BACH I, II, and III used the same 
methods of self-report utilized by the CDC and NHANES.432, 433 Specifically, participants were 
asked “Have you ever been told by a health care provider that you now have or previously had 
non-insulin dependent or adult-onset diabetes Type II?” A new report of a diagnosis of T2DM 
among those reportedly T2DM-free at baseline (BACH I) was considered to represent an incident 
case of T2DM. 
3.3.2.2 Prevalent Type 2 Diabetes Including Undiagnosed T2DM 
T2DM often develops in the absence of clinical symptoms.21 Even in the presence of symptoms, 
many individuals often do not recognize them or seek care.21 Further, because of the insidious 
nature of these symptoms, physicians often do not recognize, appropriately screen for, and 
diagnose T2DM.434 Therefore, without routine screening many individuals with diabetes remain 
undiagnosed. It is estimated that 5% of the adult population of the US has undiagnosed diabetes 
accounting for 25-40% of all diabetes.3  
Undiagnosed prevalence as a fraction of total diabetes prevalence differs by race/ethnicity and 
immigration status.3 Therefore, in order to capture the true magnitude of racial/ethnic 
disparities in T2DM, I included likely cases of undiagnosed diabetes in the cross-sectional 
analyses of prevalent diabetes (BACH III).  
Prevalent diabetes was defined as a self-report of T2DM (Section 3.3.2.1) or a fasting glucose 
(FG) > 125 mg/dL or an HbA1c ≥ 6.5%. FG was measured with a HemoCue 201 point-of-care 
analyser. HbA1c was measured by Quest Laboratories in Cambridge, MA. The cut-points for FG 
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and HbA1c were based on the guidelines promoted by American Diabetes Association (ADA) for 
T2DM diagnosis (Table 3-2).  
Table 3-2. Criteria for Clinical Diagnosis of Prediabetes and 
Diabetes  
Source: ADA Standards of Medical Care in Diabetes, 201221 
 HbA1c Fasting Plasma 
Glucose 
Oral 
Glucose 
Tolerance 
Test 
Diabetes ≥ 6.5% ≥ 126 mg/dl ≥ 200 mg/dl 
Pre-Diabetes < 6.5% 
≥ 5.7% 
< 126 mg/dl 
≥ 100 mg/dl 
< 200 mg/dl 
≥ 140 mg/dl 
Normal < 5.7% < 100 mg/dl < 140 mg/dl 
 
3.3.3 Genetic Influences 
3.3.3.1 Ancestry Informative Markers 
We measured 63 Ancestry Informative Markers (AIMs), also known as single nucleotide 
polymorphism (SNPs), which are distributed across the human genome. AIMs are helpful in 
discriminating the genetic contributions of main parental ethnic groups. These AIMs were 
selected based on their ability to estimate percent African, Native American, and European 
ancestry in admixed populations similar to the profile of the BACH study (White, Black, Hispanic). 
75, 435 Samples were genotyped at the Genetic Analysis Platform (GAP) at the Broad Institute 
(Cambridge, MA) using iPLEX (Sequenom) in three batches. HapMap samples (Utah residents 
with Northern and Western European ancestry (CEU) and Yoruba in Ibadan, Nigeria (YRI)) were 
included in each batch for quality control. All Hap Map samples had 100% HapMap concordance. 
The average call rate for all assays was 97.4%; 1.6% of samples failed quality control with call 
rates <90% and two SNPs failed with call rates <90%.  
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Ancestry proportions were estimated for individual participants using ADMIXTURE Software 
(version 1.12) under the assumption of three ancestral populations (K=3).436 Representatives of 
two parental populations were included (West African (YRI) and European (CEU)) for quality 
control.  Studies with a single known, admixed population may often weight towards a specific 
ancestry. However, for these purposes, ancestry proportions were estimated blinded to self-
reported race/ethnicity. Since these SNPs were selected based on their ability to discriminate 
between African versus European ancestry or Native American versus European ancestry, each 
SNP was given an equal weight and was used to define, for each individual, the degree to which 
their whole genome is more West African, Native American, or European.  
3.3.4 Mediating Influences 
Details on the measurement of mediating factors are discussed in detail in Section 6.2.3 
(neighbourhood influences) and Section 7.3.1 (all other influences).  
3.4 Statistical Analyses 
As described in Section 4, the BACH survey has a number of novel features that pose statistical 
challenges and opportunities. This section describes several methodological issues that are 
central to the statistical analyses of the BACH data included in the thesis papers.  
3.4.1 Survey Weighting 
As mentioned in Section 4, the BACH III survey is the second follow-up instalment to the BACH 
Survey. The BACH baseline survey was designed to ensure adequate representation of Black and 
Hispanic minority groups living in Boston. To this end, a 2-stage, stratified cluster sampling 
design was used to recruit approximately equal numbers of persons in 24 pre-specified design 
groups defined according to age group (30-39, 40- 49, 50- 59, 60- 79), race/ethnicity (Black, 
Hispanic, White), and gender (male, female).437 Weighting of the BACH Survey data is therefore 
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required to “map” the sample back to the Boston population according to the 2000 US Census 
for BACH I or 2010 US Census for BACH II/III.438 
The probability of selection at baseline was estimated as the product of three sampling fractions: 
(1) 𝑓1ℎ,  the probability of selecting the census block, (2) 𝑓2ℎ𝑖, the probability of selecting a 
household within the selected block, and (3)𝑓3ℎ, the probability of retaining the household 
under the design objective of filling 24 cells (race/ethnicity by gender by age decade) equally. 
The initial weights 𝑤ℎ𝑖 were computed as the inverse probabilities of selection. 
𝑤ℎ𝑖 = 1/(𝑓1ℎ ∗ 𝑓2ℎ𝑖 ∗ 𝑓3ℎ) 
At baseline the “weighting class method”439 was used to adjust for survey non-response. This 
method assigns survey respondents and non-respondents to classes (or cells). In the BACH 
Survey there were 24 design cells (Table 3-3).  
 
Table 3-3. BACH study design (age, sex, and racial/ethnic composition of the BACH sample) 
Demographic composition of the BACH I baseline survey (2002-2005) 
 Age at baseline (years) 
 30-39 40-49 50-59 60-69 70-79 Total 
Men 614 661 509 329 188 2301 
   Black 164 224 156 103 53 700 
   Hispanic 249 229 156 92 40 766 
   White 201 208 197 134 95 835 
Women 793 835 776 517 280 3201 
   Black 259 284 249 179 96 1067 
   Hispanic 337 319 256 138 60 1110 
   White 197 232 271 200 124 1024 
Total 1407 1496 1285 846 468 5502 
 
A combined procedure was used to simultaneously adjust for design cell non-completion and 
post-stratification weighting with the target population defined as the Boston 2000 census 
population within each of the 24 cells.  The final weights for use at T1 were defined as  
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𝑊ℎ𝑖 = 𝑁𝑖𝑥 𝑤ℎ/(∑ ∑ 𝑤ℎ𝑖)
ℎ=1,12
 
to correct the weights so that they sum up to the population 𝑁𝑖  in each design cell while 
simultaneously adjusting for non-response.  
Follow-up weights (BACH II and BACH III) were calculated using the propensity weighting class 
method.438  A logistic regression model was fit using variables from BACH I and BACH II that 
informed follow-up non-response. The estimated response probabilities from these models were 
then categorized into deciles.439 The non-response weighting adjustment was then computed as 
the inverse of the response rate in the decile. Post-stratification of the weights were calculated 
to reference the 2010 census. 
The BACH Survey sampling weights are used explicitly in all statistical analyses unless otherwise 
specified. The sample weights, as well as the sampling stratum and primary sampling unit are 
specified. The sampling weights must be used to produce unbiased estimates of the Boston, 
Massachusetts population. 
3.4.2 Multiple Imputation 
Analyses of large scale cohort studies are often complicated by missing data. Data items can be 
missing due to subject refusal, subject inability or ineligibility, or due to data collection/entry 
errors.  Missing data methods, such as complete-case analysis or available-case analysis are easy 
to implement and popular, but these methods may yield biased results440 and can be inefficient 
when they reduce sample sizes.441  
Generally, less than 1% of data are missing in BACH with the exception of income which was 
missing among 3% of Whites, 4% of Blacks, and 11% of Hispanics at baseline.30 In addition, there 
is unit non-response in a number of components of the questionnaire. For example, the blood 
draw was refused by 11% of Whites, 21% of Blacks, and 22% of Hispanics. In addition, the self-
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administered questionnaires in BACH I and II which contained a number of sensitive questions, 
like erectile dysfunction (14%), were more frequently missing.442 Currently there is no consensus 
on the best approach to dealing with unit non-response. Either sub-sample reweighting or 
multiple imputation can be used.438, 439 The research team decided to proceed with multiple 
imputation to deal with unit non-response. 
The term ‘multiple imputation’ refers to the procedure of replacing each missing value by more 
than one imputed value creating multiple complete datasets.443, 444 Multiple imputation is 
gaining credence and popularity in the fields of public health and epidemiology.445-448  
There are three steps in multiple imputation: (1) choose and fit the imputation model, (2) fit the 
model of interest/analysis model to each imputed dataset, and (3) combine/pool the results 
from the multiple datasets.  
The R (R Foundation for Statistical Computing, Vienna Austria) package “Multiple Imputation by 
Chained Equations” (MICE) was used to create 15 multiply imputed datasets. 449 The MICE 
program for multilevel imputation allows for partially observed responses at the individual-level 
but does not allow for missing data at the neighbourhood-level. Since all BACH participant 
addresses are geo-coded, there are no missing neighbourhood identifications or neighbourhood-
level variables. Nonetheless, individual participant’s neighbourhood of residence were included 
in the imputation model, as were the survey weights. The imputations were conducted 
separately for each racial/ethnic by gender strata to preserve interaction effects.  
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4 Cohort Profile: The Boston Area Community Health Survey 
4.1 Introduction 
The BACH Survey, a prospective, longitudinal, cohort study of community-dwelling participants 
from Boston, Massachusetts was used for all analyses included in this thesis. This profile of the 
BACH Survey has been published in the International Journal of Epidemiology and provides 
details on the motivation for the study, participant selection procedures, follow-up, included 
measures, and key findings. 
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4.1.1 Evidence of copyright retention 
For full Author rights see: 
http://www.oxfordjournals.org/access_purchase/publication_rights.html 
Rights retained by ALL Oxford Journal Authors 
 The right, after publication by Oxford Journals, to use all or part of the Article and 
abstract, for their own personal use, including their own classroom teaching purposes; 
 The right, after publication by Oxford Journals, to use all or part of the Article and 
abstract, in the preparation of derivative works, extension of the article into book-length 
or in other works, provided that a full acknowledgement is made to the original 
publication in the journal; 
 The right to include the article in full or in part in a thesis or dissertation, provided that 
this not published commercially; 
For the uses specified here, please note that there is no need for you to apply for written 
permission from Oxford University Press in advance. Please go ahead with the use ensuring that 
a full acknowledgment is made to the original source of the material including the journal name, 
volume, issue, page numbers, year of publication, title of article and to Oxford University Press 
and/or the learned society.  
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4.2 Article Submitted 
4.2.1 Abstract 
The Boston Area Community Health (BACH) Survey is a community-based, random sample, 
epidemiologic cohort of N=5,502 Boston, Massachusetts, residents. The baseline BACH Survey 
(2002-2005) was designed to explore the mechanisms conferring increased health risks on 
minority populations with a particular focus on urologic signs/symptoms and type 2 diabetes.  To 
this end, the cohort was designed to include adequate numbers of U.S. racial/ethnic minorities 
(Black, Hispanic, White), both men and women, across a broad age distribution. Follow-up 
surveys were conducted approximately 5 (BACH II, 2008) and 7 (BACH III, 2010) years later which 
allows for both within- and between-person comparisons over time. The BACH Survey’s 
measures were designed to cover seven broad categories: sociodemographics, health care 
access/utilization, lifestyles, psychosocial factors, health status, physical measures, and 
biochemical parameters. The breadth of measures has allowed BACH researchers to identify 
disparities and quantify contributions to social disparities in a number of health conditions 
including: urologic conditions (e.g. nocturia, lower urinary tract symptoms, and prostatitis), type 
2 diabetes, obesity, bone mineral content and density, and physical function. BACH I data are 
available through The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 
Central Repositories (www.niddkrepository.org). Further inquiries can be made through the New 
England Research Institutes, Inc., website (www.neriscience.com/epidemiology). 
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4.2.2 Why was the cohort set up? 
Despite steady improvement in the overall longevity of the United States (U.S.) population,450 
racial and ethnic minorities, with few exceptions, experience higher rates of morbidity and 
mortality than non-minorities.13, 451 The reasons for these health disparities are multifactorial 
and poorly understood, but are hypothesized to reflect differences in socioeconomic status, 
lifestyle and behavioural risk factors, environmental effects, genetic influences, and access to 
healthcare. Given these competing and interrelated potential explanations for health disparities, 
there was a compelling need for research that simultaneously examined and measured these 
multiple potential explanations using a multidisciplinary approach.  
The Boston Area Community Health (BACH) Survey was designed to explore these relative 
contributions conferring increased health risks on minority populations.452 In addition to the 
primary research interests on the effects of age, sex, and race/ethnicity the BACH Survey was 
also concerned with lack of adequate health insurance, lack of access to adequate medical care, 
and how these problems influence patterns of disease. The baseline BACH Survey was initiated 
in 2002 in response to a National Institutes of Health (NIH) consensus panel recommendation 
that research on urologic and gynaecologic conditions in racial/ethnic minorities be prioritized. 
453  At that time, epidemiologic studies in the field of urology were limited by three key factors 
which the BACH Survey designed to address: (1) lack of representation of racial/ethnic 
minorities; (2) cohorts of patients who access medical care and receive a diagnosis (i.e., non-
population-based studies); (3) reliance on variably-defined and diagnosed medical conditions. 
Prior to the BACH Survey, very little was known about the basic descriptive epidemiology (i.e., 
prevalence, incidence) of urologic symptoms in the general population, or about how they vary 
by major social determinants such as race/ethnicity. The goal of the baseline BACH Survey (BACH 
I: 2002-2005) was to measure the prevalence of urologic symptoms/conditions by race/ethnicity, 
age, sex, and socioeconomic status. To this end, the BACH Survey used a random community-
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based sample of racially/ethnically diverse men and women across a broad age range (30-79 
years) from the Boston, Massachusetts population.  From the outset, this initial survey was 
intended to provide the baseline data for a longitudinal study437 and in 2008 enrolment began 
for the first follow-up survey (BACH II: 2008-2010). Enrolment in a third wave (BACH III: 2010-
2012) has recently been completed. All three waves of the BACH Survey were funded by the 
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). 
4.2.3 Who is in the cohort? 
Table 4-1. BACH study design (age, sex, and racial/ethnic composition of the BACH sample) 
Demographic composition of the BACH I baseline survey (2002-2005) 
 Age at baseline (years)  
 30-39 40-49 50-59 60-69 70-79 Total 
Men 614 661 509 329 188 2301 
   Black 164 224 156 103 53 700 
   Hispanic 249 229 156 92 40 766 
   White 201 208 197 134 95 835 
Women 793 835 776 517 280 3201 
   Black 259 284 249 179 96 1067 
   Hispanic 337 319 256 138 60 1110 
   White 197 232 271 200 124 1024 
Total 1407 1496 1285 846 468 5502 
Composition of the BACH II survey (2008-2010) 
 Age at baseline (years)  
 34-39 40-49 50-59 60-69 70-79 Total 
Men 403 480 381 245 101 1610 
   Black 105 168 120 71 22 486 
   Hispanic 150 147 105 67 22 491 
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Table 4-1. BACH study design (age, sex, and racial/ethnic composition of the BACH sample) 
   White 148 165 156 107 57 633 
Women 610 660 643 434 188 2535 
   Black 196 229 207 143 66 841 
   Hispanic 249 240 212 112 37 850 
   White 165 191 224 179 85 844 
Total 1013 1140 1024 679 289 4145 
Demographic composition of the BACH III survey (2009-2012) 
 Age at baseline (years)  
 34-39 40-49 50-59 60-69 70-79 Total 
Men 265 350 306 188 75 1184 
   Black 76 129 98 51 16 370 
   Hispanic 96 107 85 51 15 354 
   White 93 114 123 86 44 460 
Women 460 529 514 332 132 1967 
   Black 156 187 163 108 43 657 
   Hispanic 192 193 180 85 29 679 
   White 112 149 171 139 60 631 
Total 724 879 820 520 207 3151 
The BACH Survey was designed to include adequate numbers of U.S. racial/ethnic minorities 
(Black, Hispanic, and White participants) and sufficient numbers of both men and women, and to 
balance across a broad age distribution (30-79 years, by 10-year age-groups). These 
requirements were intended to permit examination of rare conditions across major population 
subgroups of interest. The final baseline sample, by design cell, is provided in Table 4-1. A total 
of 5,502 participants were recruited with similar numbers across the three racial/ethnic groups 
considered (1,767 Black; 1,876 Hispanic; and 1,859 White). 
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4.2.4 How was this sample attained? 
The sampling strategy for the BACH Survey has been 
published previously.437 Briefly, to ensure a representative 
sample, a stratified, two-stage cluster sampling design 
was employed (Figure 4-1), with census blocks as the 
primary sampling units and households as the 
secondary sampling units. Census blocks were stratified 
by minority density and high minority strata were over 
sampled to attain a sample with roughly 1/3 Black, 1/3 
Hispanic, and 1/3 White participants. The individual 
response rate, which was calculated as the number of 
participants interviewed divided by the number of 
participants for whom contact was attempted, was 
57.3%.437 
4.2.5 How often have they been followed-up?  
Two follow-up surveys to BACH have been completed. 
BACH II was initiated in 2008 with n=4,145 participants 
participating. BACH III was initiated in 2010 with 
n=3,150 participants.  
BACH II (2008-2010) 
Approximately five years after the initial BACH Survey, a total of 4,145 participants completed 
the BACH II survey representing an 80.5% retention rate (Table 4-2). The average length of time 
between the baseline and follow-up interviews was 4.8 years. Attrition between BACH I and 
Figure 4-1. Stratified, two-stage 
cluster design employed in the 
BACH study 
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BACH II was highest among racial/ethnic minorities and men. Retention rates for men were 
77.3%, 68.1%, and 82.6% among Black, Hispanic, and White men, respectively. Retention rates 
for women were 84.1%, 79.1%, and 88.1% among Black, Hispanic, and White women, 
respectively. Retention rates were higher with increasing age, with the exception of the oldest 
age group (70-79 years at baseline). Lower retention rates were observed among lower SES 
participants. 
Table 4-2. Retention and attrition of participants in the BACH Study cohorts 
 BACH I BACH II BACH III 
Respondents 5,502 4,145 3,151 
Non-respondents    
Ineligible (deceased, 
too ill to participate, 
incarcerated, etc.) 
 348 324 
Refusal  350 170 
Unable to contact  657 535 
Total eligible  5,152 3,856 
Retention as % eligible  80.5% 81.7% 
 
BACH III (2010-2012) 
Participants were approached in 2010 to participate in BACH III (2010-2012) achieving an 81.4% 
retention rate (of those completing BACH II). Overall, 65.2% of eligible BACH I participants were 
retained through BACH III. Eleven participants participated in BACH III, but not BACH II. 
The average length of time between BACH II and BACH III was 2.5 years. Retention rates were 
lowest among men from BACH II and BACH III. Retention rates (conditional on BACH II 
participation) were 81.0%, 77.8%, and 81.6% among Black, Hispanic, and White men, 
respectively; and 83.5%, 83.5%, and 82.4% among Black, Hispanic, and White women. Retention 
rates increased slightly with older age. Retention was not significantly related to SES. 
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4.2.6 Sub-studies 
In addition to the three waves of the BACH Survey, a number of sub-studies have utilized the 
BACH cohort. 
The BACH/Bone Survey is an observational research study of musculoskeletal health in 
1,219 men recruited from the parent study, BACH.454 The baseline examination occurred 
between 2002 and 2005. A follow-up survey (BACH/Bone II) is currently recruiting men 
from the original cohort to examine longitudinal changes in fall risk and bone density.  
Endothelial Function and Erectile Dysfunction (ED/EnD) is an observational research 
study conducted among 400 men participating in the BACH/Bone Survey. This study 
investigates the association between endothelial function and erectile dysfunction (ED) 
and is designed to establish the role of endothelial dysfunction in the aetiology and 
natural history of ED. The study was initiated in January 2010.  
Beneath the Urologic Iceberg is a qualitative study linked to the BACH Survey, consisting 
of focus groups and in-depth interviews. A primary objective was to explore factors 
underlying the care-seeking process for urinary symptoms.455, 456 Participants were 
randomly sampled from each of the six subgroups of the BACH sample and included 
individuals who reported one or more lower urinary tract symptoms (LUTS) on the 
survey. Fifty-eight participants participated in a total of eight focus groups. In-depth 
interviews were conducted with 151 participants. 
The Intra-Subject Hormone Variation Study was designed to measure intraindividual 
variation in hormones among men.457 Male participants (n=134) were randomly selected 
from the BACH Survey’s study strata. Two blood samples (drawn 20 minutes apart) were 
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obtained from two study visits (1-3 days apart) at study entry and again three and six 
months later.  
4.2.7 What has been measured? 
The main outcomes of interest in the first two waves were urologic symptoms and conditions. 
Extending beyond the initial outcomes of interest, the third wave of the BACH Survey focused on 
type 2 diabetes, pre-diabetes, and metabolic syndrome risk assessment. The characterization 
and explanation of social disparities (by age, racial/ethnicity, and sex) in the prevalence of 
disease has been the central focus of the BACH Survey through all three waves of the study. All 
three waves measured a number of other factors thought to contribute to the aetiology of 
disease or to mediate the relationship between social disparities (according to racial/ethnicity, 
SES, age, sex) and health outcomes (Figure 4-2). These variables can be categorized into seven 
groups: (1) sociodemographic characteristics, (2) health care access/utilization, (3) lifestyles, (4) 
psychosocial factors, (5) health status, (6) anthropomorphic measurements, and (7) biochemical 
parameters. Table 4-3 gives details of the types of information collected in each wave of the 
BACH Survey.  
Figure 4-2. Research model for the Boston Area Community Health study 
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When possible, previously validated questionnaires were utilized in the BACH Survey. 
Specifically, measures that were previously published in a peer-reviewed journal, had reported 
metric properties, were available in English and Spanish, and were already used in field 
epidemiology settings were preferred. A National Institutes of Health (NIH) scientific advisory 
committee offered recommendations on validated scales. The BACH questionnaires and project 
correspondence were translated into Spanish and then back-translated to ensure cross-cultural 
equivalence of meaning; 26% of the BACH interviews were conducted in Spanish (76% of 
interviews among Hispanics were conducted in Spanish). All protocols, questionnaires, and 
forms used in the BACH Survey were annually reviewed and approved by the New England 
Research Institutes’ Institutional Review Board.  
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Table 4-3. Measures Available from the BACH Cohort study (2002-2012) 
Variable 
BACH I 
(2002-05) 
BACH II 
(2008-10) 
BACH III 
(2010-12) 
I. Sociodemographics 
Residential address (geo-coded), mobility       
Income, education, work status, 
occupation, marital status     
  
Sociological questionnaire including: 
acculturation, alienation, neighbourhood 
order/disorder, perceived discrimination, 
health literacy 
    
II. Health Care Access/Utilization 
Health care access/utilization 
      
Health insurance status/type        
Quality of care, satisfaction with care     
Inclination to seek care      
III. Lifestyles 
Physical activity, diet       
Abuse history      
Tobacco and alcohol use       
Sleep       
IV. Psychosocial Factors 
Depressive symptoms, interpersonal 
stress, major life events 
   
Depressive symptoms, interpersonal 
stress   
   
Major life events     
V. Health Status     
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Table 4-3. Measures Available from the BACH Cohort study (2002-2012) 
Variable 
BACH I 
(2002-05) 
BACH II 
(2008-10) 
BACH III 
(2010-12) 
Quality of Life (self-rated health, current 
and projected life satisfaction)      
  
Chronic disease/events, family medical 
history, pain, fatigue, menopausal status     
  
Inventoried Prescription/Non-
prescription Medications and 
supplements 
      
VI. Physical/Anthropomorphic Measures 
Height, weight, body fat percentage, 
hip/waist circumference, blood pressure, 
pulse    
      
VII. Biochemical Parameters     
Total cholesterol, HDL, LDL, Triglycerides      
Testosterone, estradiol, SHBG, FSH, LH 
(men only) 
     
Cortisol, c-reactive protein     
Fasting blood glucose, HbA1c, insulin     
Serum aliquots stored at -80F       
Stored DNA, ancestry informative 
markers 
    
HDL=High-density lipoprotein; LDL=Low-density lipoprotein; SHBG=Sex hormone-binding 
globulin; FSH =Follicle-stimulating hormone; LH=Luteinizing hormone 
 
An interviewer-administered questionnaire and anthropomorphic measures were included as a 
part of the BACH Survey at all three time points. For BACH I and BACH II, sensitive questions such 
as sexual functioning and abuse history were ascertained through a self-administered 
questionnaire. Blood samples were taken at the first and third study waves with serum aliquots 
stored at -80ºC for future use. DNA samples were isolated from the BACH III blood samples and 
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ancestry informative markers were collected. The ancestry informative markers are a panel of 
markers informative for geographic ancestry that can identify a participant’s proportion of 
European, West African, or Native American ancestry.75, 435 DNA samples are stored for future 
use. 
4.2.8 What has it found? Key findings and publications 
The BACH Survey’s design and the breadth of measurements have allowed researchers to 
identify disparities and quantify contributions to social disparities in a number of health 
conditions; these have included racial/ethnic disparities in obesity,458 exposure to prescription 
medications,459 variation in markers of bone turnover460 and bone mineral content and 
density,461 higher rates of vitamin D deficiency,462 and physical function.463 The study has also 
explored potential explanations for these racial/ethnic disparities464 with a particular focus on 
socioeconomic status. Recent publications from BACH demonstrate that socioeconomic status 
accounts for much of the racial/ethnic disparities seen in the rates of erectile dysfunction,465 
nocturia,466 and diabetes.30, 434 These findings are of critical importance for informing prevention 
and treatment strategies.  
BACH has also contributed to the literature on gender disparities. BACH findings have suggested 
sex-specific effects in several health conditions,467 explored previously un-researched areas of 
women’s sexual health,468-470 and has contributed significantly to the literature on the effects of 
abuse.470-472 
The BACH Survey’s novel “upstream” focus has led to new estimates on the magnitude of unmet 
need for drug treatment of urological symptoms473 and has identified populations with unmet 
health insurance needs by studying both the uninsured and the underinsured.474 
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Basic epidemiologic data on health disparities (e.g. racial/ethnic specific prevalence and 
incidence) had not previously been estimated for many urologic conditions, and disparities in 
these conditions were poorly understood. The BACH Survey provided prevalence rates by 
racial/ethnicity for urine leakage,475 LUTS,476 painful bladder syndrome (PBS),465  nocturia,466 and 
prostatitis.472 The BACH Survey contributed prevalence estimates and identified risk factors for 
female sexual dysfunction,469, 470 erectile dysfunction,442, 477, 478 and symptomatic androgen 
deficiency.479 
Prior to the BACH Survey, urologic symptoms were not considered important clinical or public 
health problems. The BACH Survey helped identify an epidemic of urologic conditions and 
estimated that 52 million adults in the U.S. will have symptoms of LUTS, urine leakage, painful 
bladder syndrome, or prostatitis in 2025.480 The BACH Survey demonstrated that urologic 
symptoms were significantly associated with other major medical conditions (type 2 diabetes, 
cardiac disease, hypertension, and depression) and a dose-response relationship between the 
severity and duration of urologic symptoms and chronic illnesses was identified.481-484 Urologic 
symptoms were also shown to have a negative impact on quality of life476, 477, 485-488 with an effect 
on quality of life similar to that of having diabetes, high blood pressure or cancer.485  
Given the newfound importance of urologic symptoms and conditions, the BACH Survey’s 
estimates on the risk factors for these conditions,465, 478, 480, 481, 483, 489-491 the overlap between 
these conditions, 492-497 and the unmet medical care needs498, 499 for these conditions are 
important contributions to the field of urology.   
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4.2.9 What are the main strengths and weaknesses? 
Strengths 
The strengths of the BACH Survey stem from its community-based random sample design. The 
study, by design, includes both sexes, a wide age range (30–79 years) and includes a large 
number of minority participants, representative of Black and Hispanic populations. Key strengths 
of the BACH Survey include: (1) the wide range of measurements covering six theoretical 
domains (Figure 2), that (2) allow for both individual-level and neighbourhood-level (multi-level) 
analyses, (3) its longitudinal design which allows for within- and between- person comparisons 
over a ten year period, (4) its focus on pre-diagnostic disparities (e.g. urologic symptoms, pre-
diabetes) rather than disparities based on variably diagnosed conditions, and (5) the multi-
disciplinary approach measures the prevalence of disease through both self-report and 
physiologic (objective) confirmation. In summary, the BACH participants are well-phenotyped in 
a number of key areas (variety of measures, over time, un-diagnosed and diagnosed conditions) 
that could lead to productive collaborations in many areas where data pooling is needed. 
Representativeness and generalizability 
While geographically limited to the city of Boston, Massachusetts, the BACH Survey sample has 
been compared to other large regional (Behavioral Risk Factor Surveillance System, Centers for 
Disease Control and Prevention) and national (the National Health and Nutrition Examination 
Survey, the National Health Interview Survey) on a number of different sociodemographic and 
health-related variables. The results suggest that the BACH Survey is highly representative of the 
city of Boston and that BACH Survey estimates of key health conditions are comparable with 
national trends. One key difference is that the BACH Survey does not include a number of other 
minority groups (e.g., Asian Americans). 
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Weaknesses 
First, several key variables in the BACH Survey (e.g. history of certain medical conditions) rely on 
self-report data. Relying on self-report data is common among observational studies and 
research has shown that self-report of major medical conditions are well correlated with medical 
record review.500-503 In addition, every attempt was made to directly measure key variables (e.g. 
height, weight, blood pressure, cholesterol, fasting glucose). 
A second limitation of the BACH Survey was the exclusion of Asians from the study. While a 
sizeable minority population in the United States, Asians comprised only 7.5% of the Boston, 
Massachusetts population in 2000.504 The feasibility of recruiting and interviewing Asians for 
inclusion in the BACH Survey (e.g. interviewer language requirements) was weighed against the 
potential public health impact.  
Finally, the initial survey response rate was 57.3%. This response rate, while low, is comparable 
with response rates among other random sample cohort studies and was not entirely 
unexpected given the lengthy in-home interview (2 hours), the blood draw, and the sensitive 
nature of many of the questions. Nonetheless, the study has maintained high retention rates, 
thus presumably mitigating concerns regarding internal validity. The BACH Survey staff have 
fostered a close relationship with the study participants and with the inner-city Boston 
community. This close contact and continued communication through newsletter, holiday cards, 
and birthday cards helps to ensure a trust between the study participants and the study research 
team and staff that leads to high retention rates and good response rates to sensitive questions. 
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4.2.10 Can I get hold of the data? Where can I find out more? 
BACH I data are available through The National Institute of Diabetes and Digestive and Kidney 
Diseases (NIDDK) Central Repositories (www.niddkrepository.org). Further inquiries can be made 
through the New England Research Institutes, Inc., website 
(www.neriscience.com/epidemiology).  
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5 The Contribution of Biogeographic Ancestry and Socioeconomic Status 
to Racial/Ethnic Disparities in Type 2 Diabetes: Results from the 
Boston Area Community Health (BACH) Survey  
5.1 Introduction 
This paper examines the contribution of biogeographic ancestry to racial/ethnic disparities in 
T2DM. Biogeographic ancestry is one example of a genetic influence thought to contribute to 
disparities. Previous research has shown that careful control of socioeconomic factors is 
necessary when examining biogeographic ancestry. Keeping this in mind, I used several different 
statistical techniques to separate genetic ancestral influences from socioeconomic influences. 
This paper was accepted for publication to the Annals of Epidemiology and was published online 
in July 2014 and in print in September 2014. 
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5.2 Article Submitted 
5.2.1 Abstract 
Purpose: Racial/ethnic disparities in the incidence of type 2 diabetes (T2DM) are well 
documented and many researchers have proposed that biogeographical ancestry (BGA) may 
play a role in these disparities. However, studies examining the role of BGA on T2DM have 
produced mixed results to date. Therefore, the objective of this research is to quantify the 
contribution of BGA to racial/ethnic disparities in T2DM incidence controlling for the mediating 
influences of socioeconomic factors. 
Methods: We analyzed data from the Boston Area Community Health (BACH) Survey, a 
prospective cohort with approximately equal numbers of Black, Hispanic, and White 
participants. We used Ancestry Informative Markers to calculate the percentages of West 
African and Native American ancestry of participants. We used logistic regression with g-
computation to analyze the contribution of BGA and socioeconomic factors to racial/ethnic 
disparities in T2DM incidence. 
Results: We found that socioeconomic factors accounted for 44.7% of the excess risk of T2DM 
among Blacks and 54.9% among Hispanics. We found that BGA had almost no direct association 
with T2DM and was almost entirely mediated by self-identified race/ethnicity and 
socioeconomic factors.  
Conclusions: It is likely that non-genetic factors, specifically socioeconomic factors, account for 
much of the reported racial/ethnic disparities in T2DM incidence. 
5.2.2 Background 
Disparities in type 2 diabetes (T2DM) by race/ethnicity are a pervasive public health problem in 
the United States and worldwide. Recent estimates from the US Centers for Disease Control 
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report that, compared to White adults, the prevalence of diabetes is 77% higher among Black 
and 66% higher among Hispanic adults in the US.2  Racial/ethnic disparities have been shown to 
be associated with poorer diabetes control,6 elevated rates of diabetes-related complications,8 
higher rates of hospitalization,505 and greater health care costs.494 It has been proposed in 
several studies that genetics, specifically, biogeographic ancestry (BGA), may explain a 
substantial proportion of these disparities.80 
The concepts of genetics, race, and ethnicity are often confused.61-63 The term ‘race’ is 
commonly defined in terms of biological differences between groups assumed to have different 
biogeographical ancestries. 64Analysis of variance of genetic variation has indicated that 
approximately 75% of genetic variance is found ‘within’ racial/ethnic groups, while 10% of the 
variance is found ‘between’ races.64 Furthermore, the US Census categorizations (White, Black, 
Asian, etc.) are largely artificial constructs, as is the concept of biological race itself.63, 68In 
contrast, ethnicity is a complex multidimensional construct that reflects biological factors, 
geographical origins, historical influences, as well as social, cultural, economic factors.69  
A genetic basis for racial/ethnic differences in diabetes risk, the ‘thrifty gene’ hypothesis, was 
first proposed over 40 years ago 70. The hypothesis has been heavily criticized from several 
different perspectives,61 but has nevertheless been revived in recent years as the rapid evolution 
of science and technologies have facilitated an expansion in genetic research. Genetic studies 
have established approximately 70 loci that are associated with small increases in T2DM risk.84-86, 
506, 507 While early studies focused primarily on people of European descent, recent studies 
extended this research to Black and Hispanic populations.88-90 These studies indicate substantial 
overlap in the susceptibility loci across racial/ethnic groups signifying that common genetic 
variants contribute similarly to diabetes risk across races/ethnicities80, 85, 90, 91 and are therefore 
unlikely to explain racial/ethnic differences in diabetes risk.  
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Since T2DM has a complex genetic etiology, it may be important to account for the substantial 
heterogeneity in genetic heritage that exists in admixed populations.73-76 Individual proportions 
of European, African, and Native American ancestry can vary substantially among the commonly-
used categories of Black,73 Hispanic,75 and White.77 Several studies have suggested that the 
biologic mechanisms leading to increased T2DM risk in Black and Hispanic Americans may be 
related to genes associated with BGA.58, 64, 80 However, studies examining this hypothesis by 
measuring Ancestry Informative Markers (AIMs), a method of estimating an individual’s genetic 
marker-based race/ethnicity have produced mixed results. The Atherosclerosis Risk in 
Communities (ARIC) Study found that BGA was not associated with HbA1c among African 
Americans and found that the contributions of demographic and metabolic factors outweighed 
the contributions of BGA.79 However, an analysis of ARIC/Jackson Heart data, found that BGA 
was associated with T2DM among African Americans, a finding that was robust to adjustment 
for lifestyle and socioeconomic factors.80 Studies among Hispanic populations have similarly 
produced mixed results. In a study of Columbian and Mexican participants, the association 
between ancestry and T2DM was attenuated, if not eliminated, when adjusting for 
socioeconomic factors.36 In contrast, a study of Puerto Rican participants living in the continental 
US showed a negative association between African ancestry and prevalent T2DM.81 In one of the 
few studies to examine the associations between ancestry and diabetes risk among African and 
Hispanic Americans, the Women’s Health Initiative (WHI) found that ancestry was significantly 
associated with diabetes risk, but that socioeconomic factors attenuated the effects among 
Hispanic but not African American women.37  
In light of these conflicting findings, further research is needed in order to validly estimate the 
contributions of BGA and other factors to T2DM disparities. Therefore the objectives are two-
fold: 1) to quantify the contribution of African and Native American ancestry to racial/ethnic 
disparities in T2DM incidence, and 2) to measure the contribution of socioeconomic status to 
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racial/ethnic and BGA disparities in T2DM incidence  (Figure 5-1). The Boston Area Community 
Health (BACH) Survey 508 is uniquely positioned to address these research objectives given the 
racial/ethnic diversity of the cohort and its prospective cohort design.   
1. What is the contribution of BGA to racial/ethnic disparities in T2DM? (pink arrows) 
2. What is the indirect effect (mediation) of SES on racial/ethnic and ancestral 
disparities on T2DM?  
Figure 5-1. Research Model 
 
 
 
5.2.3 Materials and Methods 
The Boston Area Community Health (BACH) Survey 
The Boston Area Community Health (BACH) Survey is a prospective cohort study of men and 
women from Boston, Massachusetts. The BACH Survey used a random stratified cluster sample 
design to recruit 5,502 residents (2,301 men, 3,201 women) aged 30-79 years from three 
racial/ethnic groups (1767 Black, 1876 Hispanic, 1859 White). Participants completed an in-
person interview at baseline (2002-2005) and were contacted approximately five (BACH II: 2006-
2010) and seven (BACH III: 2010-2012) years later for follow-up assessments. BACH III interviews 
were conducted among 3,155 (BACH III) individuals (an 81.4% conditional retention rate).  
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At all three time points, a home visit was conducted that included anthropometric 
measurements and an in-person interview, conducted in English or Spanish, to obtain 
information about diabetes status, comorbidities, sociodemographics, and lifestyle. AIMs were 
collected at BACH III only. The detailed methods have been described elsewhere 508. All 
participants provided written informed consent and the study was approved by New England 
Research Institutes’ Institutional Review Board.  
 
Measures 
Biogeographical ancestry (BGA) 
A panel of 63 uncorrelated single nucleotide polymorphism (SNPs) were genotyped. These AIMs 
were selected based on their ability to estimate percent African, Native American, and European 
ancestry in admixed populations 75, 435. Samples were genotyped at the Genetic Analysis Platform 
(GAP) at the Broad Institute (Cambridge, MA) using iPLEX (Sequenom) in three batches. HapMap 
samples (Utah residents with Northern and Western European ancestry (CEU) and Yoruba in 
Ibadan, Nigeria (YRI)) were included in each batch for quality control. All Hap Map samples had 
100% HapMap concordance. The average call rate for all assays was 97.4%; 1.6% of samples 
failed quality control with call rates <90% and two SNPs failed with call rates <90%. Ancestry 
proportions were estimated for individual participants using ADMIXTURE Software (version 1.12 
http://www.genetics.ucla.edu/software/admixture/) using a k (the number of ancestral 
populations) of 3.   
Race/ethnicity 
Self-identified race/ethnicity was recorded using two separate survey questions as 
recommended by the Office of Management and Budget.  The racial/ethnic categories used in 
92 
 
this research are 1) non-Hispanic Black (Black), 2) Hispanic of any race (Hispanic), and 3) non-
Hispanic White (White).  
Socioeconomic status (SES) 
The individual SES indicators considered were: household income, educational attainment and 
occupation, measured at baseline. Household income, originally grouped into 12 ordinal 
categories, was collapsed into the following three categories of US dollars: <20,000, 20-49,999, 
and ≥50,000. These categories were specified a priori based on literature review. However, other 
parameterizations were considered to ensure adequate control of confounding. Educational 
attainment was categorized as: 1) less than high school; 2) high school graduate or equivalent; 
3) some college; and 4) college or advanced degree.  Current or former occupation was 
categorized as follows: 1) management, professional, sales and office occupations; 2) service 
occupations; 3) manual labor; and 4) never worked. We use the broader term ‘SES’ when 
referring to these three distinct socioeconomic factors in the aggregate, all of which are strongly 
related to overall health. 
Type 2 diabetes 
Participants were asked at baseline (BACH I) and follow-up (BACH II and III) whether a doctor or 
health care professional had ever told them that they have diabetes. Individuals diagnosed with 
diabetes at baseline were excluded from these analyses (n=432). Incident cases of T2DM were 
defined as new diagnoses of T2DM at BACH II or BACH III (n=260, 6.4%). The use of insulin or oral 
medications for diabetes was collected by medication inventory at all three time-points and 
sensitivity analyses were conducted to assess the potential for self-report bias. We also 
conducted confirmatory cross-sectional analyses using BACH III data. At BACH III prevalent 
diabetes cases were defined as fasting plasma glucose ≥ 126 mg/dL, HbA1c ≥ 6.5% or self-report 
of a diabetes diagnosis confirmed by medication inventory (Section 5.4). 
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Statistical methods 
In order to reduce the potential for bias due to missing data and to minimize reductions in 
precision,439, 509 multiple imputation was implemented for item non-response using Multivariate 
Imputation by Chained Equations (MICE) 510 in R (R Foundation for Statistical Computing, Vienna 
Austria). 822 participants (26%) were missing data on BGA (i.e. % West African, Native American, 
and European ancestry), 248 (8%) education, 184 (6%) household income, <1% occupation, and 
<1% BMI. Fifteen multiple imputation datasets were created for each racial/ethnic by gender 
combination. Analyses were replicated on the complete data and the results were essentially the 
same as those obtained from the multiple imputation. In this paper, we therefore present 
results from the multiple imputation models because the precision of the estimates is improved 
by the increased sample size, and the full data set is less likely to be subject to bias.446, 511 
Statistical analyses were performed using SUDAAN 11 (Research Triangle Park, North Carolina), 
Stata/SE Version 12 (StataCorp, College Station, Texas), and Mplus Version 7 (Muthen and 
Muthen, Los Angeles, CA). To account for the BACH survey design (a stratified, two-staged 
cluster sample including oversampling of Black and Hispanic participants),437, 508 data 
observations were weighted inversely to their probability of selection at baseline to produce 
unbiased estimates of the Boston population. Survey weights were adjusted for non-response 
bias at follow-up using the propensity cell adjustment approach,438 and post-stratified to the 
Boston census population in 2010.  
Logistic regression models were used to estimate risk ratios (RRs) and 95% confidence intervals 
(CIs) based on the predicted marginal risk in SUDAAN.  All p-values are two-sided. BMI and other 
relevant lifestyle/behavioral mediators were considered including physical activity, dietary 
patterns, alcohol consumption, high blood pressure and high cholesterol. BGA was modeled as 
the proportion of West African (ranging from 0 to 1) and Native American ancestry (also ranging 
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from 0 to 1). The RRs for 100% West African and 100% Native American ancestry versus 100% 
European ancestry are reported for ease of interpretation.  
We performed mediation analysis to assess what degree of the racial/ethnic (or ancestry) effect 
is explained by socioeconomic status (the mediating influence). The excess relative risk (ERR) 
was calculated to quantify the risk attributable to a given exposure (i.e. Black race or Hispanic 
ethnicity). The unadjusted ERR is one method to estimate the “total effect” of race/ethnicity. 
The “indirect effect” or “mediated effect” due to SES was estimated using the SES-adjusted ERR. 
An estimate of the percent of the total effect that is mediated by SES was calculated as: 
(unadjusted ERR -  adjusted ERR)/unadjusted ERR. Since BMI is likely influenced by SES (Figure 
5-1), BMI was introduced only in the SES-adjusted models and is not included in the calculation 
of mediation effects.  
There are limitations to using standard regression techniques to estimate mediation512 and 
under some circumstances, these techniques may fail to produce valid estimates. For example, 
traditional regression techniques may not adequately control for confounding between the 
mediator and the outcome513. Therefore, we also used g-computation514 to supplement the 
traditional regression techniques. The g-computation procedure estimates the total causal 
effects as well as natural direct and indirect effects513, 514. Since the g-computation procedure in 
Stata (gformula) has only been developed on an additive (risk difference) scale and does not 
currently support survey sample weights, we conducted an unweighted analysis with three 
estimates: 1) excess relative risk estimates using unweighted data (for comparison to the 
weighted estimates), 2) risk differences estimates from traditional regression techniques, and 3) 
risk differences obtained from g-computation. All models were age and gender adjusted. We 
included BMI in the g-computation estimate as an exposure dependent confounder of the 
mediator outcome association.  
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5.2.4 Results 
The demographic characteristics of the 2,723 men and women in the analytic sample are 
presented in Table 5-1. The mean and standard error (SE) time between the baseline (BACH I) 
and follow-up (BACH III) assessments was 7.2 (0.3) years. Over 25% of the sample had a 
household income < $25,000, over one-third had a high school education or less, and over two-
thirds were overweight or obese.  
We estimated individual ancestry with respect to three ancestral populations: West African, 
Native American, and European (Figure 5-2). For Black participants, the ancestral composition is 
on average 78% West African (95% CI: 75-80%), 5% Native American (4-6%), and 17% European 
(15-20%). Hispanic participants were on average 29% West African (26-33%), 22.4% Native 
American (19-26%), and 48% European (45-52%) and had the greatest degree of variability 
around these measures due to the high degree of admixture. White participants were on 
average 9% West African (8-9%), 5% Native American (4-6%), and 87% European (86-88%).  
Figure 5-2 demonstrates that while BGA (represented as % Native American and % African 
ancestry) was highly correlated with self-identified race/ethnicity, there was substantial 
variability in the individual proportions, particularly among Blacks and admixed Hispanics. For 
example, among self-identified Black participants, the minimum percentage of West African 
ancestry was 0.001% and the maximum was 99.99% (not imputed). Similarly wide ranges were 
seen for Native American ancestry (min: 0.001%, max: 80.9%) among Black participants; for 
African (min: 0.001%, max: 99.99%) and Native American (min: 0.001%, max: 99.99%) ancestry 
among Hispanic participants; and even African (min: 0.001%, max: 82.4%) and Native American 
(min: 0.001, max: 50.3%) ancestry among White participants (Figure 5-2). The overall cumulative 
incidence of T2DM over the follow-up period was 6%, with a cumulative incidence of 10% among 
Black, 6% among Hispanic, and 5% among White participants.  
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Table 5-1. Demographic Characteristics by Self-Reported Race/Ethnicity at Baseline 
 Race/ethnicity 
Number (%) 
 Black 
N=863 
Hispanic 
N=870 
White 
N=990 
Total 
N=2723 
Age     
30-39 225 (50.38) 278 (63.72) 199 (39.11) 702 (45.10) 
40-59 281 (23.27) 267 (21.34) 247 (24.34) 795 (23.69) 
60-69 210 (14.56) 198 (8.62) 260 (14.41) 668 (13.74) 
70-79 108 (7.75) 96 (4.49) 194 (13.09) 398 (10.62) 
80+ 39 (4.04) 31 (1.84) 90 (9.05) 160 (6.84) 
Gender     
Male 312 (42.57) 292 (45.77) 420 (48.33) 1024 (46.49) 
Female 551 (57.43) 578 (54.23) 570 (51.67) 1699 (53.51) 
Biogeographical Ancestry 
(mean %, SE) 
    
African 77.72 (1.25) 29.24 (1.70) 8.52 (0.46) 29.41 (1.33) 
Native American 5.01 (0.41) 22.35 (1.62) 4.93 (0.30) 7.08 (0.32) 
European 17.27 (1.19) 48.41 (1.95) 86.55 (0.54) 63.51 (1.35) 
Income     
<$20,000 372 (38.16) 552 (51.34) 237 (17.82) 1161 (27.31) 
$20,000 - $49,999 322 (38.62) 252 (35.53) 281 (26.70) 855 (30.94) 
≥ $50,000 169 (23.22) 66 (13.13) 472 (55.48) 707 (41.75) 
Education     
Less than High School 137 (11.26) 367 (36.58) 74 (4.04) 578 (9.93) 
High school or 
equivalent 375 (45.47) 293 (35.53) 235 (19.13) 903 (28.12) 
Some college 181 (22.60) 109 (12.29) 131 (11.02) 422 (14.25) 
College or advanced 
degree 170 (20.67) 101 (15.60) 550 (65.81) 821 (47.70) 
Occupation     
Professional, 
Managerial, Sales, and 
Office 449 (58.55) 270 (37.72) 735 (80.03) 1454 (69.17) 
Service  223 (21.10) 341 (36.81) 121 (8.17) 685 (15.09) 
Manual labor 180 (19.52) 209 (20.74) 118 (9.42) 507 (13.48) 
Never worked 11 (0.83) 50 (4.73) 16 (2.39) 77 (2.26) 
Neighborhood SES     
Low 581 (66.24) 482 (51.00) 255 (18.24) 1318 (34.97) 
Middle 143 (16.42) 192 (24.16) 372 (39.55) 707 (31.54) 
High 138 (17.34) 196 (24.84) 363 (42.21) 697 (33.49) 
BMI     
Normal (<25) 177 (21.48) 175 (28.01) 314 (34.39) 666 (30.18) 
Overweight (25-30) 269 (29.33) 359 (38.69) 351 (39.53) 978 (36.72) 
Obese (≥30) 417 (49.19) 336 (33.30) 325 (26.08) 1078 (33.10) 
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Figure 5-2. Biogeographical Ancestry by Self-Identified Race/Ethnicity 
 
What is the contribution of African and Native American ancestry to racial/ethnic disparities in 
T2DM incidence? 
In age and gender adjusted models, Black participants were 2.3 times as likely to report having 
developed diabetes (RR=2.3; 95% CI: 1.4-3.7) and Hispanics were 1.7 times as likely to report 
new diabetes (RR=1.7; 1.0-2.8) than White participants (Table 5-2). The excess relative risk (ERR) 
indicates that Black participants are 128% more likely, and Hispanic participants 67% more likely, 
to develop T2DM over the study period compared to White participants. Adjustment for BGA 
increased these estimates slightly and widened the confidence intervals (Black vs. White: 
RR=2.6; 0.9-7.2; Hispanic vs. White: RR=2.0; 1.1-3.8).  
We examined the relationship between 1 unit increments of African and Native American 
ancestry on incident T2DM (Table 5-3).  In age- and gender-adjusted models, the risk of 
developing T2DM was, on average, 1.6 times higher (RR= 2.6; 1.3-5.0) for an individual with 
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100% African ancestry versus an individual with 100% European ancestry. There was no 
relationship between Native American ancestry and developing T2DM (RR=1.0; 0.2-4.9). 
 
What is the contribution of socioeconomic status to racial/ethnic and ancestral disparities in 
T2DM? 
Adjusting for SES (income, occupation, and education) attenuated the racial/ethnic disparities 
(Black vs. White: RR=1.7; 0.6-5.1; Hispanic vs. White: RR=1.1; 0.6-2.2, Table 5-2). The traditional 
mediation analyses indicated that SES accounted for 64% of the total effect attributed to Black 
race and 100% of the total effect attributed Hispanic ethnicity. Further adjustment for BMI only 
changed the risk ratios slightly. Estimates adjusting for other lifestyle/behavioral factors are not 
reported since their effects were negligible (< 3%). Consistent with previous studies and with the 
results by self-report race/ethnicity, the effects of BGA were attenuated with adjustment for 
socioeconomic factors (African ancestry: RR=1.5; 0.8-3.0; Native American ancestry: RR=0.4; 0.1-
2.3, Table 5-3). The mediation analyses indicated that SES accounted for 67% of the total effect 
attributed to West African ancestry. We tested for statistical interaction between ancestry and 
socioeconomic factors and found no statistically significant interactions. 
Table 5-2. Risk Ratios for Diabetes Incidence by Self-Identified Race/Ethnicity (Longitudinal)1 
 Black vs. White Hispanic vs. White Adjusted for 
 RR CI ERR RR CI ERR  
Base model 
 
2.28 1.40-3.71 1.28 1.67 1.00-2.80 0.67 
Gender and age 
Ancestry adjusted 
 
2.57 0.92-7.19 1.57 2.02 1.07-3.80 1.02 
Gender, age, African, and 
Native American ancestry 
SES adjusted 
 
1.46 0.88-2.44 0.46 0.84 0.47-1.51 -0.16 
Gender, age, income, 
education, and occupation  
Ancestry and SES 
adjusted 
1.71 0.58-5.07 0.71 1.02 0.50-2.09 0.02 
Gender, age, African, and 
Native American ancestry, 
income, education, and 
occupation  
Ancestry, SES, and 
BMI adjusted 
1.55 0.52-4.61 0.55 1.11 0.55-2.21 0.11 
Gender, age, African, and 
Native American ancestry, 
income, education, 
occupation, and BMI 
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% mediated by 
SES2  64%   100%   
Indirect effect through 
SES/Total effect of 
race/ethnicity * 100 
1 Corresponds to the Black arrows in Figure 1 
2 % mediated (indirect effect over the total effect) is calculated as:  
((ERRBase model) – (ERRSES adjusted model )) / (ERRBase model) 
RR=Relative Risk 
ERR=Excess Relative Risk (RR-1) 
 
Table 5-3. Risk Ratios for Diabetes Incidence by Biogeographical Ancestry (Longitudinal)1 
 100% West African  
vs. 100% European 
100% Native American 
vs. 100% European 
Adjusted for 
 RR CI ERR RR CI ERR  
Base model 2.56 1.33-4.95 1.56 1.01 0.21-4.90 0.01 Gender and age 
Race/ethnicity 
adjusted 
0.86 0.19-3.94 -0.14 0.42 0.07-2.66 -0.58 
Gender, age, and self-
identified race/ethnicity 
SES adjusted 
1.52 0.77-3.01 0.52 0.43 0.08-2.31 -0.57 
Gender, age, income, 
education, and occupation 
Race/ethnicity and 
SES adjusted 0.82 0.18-3.76 -0.18 0.46 0.07-2.96 -0.54 
Gender, age, self-identified 
race/ethnicity, income, 
education, and occupation 
Race/ethnicity, SES, 
and BMI adjusted 
0.83 0.18-3.90 -0.17 0.40 0.06-2.59 -0.60 
Gender, age, self-identified 
race/ethnicity, income, 
education, occupation, and 
BMI 
% mediated by SES2 
67%   N/A4   
Indirect effect through 
SES/Total effect of 
race/ethnicity * 100 
% mediated by 
Race/ethnicity and 
SES3 
100%   N/A4   
Indirect effect through 
Race/ethnicity and 
SES/Total effect of 
race/ethnicity * 100 
1 Corresponds to the Black arrows in Figure 1 
2 % mediated (indirect effect over the total effect) is calculated as:  
 ((ERRBase model ) – (ERRRace/ethnicity and SES adjusted model )) / (ERRBase model ) 
4 The base model indicated no total effect, % mediated was not calculated 
RR=Relative Risk 
ERR=Excess Relative Risk (RR-1) 
 
The findings from the G-computation (Table 5-4, unweighted data) largely agree with the 
findings from the standard regression techniques. The g-computation estimated the proportion 
mediated by SES to be lower, indicating that 45% of the Black vs. White effect, and 55% of the 
Hispanic vs. White effect was mediated by SES. Both the traditional regression techniques and 
the g-computation indicated that African ancestry was 82% mediated by race/ethnicity and SES 
and that there was no direct effect of Native American Ancestry on T2DM.
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Table 5-4. The Total, Direct, and Indirect Effects of Race/Ethnicity and Biogeographical Ancestry on T2DM, Estimated Using 
Standard Regression Models and G-computation Using Unweighted Data 
 Excess Relative Risk Method1 Risk difference Method1 G-computation1,2 
 Black Hispanic Black Hispanic Black Hispanic 
  CI  CI  CI  CI  CI  CI 
Total effect 
0.90  0.39, 1.59 1.19  0.61, 1.98 0.05  0.03, 0.07 0.07  0.05, 0.09 0.01  
-0.002, 
0.03 
0.03  0.01, 0.04 
Direct effect 
0.42  0.01, 1.00 0.40 
-0.02, 
1.01 
0.03 
-0.009, 
0.07 
0.03  
-0.009, 
0.07 
0.008  
-0.008, 
0.02 
0.01  -0.005, 0.03 
Indirect/ 
Total effect3 
53.3%  66.4%  60.0%  42.9%  44.7%  54.9%  
 African Ancestry 
Native American 
Ancestry 
African Ancestry 
Native American 
Ancestry 
African Ancestry 
Native American 
Ancestry 
  CI  CI  CI  CI  CI  CI 
Total effect 0.84  0.29, 1.64 1.12  0.04-3.32 0.06  0.02, 0.10 0.10  -0.02, 0.22 0.05  0.02, 0.07 0.008  -0.01,0.03 
Direct effect 
0.15  
-0.49, 
1.60 
-0.28  
-0.75, 
1.09 
0.01  -0.07, 0.09 -0.03  -0.11, 0.05 0.009  -0.02, 0.04 -0.0006  -0.02, 0.02 
Indirect/ 
Total effect4 
82.1%  100.0%  83.3%  100.0%  82.1%  100.0%  
 
1 All estimates are adjusted for age and gender 
2 BMI is allowed to be an intermediate confounder in the mediator – outcome relationship 
3 The indirect/total effect is the % that of the racial/ethnic effect on T2DM that is mediated by SES 
4 The indirect/total effect is the % that of the BGA effect on T2DM that is mediated by race/ethnicity and/or SES 
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5.2.5 Discussion 
In this population-based study, we report on two key findings. First, we found that racial/ethnic 
disparities in T2DM were potentially mediated by SES, whereas BGA had no effect on this 
relationship. Second, we found that while African ancestry is significantly associated with T2DM 
incidence, a large proportion of this association was mediated by self-identified race/ethnicity 
and socioeconomic factors. These findings were consistent with the results from g-computation, 
which indicated that SES accounted for approximately half of the racial/ethnic disparities in 
T2DM incidence and nearly all of the BGA differences.  
Our estimates of the magnitude of racial/ethnic disparities in T2DM risk are in line with national 
trends 2.  In the BACH sample, the approximate 7-year incidence of T2DM was twice as high 
among Black versus White participants, and 60% higher among Hispanic versus White 
participants. In our unadjusted estimates of the effect of BGA we found that having 100% 
African ancestry versus 100% European ancestry conferred a 1.5 fold risk of T2DM. Due to the 
conflicting findings regarding BGA to date, the finding that socioeconomic status explains a large 
proportion of this association agrees with some studies36, 37, 79  but is in contrast with others.37, 80, 
81  
Race/ethnicity is a complex multidimensional construct reflecting biological factors, geographical 
origins, as well as social, cultural, and economic factors.69 These analyses indicate that while 
genetic factors, including bio-geographic ancestry, may play a role in T2DM, it is likely that the 
social, cultural, and economic facets of race/ethnicity better explain T2DM disparities in the US. 
Specifically, the lower average SES of Blacks and Hispanics in the US, compared with that of 
Whites, provides a plausible explanation for a large proportion of the excess risk of T2DM. 
Strengths and limitations 
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A potential limitation of this study is the reliance on self-report for incident diabetes outcomes. 
However, our sensitivity analyses (available as an Appendix), which use objective measures of 
diabetes status, largely agree with the data presented here. In addition, research has shown that 
self-report of major medical conditions correlate well with medical record review 501 and over 
80% of self-report incident cases were confirmed by medication inventory. Another limitation to 
this analysis is the lack of detailed information on changes in risk factors over time. While BGA 
and race/ethnicity are constant, the effects of socioeconomic and lifestyle/behavioral factors 
may be fine-tuned in a proportional hazards regression model. However, our study does provide 
evidence for a temporal effect between SES and diabetes incidence whereas many studies of 
BGA have been limited to cross-sectional 36, 80, 81 or limited measures of SES 36, 37, 81. Finally, 
although the sample is geographically limited to Boston, Massachusetts, the BACH Survey 
sample has been compared to other large regional (Behavioral Risk Factor Surveillance System) 
and national (the National Health and Nutrition Examination Survey) on a number of socio-
demographic and health-related variables.437 The results suggest that the BACH Survey estimates 
of key health conditions are comparable with national trends. 
The key strengths of this study stem from the community-based random sample design of the 
BACH Survey. To our knowledge, this is the first study to report the effects of BGA in a large 
cohort of Black, Hispanic, and White men and women. Most of the literature on the effects of 
BGA on T2DM have been restricted to one racial or ethnic group, such as African Americans 80 or 
Hispanics 36, 81 with the exception of the WHI.37 Limiting the sample to one racial/ethnic group 
may restrict on the cultural, social, and economic factors that most directly appear to influence 
T2DM. 
Another key strength of this study is the analytic strategy which was grounded in a causal 
modeling framework. The sensitivity analyses using the G-computation formula allow us to 
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estimate the total causal effect as well as natural direct/indirect effects and allowed flexibility to 
the modeling assumptions 513. 
Conclusions 
Racial/ethnic disparities in T2DM are well documented. However, it is likely that a proportion of 
the excess risk in T2DM attributed to race/ethnicity is explained by differences in social and 
economic circumstances. These results have profound implications for informing appropriate 
prevention strategies. It is likely that non-genetic factors, namely socioeconomic factors, lead to 
the observed racial/ethnic disparities in T2DM incidence, and the continued focus on genetic 
causes of disparities in T2DM is likely misplaced. Appropriate prevention strategies need to 
address the root causes for these disparities, which appear to be largely socioeconomic in 
nature. 
5.3 Supplementary Structural Equation Modelling 
In order to estimate the full pictures of the relationships between BGA, race/ethnicity, SES, BMI, 
and T2DM as depicted in Figure 5-1, we used structural equation modelling (SEM). SEM (also 
referred to as path analysis) provides several distinct advantages over traditional regression 
techniques. First, BMI could be treated as a secondary mediator of interest and allowed to 
contribute to the direct or indirect paths. Second, SES is a complex construct that is imperfectly 
measured by income, education, and occupation. In the path analysis, SES can modelled as a 
latent (indirectly observed) variable. SEMs were estimated using Mplus, which fits path and 
latent variable models using linear and logistic regression to complex survey data using 
maximum likelihood. Overall model fit was assessed using the root mean square error of 
approximation (RMSEA), which is based on comparisons between observed correlations to those 
implied by the model. By convention, models are said to fit the data well if the RMSEA is 0.08 or 
less.515 Standardized coefficients are reported (β) and are interpreted as a 1 standard deviation 
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difference in the predictor is associated with a “β” standard deviation difference in the outcome. 
Due to space limitations the following analyses were not included in the submitted paper. 
The full structural model for BGA, race/ethnicity, SES, BMI and T2DM is presented in Figure 5-3. 
 
The data fitted the a priori model well (RMSEA = 0.072). As expected, there were strong, highly 
significant relationships between BGA and an individual’s self-reported race/ethnicity (β=0.90, P 
< 0.001 for African ancestry predicting Black race and β=0.57, P < 0.001 for Native American 
ancestry predicting Hispanic race). When BGA was accounted for, Black race was not associated 
with low SES (β=-0.22, P=0.18) while Hispanic ethnicity was (β=0.81, P=0.009). Low SES (β=0.55, 
P=0.02), Native American ancestry (β=0.12, P=0.05) and Black race (β=0.51, P=0.001) were all 
associated with increased BMI and BMI had the only positive, significant association with 
incident T2DM (β=0.18, P=0.02). Although low SES did not have a significant direct effect on 
T2DM (β=0.54, P=0.08), it had a larger effect on BMI (β=0.55) and on T2DM (β=0.54), than any 
other measured construct. 
Figure 5-3. Results from the supplementary structural equation modelling 
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The SEM reinforces our findings from the submitted paper. Both the traditional regression 
techniques as well as the g-computation demonstrated that racial/ethnic disparities in T2DM 
were largely mediated through SES, whereas BGA had little effect on this relationship. However, 
the SEM clarifies this relationship by demonstrating that SES appears to influence T2DM largely 
through BMI. This finding demonstrates the complexity of the relationships between genetic, 
socioeconomic, and lifestyle/behavioural characteristics and T2DM. Chapter 7 further examines 
these complex relationships.     
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5.4 Supplementary Cross-Sectional Analysis Examining the Contribution of 
Biogeographic Ancestry and Socioeconomic Status to Racial/Ethnic Disparities in 
Type 2 Diabetes 
Peer reviewers of this paper noted that the analyses did not utilize additional data collected at 
BACH III, including fasting glucose measures which can be used to capture likely undiagnosed 
diabetes. Undiagnosed diabetes prevalence differs by race/ethnicity3 meaning that analyses of 
diagnosed illness only may underestimate the true inequality in T2DM by race/ethnicity.  To 
address these concerns, I also conducted confirmatory cross-sectional analyses of prevalent 
T2DM including undiagnosed T2DM and included them in a supplement which is in the online 
version of the published paper (http://dx.doi.org/10.1016/j.annepidem.2014.06.098) as well as 
below.  
The prevalence of diabetes was 21.8% (980 prevalent cases). In age and gender adjusted models, 
Black participants were 2.1 times as likely to have diagnosed or undiagnosed diabetes (RR=2.1; 
95% CI: 1.6-2.6) and Hispanics were 1.6 times as likely to have T2DM (RR=1.6; 1.2-2.1) than 
White participants (Table 5-5). Similar to the longitudinal findings, we found that income, 
education, and occupation accounted for much of the racial/ethnic disparity in prevalent T2DM. 
After adjustment for these socioeconomic factors the risk ratio for Black versus White 
participants was reduced to 1.6, but still remained statistically significant (95% CI: 1.2-2.0). The 
risk ratio for Hispanic versus White participants was reduced to non-statistical significance (95% 
CI: 0.7-1.3, Table 5-5).  
However, in contrast to the longitudinal findings, we found some indication that biogeographic 
ancestry contributed to the Black/White disparities in T2DM prevalence. When BGA was added 
to the age, gender, and SES adjusted models, there was a further reduction in the risk ratio for 
Black vs. White participants (RR=1.5, 95% CI: 0.9-2.5) and the effect estimate was no longer 
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significant. This could be attributed to the high degree of correlation between biogeographic 
ancestry and self-identified race/ethnicity. However, results from the SEM suggest that this 
finding is not a statistical artefact.  
1 Diabetes prevalence defined as fasting plasma glucose ≥ 126 mg/dL, HbA1c ≥ 6.5% or self-
report of a diabetes diagnosis 
2 Corresponds to the Black arrows in Figure 1 
3 The excess relative risk which is the indirect effect over the total effect is calculated as:  
100 * ((Base model -1) – (SES adjusted model - 1)) / (Base model - 1) 
 
 
 
 
 
  
Table 5-5. Risk Ratios for Diabetes Prevalence1 by Self-Identified Race/Ethnicity (BACH III 
Confirmatory Cross-Sectional Analysis)2 
 Black vs. White Hispanic vs. White Adjusted for 
 RR CI RR CI  
Base model 
 
2.05  1.59-2.63 1.57  1.18-2.11 
Gender and age 
Ancestry adjusted 
 
1.91  1.18-3.09 1.60  1.09-2.36 
Gender, age, African, and 
Native American ancestry 
SES adjusted 
 1.57  1.22-2.02 0.98  0.72-1.34 
Gender, age, income, 
education, and 
occupation  
Ancestry and SES 
adjusted 
1.49  0.89-2.50 1.02  0.67-1.56 
Gender, age, African, and 
Native American 
ancestry, income, 
education, and 
occupation  
Ancestry, SES, and 
BMI adjusted 
1.43  0.85-2.38 1.02  0.67-1.54 
Gender, age, African, and 
Native American 
ancestry, income, 
education, occupation, 
and BMI 
% Mediated by 
SES3 
45.7%   100%  
Indirect effect/Total 
effect 
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1 Diabetes prevalence defined as fasting plasma glucose ≥ 126 mg/dL, HbA1c ≥ 6.5% or self-
report of a diabetes diagnosis 
2 Corresponds to the gray arrows in Figure 1 
3 The excess relative risk which is the indirect effect over the total effect is calculated as:  
100 * ((Base model -1) – (Race/ethnicity and SES adjusted model - 1)) / (Base model - 1)  
 
Figure 5-4. Results from the Structural Equation Modelling (BACH III confirmatory cross-
sectional analysis) 
 
Table 5-6. Risk Ratios for Diabetes Prevalence1 by Biogeographical Ancestry (BACH III 
Confirmatory Cross-Sectional Analysis)2 
 West African Native American Adjusted for 
 RR CI RR CI  
Base model 2.35  1.72-3.21 1.41  0.65-3.05 Gender and age 
Race/ethnicity 
adjusted 
1.13  0.58-2.21 0.80  0.27-2.36 
Gender, age, and self-
identified race/ethnicity 
SES adjusted 
1.74  1.26-2.39 0.73  0.29-1.85 
Gender, age, income, 
education, and 
occupation 
Race/ethnicity and 
SES adjusted 
1.10  0.55-2.20 0.76  0.26-2.24 
Gender, age, self-
identified race/ethnicity, 
income, education, and 
occupation 
Race/ethnicity, 
SES, and BMI 
adjusted 
1.11  0.56-2.21 0.79  0.28-2.22 
Gender, age, self-
identified race/ethnicity, 
income, education, 
occupation, and BMI 
% Mediated by 
Self-Identified 
Race/ethnicity and 
SES3 
92.5%  100%  
Indirect effect/Total 
effect 
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The SEM for the cross-sectional analyses of BGA, race/ethnicity, SES, and BMI on T2DM is 
presented in Figure 5-4. Similar to the longitudinal analyses, when BGA was accounted for, Black 
race was not associated with low SES (β=-0.27) while Hispanic ethnicity was (β=0.79). Low SES 
(β=0.59), West African ancestry (β=-0.41) and Black race (β=0.48) were all associated with 
increased BMI. However, an important difference between the longitudinal results and the 
cross-sectional results is that lower SES (β=0.59), higher BMI (β=0.15), lower West African 
ancestry (β=-0.59), and self-identified Black race (β=0.67) were all associated a higher prevalence 
of T2DM.  
These findings could be due to an increase in statistical power due to the greater number of 
events when examining prevalent versus incident cases. Future studies should consider 
examining incident T2DM in a larger population and over a longer period of time to fully explore 
these findings. 
It is important to note that research from the BACH III Survey also demonstrated that West 
African ancestry is associated with higher fasting glucose and HbA1c among non-diabetic 
individuals.82 These results did not change with adjustment for socioeconomic indicators (the 
same socioeconomic indicators captured here). These results indicate that West African ancestry 
may play a role in a biophysiologic pathway toward T2DM. These implications will be examined 
in further detail in Chapter 7. 
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6 The role of Neighborhood Characteristics in Racial/Ethnic Disparities in 
Type 2 Diabetes: Results from the Boston Area Community Health 
(BACH) Survey 
6.1  Introduction 
This paper examines the contribution of neighbourhood factors to racial/ethnic disparities in 
T2DM. The residential addresses of BACH III participants were geocoded and merged with 
contextual information gathered from InfoUSA (geocoded addresses of supermarkets, grocery 
stores, fast food outlets, and convenience stores), the Boston Police Department (X and Y 
coordinates of violent and property crime), and the US Census Bureau (e.g. poverty, racial 
composition measured at the census tract level). The goal was to not only quantify the 
contribution of neighbourhood factors to racial/ethnic disparities in T2DM, but to also identify 
which factors contributed the most. Geospatial analyses as well as multilevel modelling 
techniques were used to address these objectives. 
This paper was accepted for publication to Social Science and Medicine and published online in 
January 2015 and in print February 2015. 
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6.2 Article Submitted 
6.2.1 Abstract 
Racial/ethnic disparities in the prevalence of type 2 diabetes mellitus (T2DM) are well 
documented and until recently, research focused almost exclusively on individual-based 
determinants as potential contributors to these disparities (health behaviours, biological/genetic 
factors, and individual-level socio-demographics). Research on the role of neighbourhood 
characteristics in relation to racial/ethnic disparities in T2DM is very limited. Therefore, the aim 
of this research is to identify and estimate the contribution of specific aspects of 
neighbourhoods that may be associated with racial/ethnic disparities in T2DM.  
Data from the Boston Area Community Health III Survey (N=2,764) was used in this study, which 
is a community-based random-sample survey of adults in Boston, Massachusetts from three 
racial/ethnic groups (Black, Hispanic, and White). We applied two-level random intercepts 
logistic regression to assess the associations between race/ethnicity, neighbourhood 
characteristics (census tract socioeconomic status, racial composition, property and violent 
crime, open space, geographic proximity to grocery stores, convenience stores, and fast food, 
and neighbourhood disorder) and prevalent T2DM (fasting glucose > 125 mg/dL, HbA1c ≥ 6.5%, 
or self-report of a T2DM diagnosis).  
Black and Hispanic participants had 2.89 times and 1.48 times the odds of T2DM as White 
participants, respectively. Multilevel models indicated a significant between-neighbourhood 
variance estimate of 0.943, providing evidence of neighbourhood variation. Individual 
demographics (race/ethnicity, age and gender) explained 22.3% of the neighbourhood variability 
in T2DM. The addition of neighbourhood-level variables to the model had very little effect on 
the magnitude of the racial/ethnic disparities and on the between-neighbourhood variability. 
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For example, census tract poverty explained less than 1% and 6% of the excess odds of T2DM 
among Blacks and Hispanics and only 1.8% of the neighbourhood variance in T2DM. 
While the findings of this study overall suggest that neighbourhood factors are not a major 
contributor to racial/ethnic disparities in T2DM, further research is needed including data from 
other geographic locations.  
6.2.2 Background 
Racial/ethnic disparities in the prevalence and incidence of type 2 diabetes mellitus (T2DM) are 
an important public health problem in the United States (US) and worldwide. Disparities are 
defined here as differences in the incidence, prevalence, mortality, and burden of diseases and 
other adverse health conditions that exist among specific population groups such as 
racial/ethnic minorities. To illustrate, compared to White adults, the prevalence of diabetes is 
77% higher among Black and 66% higher among Hispanic adults in the US.2, 433  Racial/ethnic 
disparities in diabetes are associated with poorer diabetes control,6, 7 greater diabetes-related 
complications,8, 9, 16 higher rates of hospitalization,505 and increased health care costs.494 
Extensive research has been conducted on individual-level explanations for these disparities 
including: variations in lifestyles and behaviours, biological and genetic factors, family history 
and individual-level socio-demographic characteristics. However, this prevailing paradigm, which 
puts emphasis on the individual, fails to consider contextual factors (such as residential 
neighbourhoods) which may in part explain existing disparities in T2DM.  
The notion that where we live can influence our health is not new. The influence of 
neighbourhood context on health has been the focus of an extensive body of research over the 
past decade. The worldwide increase in T2DM is largely attributed to increases in obesity (BMI ≥ 
30 kg/m2), poor diet, and physical inactivity.21, 118, 119 There is an abundance of research linking 
neighbourhood resources and precursors to/risk factors for T2DM (i.e. dietary patterns,218-220 
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physical activity,219, 221  and body mass index/obesity219, 220, 222, 516-518). However, to our 
knowledge, studies linking neighbourhood characteristics directly with T2DM are limited.31, 223-225 
Furthermore, few studies focused on the local contextual environment as a fundamental 
contributor to racial/ethnic disparities in health—including T2DM. The emerging socio-ecological 
framework attempts to identify both individual and contextual characteristics that may amplify, 
or moderate, racial/ethnic disparities in health. Neighbourhoods are a context in which 
disparities may be fostered as they possess both social and physical attributes which can affect 
the health of individuals. 
Neighbourhood Deprivation and Socioeconomic Status 
It has previously been suggested that most of the racial/ethnic variation in T2DM is explained by 
social and economic factors at the neighbourhood-level.260 Neighbourhood socioeconomic status 
(SES) appears to be an important contributor to obesity,234, 261, 262 cardiovascular disease risk 
factors ,263-267 metabolic syndrome among women,264 as well as T2DM prevalence35 and 
incidence.31, 223 The neighbourhood socioeconomic environment can influence the availability of 
grocery stores, recreational facilities, and educational resources which may influence diet, 
physical activity and subsequent T2DM.  In addition, economically deprived neighbourhoods 
may increase exposure to chronic stress (i.e. noise, violence, and poverty) which is a known risk 
factor for negative health outcomes including T2DM.268, 269 These results suggest that 
neighbourhood-level SES may modify the relationship between individual-level SES and negative 
health outcomes. This underscores the potential importance of accounting for indicators of 
neighbourhood deprivation in studies examining health disparities. 270, 271 
Racial Composition 
Contextual research on the local environment often fails to account for the fact that the US is 
largely racially segregated. Racial segregation, which refers to the physical separation of racial 
subgroups in space, is a by-product of institutional discrimination and often affects the social, 
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economic and health-related well-being of the segregated minority group.275, 276  Racial and 
socioeconomic segregation are also considered to be a fundamental cause of racial/ethnic 
disparities in health outcomes.257, 280 Racial segregation often perpetuates disparities in 
educational and employment opportunities, results in concentrated poverty, and shapes the 
social and physical contextual environment.280 These patterns of segregation are posited to 
influence obesity519 and T2DM by shaping disparities in neighbourhood environments. A few 
studies have examined the association between racial segregation and neighbourhood 
amenities. While some studies have indicated that high levels of residential segregation are 
associated with obesogenic characteristics (less access to healthy food options,231, 282, 283 greater 
access to unhealthy food,284 and less open spaces for recreational activities285, 286) other studies 
have found that spatial inequalities in racial/ethnic composition and socioeconomic 
disadvantage do not always result in disparate access to physical resources.258, 287  
Built Environment 
The term ‘built environment’ refers to the man-made surroundings of a neighbourhood (e.g. 
density of fast food restaurants, distance to nearest park, and sidewalk completeness) that may 
or may not provide the setting for healthy behaviours, including healthy eating and physical 
activity. The domains and measures of the built environment used in scientific research vary 
considerably, in part, because of the large number of features that could potentially influence 
health behaviour.229 Some aspects of the built environment, such as access to grocery stores, 
convenience stores, and restaurants, are the focus of research because they are potentially 
modifiable.230 Access to supermarkets and grocery stores are positively associated with healthy 
food behaviours such as increased fruit and vegetable intake, more healthful diets, and lower 
BMI in a number of studies.33, 34, 231-234 On the other hand, a high density of fast food restaurants 
has been associated with detrimental effects on BMI.233-237 Differential rates of local area food 
store type availability by neighbourhood characteristics (i.e. neighbourhood deprivation, racial 
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composition) may contribute to the differential prevalence of obesity, and subsequent T2DM, by 
race/ethnicity.238, 239  
The distribution of parks and other “green spaces” e (i.e. walking/biking trails) are increasingly 
viewed as a target for policymakers and urban planners for promoting healthier, more active 
lifestyles in disadvantaged communities  Proximity to parks has been linked to and increased 
frequency of and the intensity of physical activity,240, 241 lower BMI,242, 243 and lower risk of 
T2DM244.  These  health benefits are manifested even among people living in deprived 
neighbourhoods.245 These findings indicate that increased access to parks and green space may 
potentially reduce obesity and T2DM disparities.   
Crime/Safety and Neighbourhood Disorder 
Racial/ethnic minorities, specifically African Americans and Hispanics, are more likely to live in 
neighbourhoods with higher levels of social, physical and economic disorder, which include 
features such as crime, graffiti, lack of trust among neighbours, abandoned buildings, and 
concentrated poverty that contribute to social instability.295, 296 Residents of neighbourhoods 
with high crime rates are less likely to walk and be physically active, particularly women and 
young children.259, 297-299 This physical inactivity likely contributes to greater risk for obesity and 
T2DM. There is also evidence that residents’ beliefs, or perceptions, about the safety of their 
neighbourhood may influence their behaviour thus influencing (or mediating) BMI and T2DM 
risk.300 There are several studies that demonstrate evidence for this mediating effect. In two 
studies, perceived neighbourhood disorder mediated the associations between neighbourhood 
disadvantage and self-rated health, physical function, adolescent obesity and several chronic 
conditions.301, 302 Reports of physical disorder (abandoned buildings, vacant lots, graffiti, etc.) 
have been shown to partly mediate the association between racial isolation and BMI, while 
incident crime was not associated with BMI.303  
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In summary, the influence of neighbourhood context on diet, physical activity and obesity 
has been the subject of considerable research over the past decade. However, few studies have 
examined the role of neighbourhood characteristics as a fundamental contributor to 
racial/ethnic disparities in T2DM. Further, very little research has examined which specific 
aspects of neighbourhoods influence these facets of health, including T2DM.  
Research Objective 
Our research aims to fill two key gaps in the literature. First, we aim to quantify the contribution 
of neighbourhood versus individual factors to racial/ethnic disparities in T2DM. In particular, we 
aim to assess whether neighbourhood characteristics will explain a substantive proportion of the 
disparities in T2DM beyond the contribution of individual-level factors/mediators (i.e. individual-
level socioeconomic status, diet, exercise, BMI). Second, we aim to identify specific aspects of 
neighbourhoods that are associated with disparities in T2DM and measure their relative 
contributions to disparities. Specifically, we propose to examine the roles of five important 
contextual factors as potential mediators of racial/ethnic disparities: (1) neighbourhood 
socioeconomic status, (2) racial composition, (3) built environment, (4) safety, and (5) 
neighbourhood disorder.   
6.2.3 Methods 
The Boston Community Health (BACH) Survey 
The Boston Area Community Health Survey (BACH) is a longitudinal, community-based random 
sample survey of 5,502 residents (2,301 men, 3,201 women) aged 30-79 years from three 
racial/ethnic groups (Black, Hispanic, and White) in Boston, MA.508  BACH was initiated in 2002 
and was conducted in participants’ homes approximately every 5 years, with a total of three 
surveys to date. The current analysis uses cross-sectional data from the third round conducted 
between 2010 and 2012. A total of 3,155 men and women participated in BACH III. Only 
participants who had a geocodable address (99.9%) and who resided in Boston proper at the 
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third round were included in the analysis, leaving 2,764 subjects. Participants who moved out of 
Boston proper were more likely to be White (vs. Black), younger (< 45), and of higher income (≥ 
$50,000 vs. < $20,000). In all surveys, data were collected during a two-hour interview in English 
or Spanish, after written informed consent. The study was approved by New England Research 
Institutes’ Institutional Review Board. 
Address geocoding 
BACH III participants provided their house number, street name and nearest cross-street in 
addition to other geographic information (e.g. zip code). All addresses were pre-processed 
before geocoding to improve their quality. For example, addresses were cross-checked against 
previous reported addresses for misspelled street names. The ArcGIS 10.1 (ESRI, Redlands, CA) 
North America Geocode Service (ArcGIS Online) address locator was used to geocode 
participants’ addresses to the building level. Positional error for ArcGIS in comparison to aerial 
photography is on average 40 meters520 and addresses with a match rate ≥80 have been found 
to be positionally accurate in a previous study.521 All failures (match rate <80) were cross-
checked with Google Maps to assist in remedying incorrect addresses. Geocoded residences 
were then used to link participants with 2010 US census tract-level data. BACH III participants 
were located within 155 of the 179 census tracts within Boston. We used census tracts as the 
primary measure of the contextual unit following conventions established in previous studies of 
neighbourhoods and health,522 including in Boston.258, 285 Census tracts generally contain 2500-
8000 people and when first delineated, were designed to be homogeneous with respect to 
population characteristics, economic status, and living conditions.294  Neighbourhood 
socioeconomic status, neighbourhood racial composition, neighbourhood recreational open 
space and neighbourhood crime were measured at the census tract level.  
Neighbourhood measures 
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Neighbourhood Socioeconomic Status (SES). Neighbourhood SES was based on methods used by 
Diez-Roux.431  A composite index Z-score was created for census tract based on six measures 
including: log median household income; log median value of owner occupied housing; percent 
of households receiving interest, dividend or net rental income; percent of adults 25 and over 
with a high school degree; percent of adults 25 and over with a college degree; and percent of 
individuals ages 16 and over in management and professional occupations. An increasing score 
signifies increasing neighbourhood socioeconomic advantage. Census tracts were designated as 
low, middle, or high SES according to the tertiles of the Z-score.263 Census tract poverty was 
categorized using standard categories: less than 5% poverty, 5-9.9% poverty, 10-19.9% poverty, 
and 20% or greater poverty.523  
Neighbourhood racial composition. The percentages of non-Hispanic Black, non-Hispanic White, 
and Hispanic residents in a census tract were used to measure racial composition (surrogates for 
residential segregation) and have been used in previous research.285, 295  
Recreational open space. The percentage of recreational open space per census tract was 
estimated from shapefiles obtained from the Massachusetts Office of Geographic Information 
(MassGIS).524 This data layer of outdoor recreational facilities includes parks, playing fields, 
school fields, and playgrounds, whether privately or publicly owned. 
Crime. Crime incident reports provided by the Boston Police Department were downloaded from 
the City of Boston website at https://data.cityofboston.gov/. Data were coded using conventions 
described by others.525 The property crime rates in 2010-2011 were calculated as the number of 
offenses of burglary, larceny, and motor vehicle theft per 1,000 population. Violent crime was 
calculated as murder, robbery, and assault (including sexual assault) per 1,000 population. 
Food environment. Data on food establishments located in the Boston metro area were 
purchased from InfoUSA Inc., a proprietary information service. Food environment was 
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operationalized as the distance to the closest grocery store, convenience store, and fast food 
restaurant from each participant’s residence.526, 527  
Neighbourhood disorder. Social and physical neighbourhood order and disorder were measured 
using the “Perceived Neighbourhood Disorder” scale developed by Ross and Mirowsky.528 Social 
disorder refers to people hanging around on the streets, drug and alcohol use, trouble with 
neighbours, and a general perception of lack of safety. Physical disorder refers to graffiti, 
vandalism, abandoned buildings, cleanliness, and maintenance of homes and apartments. The 
physical and social disorder indices were created by reverse coding “order” items and summing 
the six items in each subscale with higher scores indicating greater perceived disorder.182, 430 
Individual Factors 
Race/ethnicity. Race/ethnicity was self-reported by survey participants according to two 
separate survey questions: “Do you consider yourself to be Spanish, Hispanic, or Latino 
(Latina)?” and “What do you consider yourself to be? Select one or more of the following” with 
response categories of American Indian or Alaska Native, Asian, Black or African American, 
Native Hawaiian or other Pacific Islander, White or Caucasian, and Other (Specify). These 
questions are the standard used in the US as recommended by the Office of Management and 
Budget.423 Consistent with our previous work,437 the racial/ethnic categories used in this 
research are 1) non-Hispanic Black (Black), 2) Hispanic of any race (Hispanic), and 3) non-
Hispanic White (White). 
Socioeconomic Status (SES). The individual SES indicators considered were: self-reported 
household income, educational attainment and occupation. Household income was collapsed 
into three categories of US dollars: <20,000, 20-49,999, and ≥50,000. Education was categorized 
as less than high school, high school graduate or equivalent, some college, and college or 
advanced degree were combined due to smaller numbers.  Current or former occupation was 
122 
 
categorized into four groups: (1) management, professional, sales and office occupations; (2) 
service occupations; (3) manual labour which includes construction, maintenance, farming, 
production, and transportation occupations; and (4) never worked. We use the broader term 
‘SES’ when referring to these three distinct socioeconomic factors in the aggregate, all of which 
have strongly been related to overall health.529 
Lifestyle/Behavioural Factors. BMI was measured by trained field interviewers during an in-home 
visit. Physical activity was categorized as low, moderate, or high using the Physical Activity Scale 
for the Elderly (PASE).530-532 Participants completed the Block 2005 food frequency questionnaire 
to assess dietary patterns.533, 534 Diet was operationalized as indicator variables representing 
intake of vegetables, fruit, meat and grain servings per the USDA MyPyramid.535  
Type 2 Diabetes (T2DM)  
Trained field interviewers (phlebotomists) collected fasting blood samples in BACH III using a 
HemoCue 201 point-of-care analyser. Self-reported diabetes status was identified by affirmative 
answers to the question, “Have you ever been told by a health care provider that you now have 
or previously had non-insulin dependent or adult-onset diabetes Type II?” The primary outcome 
for this study was operationalized as fasting glucose > 125 mg/dL, HbA1c ≥ 6.5% or self-report of 
a diabetes diagnosis.21  
Statistical Methods 
Descriptive statistics of the study population were calculated in SUDAAN 11 (Research Triangle 
Park, North Carolina). ArcGIS 10.1 (ESRI, Redlands, CA) was used to geocode participants’ 
addresses, measure distances, link individual to contextual data, and visually inspect the data for 
potential spatial patterns. We assessed the presence of overall spatial dependence in diabetes 
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with the Global Moran’s I statistic, a common test statistic for spatial autocorrelation, using the k 
nearest neighbour (KNN) method. 
We applied two-level random intercepts logistic regression to assess the associations between 
individual-level race/ethnicity, neighbourhood characteristics and T2DM. Multilevel regression 
methods accommodate clustering of participant observations within their census tract of 
residence.  Multilevel models were constructed in steps of increasing complexity. First, an 
intercept-only model was constructed to quantify the between neighbourhood variance (σ2B) of 
the outcome and to test for significant variation in T2DM by neighbourhood. A pseudo intra-
class correlation coefficient (ICC) was computed using the latent variable approach to 
approximate the ICC for a binary outcome, where the within-neighbourhood variance for a 
standard logistic regression is π2/3. The ICC roughly quantifies the amount of variability in T2DM 
attributable to the neighbourhood level relative to the sum of within (σ2W= π2/3) and between 
neighbourhood variances (σ2BW) (i.e. total variability) (ICC = [σ2B/( π2/3 + σ2B)])536.  
Next, multilevel random intercepts models were constructed, with individual-level predictors 
modelled as fixed effects, to examine the influence of neighbourhood characteristics on 
racial/ethnic disparities in T2DM.  We first included exogenous demographic variables 
(race/ethnicity, gender, and age), and then individual-level socioeconomic factors, both are 
hypothesized to influence neighbourhood of residence and therefore neighbourhood exposures. 
Next, lifestyle factors, hypothesized to be influenced by neighbourhood exposures and to be 
potential mediators, were added to the model. Finally, individual- and neighbourhood-level 
contextual factors were added to the demographic and socioeconomic adjusted random 
intercepts models. At each step two metrics were evaluated. First, the magnitude of the 
racial/ethnic disparities (ORs) were evaluated to determine the contribution of the individual- 
and neighbourhood- factors to racial/ethnic disparities in the prevalence of T2DM.  Comparing 
these ORs allows us to evaluate whether individual- and/or neighbourhood- level factors 
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mediate or “explain” a proportion of the racial/ethnic disparities in T2DM.537, 538 Second, the 
proportion of neighbourhood variability in T2DM that was explained by the model was calculated 
to determine whether neighbourhood variation persisted after accounting for these factors. 
Next, a parsimonious multilevel model was constructed by first including all variables marginally 
associated (p < 0.20) with T2DM in bivariate analyses. The model was then purposefully reduced 
to all individual- and neighbourhood-level factors either: 1) proving to have a confounding or 
mediating effect on the main determinant (race/ethnicity) outcome (T2DM) relationship (> 
10%); or 2) were marginally significant in bivariates with the outcome (T2DM) (p < 0.20). All 
multilevel models were estimated using Mplus Version 7 (Muthen and Muthen, Los Angeles, CA). 
Residuals from the final regression model were tested using the Global Moran’s I for evidence of 
spatial autocorrelation.  
In order to minimize reductions in precision, multiple imputation was implemented using the 
Multivariate Imputation by Chained Equations (MICE)510 algorithm in R.539 Fifteen multiple 
imputation datasets were created. Imputations were conducted separately for each racial/ethnic 
by gender combination to preserve interaction effects, and the complex survey sample design 
was taken into account. 17% of participants were missing household income and 21% were 
missing dietary data. The proportion of missing data on other covariates was low with 9% having 
ambiguous diabetes status and less than 1% missing education, occupation, or weight. BACH’s 
sampling design requires weighting observations inversely proportional to their probability of 
selection for results to be generalizable to the base population.438, 540 Sampling weights were 
post-stratified in order to produce estimates representative of the Black, Hispanic, and White 
population of Boston, MA between the ages of 34 and 88 years (based on the 2010 US Census). 
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6.2.4 Results 
The study population consisted of 2,764 BACH III participants (33.6% Black, 33.9% Hispanic, 
32.5% White) living in 155 census tracts. The average age of participants was 55.9 years. Sample 
characteristics by race/ethnicity are shown in Table 6-1. Black and Hispanic participants tended 
to have lower incomes, less education, and live in neighbourhoods (census tracts) with lower SES 
and higher poverty. Black participants tended to live in high minority neighbourhoods; 54.9% 
lived in neighbourhoods where >75% of residents were non-White and 39.7% lived in 
neighbourhoods where 25-75% of residents were non-White (Table 6-1 and Figure 6-1). Hispanic 
participants were more likely to live in mixed-race (25-75% non-White) neighbourhoods (57.2%) 
followed by high (>75% non-White) minority neighbourhoods (34.7%). White participants 
tended to live in mixed-race (25-75% non-White, 49.3%) or low minority (<25% non-White, 
48.0%) neighbourhoods (p<0.001).  
 
Table 6-1. Characteristics of the BACH III study population overall by diabetes status 
(N=2,764) 
 Overall 
N=2764 
Black 
N=929 
Hispanic 
N=937 
White 
N=898 
Individual characteristics     
Age (continuous)1 55.89 (0.53) 53.99 (0.69) 50.58 (0.59) 57.80 (0.74) 
Age (categorical)2     
34-44 406 (29.85) 138 (33.88) 171 (44.93) 97 (24.47) 
45-54 741 (26.23) 286 (27.25) 262 (28.31) 193 (25.26) 
55-64 813 (19.09) 261 (20.03) 281 (14.88) 271 (19.55) 
65-74 536 (13.97) 165 (12.08) 161 (8.28) 210 (16.19) 
75-88 272 (10.86) 81 (6.77) 63 (3.60) 128 (14.53) 
Gender, % Male 1019 (44.57) 327 (40.96) 318 (45.39) 374 (46.19) 
BMI (continuous)2 29.64 (0.23) 31.26 (0.41) 29.96 (0.31) 28.75 (0.29) 
BMI (categorical)     
Normal 551 (24.33) 168 (18.76) 137 (16.99) 246 (28.75) 
Overweight 934 (34.64) 295 (31.36) 338 (38.74) 301 (35.37) 
Obese 1283 (41.03) 468 (49.88) 463 (44.26) 352 (35.88) 
Diet     
3-4 Vegetable servings  277 (11.83) 114 (10.98) 46 (4.19) 116 (13.96) 
2-3 Fruit servings 382 (17.90) 126 (12.67) 90 (12.76) 166 (21.66) 
2-3 Meat servings 590 (22.41) 177 (20.59) 209 (22.87) 205 (23.22) 
6-11 Grain servings 401 (18.15) 115 (12.61) 117 (16.80) 169 (21.22) 
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Table 6-1. Characteristics of the BACH III study population overall by diabetes status 
(N=2,764) 
 Overall 
N=2764 
Black 
N=929 
Hispanic 
N=937 
White 
N=898 
Physical activity     
Low 1132 (34.67) 378 (33.63) 399 (33.03) 355 (35.56) 
Medium 1288 (50.16) 417 (48.47) 432 (51.25) 439 (50.76) 
High 348 (15.17) 136 (17.90) 107 (15.72) 105 (13.68) 
Income     
<$20,000 1234 (30.50) 389 (36.26) 581 (47.34) 265 (23.86) 
$20,000 - $49,999 801 (26.62) 321 (34.90) 271 (35.64) 209 (20.46) 
≥ $50,000 733 (42.87) 221 (28.83) 87 (17.01) 425 (55.68) 
Education     
Less than High School 560 (8.73) 146 (11.06) 363 (30.40) 51 (2.73) 
High school or 
equivalent 
867 (27.11) 348 (38.15) 318 (39.60) 201 (18.79) 
Some college 579 (20.63) 258 (30.86) 151 (15.79) 170 (16.58) 
College or advanced 
degree 
762 (43.53) 179 (19.92) 106 (14.21) 477 (61.90) 
Occupation     
Professional, 
Managerial, Sales, and 
Office 
1328 (63.10) 473 (54.78) 227 (31.61) 628 (74.29) 
Service  715 (18.85) 246 (24.46) 338 (31.95) 131 (13.12) 
Manual labour 495 (13.92) 180 (17.48) 206 (21.85) 109 (10.36) 
Never worked 229 (4.13) 32 (3.28) 166 (14.58) 31 (2.23) 
Census Tract (CT) Characteristics 
Number of census tracts 155 111 115 126 
CT SES     
Low 962 (21.57) 448 (43.31) 373 (37.83) 141 (7.05) 
Middle 1192 (44.95) 393 (45.51) 415 (44.89) 384 (44.68) 
High 614 (33.48) 90 (11.18) 150 (17.28) 374 (48.27) 
CT Poverty     
< 5% 160 (9.57) 11 (0.79) 18 (1.61) 131 (15.76) 
5-9.9% 280 (13.21) 37 (3.43) 81 (6.24) 162 (19.68) 
10-19.9% 792 (35.55) 240 (31.36) 216 (28.02) 336 (39.34) 
≥ 20% 1535 (41.66) 643 (64.42) 623 (64.13) 269 (25.22) 
CT racial composition, 
continuous 
    
% Black 28.03 (1.14) 51.98 (1.89) 36.23 (2.04) 14.19 (0.98) 
% Hispanic 16.62 (0.53) 19.71 (0.76) 25.89 (1.02) 13.38 (0.62) 
% White 52.11 (1.30) 26.80 (1.69) 37.90 (1.89) 67.98 (1.36) 
CT racial composition, 
categorical 
    
> 75% non-White 863 (20.75) 531 (54.93) 299 (34.72) 33 (2.70) 
25-75% non-White 1439 (47.67) 357 (39.67) 564 (57.15) 518 (49.34) 
< 25% non-White 462 (31.57) 41 (5.40) 74 (8.14) 347 (47.97) 
Property crime per 1,000 6.35 (0.29) 7.22 (0.24) 7.44 (0.55) 5.67 (0.42) 
Violent crime per 1,000 74.75 (3.18) 94.49 (3.31) 91.55 (5.90) 61.10 (4.46) 
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Table 6-1. Characteristics of the BACH III study population overall by diabetes status 
(N=2,764) 
 Overall 
N=2764 
Black 
N=929 
Hispanic 
N=937 
White 
N=898 
Built environment Average 
distance to closest…, in 
miles 
    
Grocery Store 0.30 (0.01) 0.30 (0.01) 0.26 (0.01) 0.31 (0.02) 
Convenience Store 0.23 (0.01) 0.23 (0.01) 0.20 (0.01) 0.24 (0.01) 
Fast food 0.42 (0.02) 0.44 (0.01) 0.40 (0.02) 0.42 (0.02) 
CT % open space, 
continuous 
0.08 (0.01) 0.06 (0.01) 0.07 (0.01) 0.09 (0.01) 
CT open space, categorical     
≤ 5% 1393 (47.95) 518 (58.36) 501 (55.80) 374 (41.73) 
5.1-10% 686 (26.66) 198 (20.46) 229 (22.02) 259 (30.36) 
10.1-20% 440 (16.07) 146 (14.45) 141 (15.28) 153 (16.96) 
> 20% 245 (9.32) 67 (6.74) 66 (6.90) 112 (10.96) 
Physical disorder 13.67 (0.14) 14.27 (0.22) 14.52 (0.24) 13.18 (0.20) 
Social disorder 14.07 (0.16) 15.50 (0.26) 15.36 (0.29) 13.06 (0.21) 
1 Mean and standard error presented for continuous variables  
2 n and column percent presented for categorical variables 
CT= census tract 
 
Figure 6-1. Boston Area Community Health (BACH) III Survey participants by 
race/ethnicity by the racial composition of census tracts in Boston, MA 
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Overall, 892 (22.8%) of participants had diabetes (64.9% diagnosed, 35.1% undiagnosed). Black 
(33.3%) and Hispanic (23.5%) participants were more likely to have diabetes than White participants 
(18.0%, p<0.001).The prevalence of diabetes was higher among individuals with lower income 
(p<0.001), less education (p<0.001), and with non-professional occupations (p<0.001, bivariate 
results not shown). Diabetes was more prevalent among individuals living in low (34.1%) or middle 
(40.7%) SES neighbourhoods (p=0.002), high poverty neighbourhoods (48.0% among participants 
living in neighbourhoods with ≥20% of residents living in poverty, p=0.02), and greater minority 
populations (p=0.003). Participants with diabetes were more likely to perceive their neighbourhood 
as socially disordered (i.e. people hanging around on the streets, drug and alcohol use, trouble with 
neighbours, and a perception of lack of safety, p=0.003). 
There appeared to be a spatial pattern in the distribution of T2DM (Figure 6-2, map a). This was 
confirmed statistically via the Global Moran’s I statistic (I=0.09, p=0.03). Figure 6-2, maps b-d 
demonstrate the patterning of SES, poverty and % White in Boston measured at the census tract 
level. The Global Moran’s I statistic evaluating spatial autocorrelation in the ordinary multilevel 
model of census tract-level poverty on T2DM, however, indicated no significant positive 
autocorrelation (I=0.003, p=0.77). Therefore analyses proceeded using ordinary multilevel models as 
opposed to spatial autoregressive models. Multilevel models indicated a significant between-
neighbourhood variance estimate of σ2B = 0.943, providing evidence of geographic variation in 
T2DM (Table 6-2). The ICC indicated that 22.3% of the total variability in T2DM is due to variation 
between neighbourhoods, while the remainder of the variation in T2DM is due to variation within 
neighbourhoods (i.e. individual variation). With the addition of individual-level demographic 
variables (Model 1: race/ethnicity—our primary determinant of interest--age, and gender) to the 
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model, between-neighbourhood variance (σ2B) persisted but was reduced by 22.3% [(0.943- 
0.733)/0.943 x 100%]. In other words, the composition of the neighbourhood (i.e. clustering of 
demographic characteristics by neighbourhood) explained 22.3% of the neighbourhood variability in 
T2DM. Racial/ethnic disparities in T2DM were large, with Black participants having 2.89 times the 
odds of having T2DM as White participants (95% CI: 1.20-3.97) and Hispanic participants having 1.48 
times the odds (95% CI: 1.91-3.51).  With the addition of individual-level socioeconomic factors 
(Model 2), neighbourhood variation in T2DM was further reduced so that nearly 31.9% of the 
between-neighbourhood variability was explained by these factors. The excess odds of diabetes 
among Black participants was reduced by 34.4%, and the excess odds among Hispanic participants 
by 69.8%, with the introduction of individual socioeconomic factors (ORBlack vs. White=2.24, 95% CI: 
1.61-3.13; ORHispanic vs. White=1.48, 95% CI: 1.03-2.12). Further inclusion of all individual lifestyle factors 
marginally associated with T2DM (physical activity, grains servings, and BMI) had little impact on 
between-neighbourhood variability in T2DM or the magnitude of the racial/ethnic disparities (Table 
6-2, Models 3 and 4). The addition of neighbourhood-level variables to the model had very little 
effect on the magnitude of the racial/ethnic disparities and on the between-neighbourhood 
variability (Models 5-10). For example, the addition of census tract poverty (Model 5) explained less 
than 1% of the excess odds of T2DM among Blacks and 6% of the excess odds among Hispanics and 
explained only 1.8% of the neighbourhood variance in T2DM. 
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Figure 6-2. The Distribution of T2DM, Socioeconomic Status, Poverty, and Minority Status in 
Boston, Massachusetts 
 
 
 
 
  
a. The distribution of T2DM prevalence in 
Boston, MA as measured by the BACH 
Survey 
b. The distribution of socioeconomic status 
by census tracts in Boston, MA 
c. The distribution of poverty by census 
tracts in Boston, MA 
d. The racial composition of census tracts in 
Boston, MA 
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Table 6-2. Within and between neighbourhood variance estimates from null and adjusted 
multilevel models of diabetes from the Boston Area Community Health Survey 
  
OR (95% CI) 
Black vs. White 
OR (95% CI) 
Hispanic vs. 
White 
σ2betwe
en 
% of neigh-
bourhood 
variance 
explained 
ICC1 
Null Model (intercept only)   0.943 -- 0.223 
Random Intercept Models (Individual-level 
variables only) 
    
Model 1: Race/ethnicity, 
Age, Gender 
2.89 (1.20-3.97) 2.59 (1.91-3.51) 0.733 22.3 0.182 
Model 2: Model 1 + 
Socioeconomic factors 
2.24 (1.61-3.13) 1.48 (1.03-2.12) 0.642 31.9 0.163 
Model 3: Model 2 + BMI 2.33 (1.66-3.29) 1.74 (1.20-2.52) 0.652 30.9 0.165 
Model 4: Model 3 + Grains, 
physical activity 
2.30 (1.63-3.24) 1.57 (1.08-2.28) 0.650 31.1 0.165 
Random Intercept Models (Contextual 
variables) 
    
Model 5: Model 2 + CT 
Poverty 
2.23 (1.57-3.16) 1.45 (1.00-2.10) 0.625 33.7 0.160 
Model 6: Model 2 + % Black 2.31 (1.58-3.39) 1.50 (1.04-2.16) 0.641 32.0 0.163 
Model 7: Model 2 + Violent 
and Property Crime 
2.22 (1.58-3.12) 1.47 (1.02-2.11) 0.642 31.9 0.163 
Model 8: Model 2 + Built 
Environment (Distances) 
2.26 (1.62-3.16) 1.47 (1.02-2.10) 0.628 33.4 0.160 
Model 9: Model 2 + Open 
Space 
2.24 (1.61-3.13) 1.48 (1.03-2.12) 0.639 32.2 0.163 
Model 10: Model 2 + 
Disorder (Physical and 
Social) 
2.23 (1.60-3.12) 1.47 (1.02-2.11) 0.642 31.9 0.163 
1 latent variable approach to approximate ICC for a binary outcome, where the within variance for a 
standard logistic regression is π2/3. 
Table 6-3 shows the most parsimonious model for racial/ethnic disparities in T2DM and includes all 
variables with either an influence on the magnitude of the racial/ethnic disparities or that were 
independently associated with T2DM. In this model, the between-neighbourhood variability (σ2B) 
was reduced to 0.614. While this still involved a significant between-neighbourhood variance 
(p=0.002), the compositional (race/ethnicity, gender, age, income, education, physical activity, and 
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BMI) and contextual (proximity to grocery stores, and census tract poverty) variables included in this 
model explained 34.9% of the between-neighbourhood variance in T2DM [(0.943- 0.614)/0.943 x 
100%].  Only two contextual factors had marginally significant (p<0.20) associations with prevalent 
T2DM: (1) the distance to the nearest grocery store for each participant and (2) census tract 
poverty. Participants living one mile further from a grocery store had approximately half the odds of 
having T2DM though this result was not statistically significant (OR=0.53; 95% CI: 0.25-1.15). 
Participants living in lower poverty census tracts (< 5%, 10-20%) had lower odds of T2DM but again 
this finding was not statistically significant (OR10-19.9% vs. ≥20%=0.79; 95% CI: 0.59-1.06).  
 
Table 6-3. Full multilevel model, σ2between=0.614 (p=0.002) 
 Full Model 
  OR 95% CI 
Demographics   
Race   
  Black vs. White 2.34 1.64-3.34 
  Hispanic vs. White 1.54 1.07-2.21 
Male vs. female 1.68 1.31-2.15 
Age 1.04 1.03-1.05 
SES   
Income   
<$20,000 vs. ≥ $50,000 1.77 1.21-2.58 
$20,000-$49,999 vs. ≥ $50,000 1.18 0.81-1.72 
Education   
Less than High School vs. college or advanced 
degree 
2.09 1.37-3.19 
High school or equivalent vs. college or advanced 
degree 
1.4 0.96-2.04 
Some college vs. college or advanced degree 1.21 0.82-1.78 
Lifestyle   
Physical Activity   
Low vs. Medium or High 1.37 1.06-1.78 
BMI   
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Table 6-3. Full multilevel model, σ2between=0.614 (p=0.002) 
 Full Model 
  OR 95% CI 
Overweight vs. Normal 1.81 1.24-2.63 
Obese vs. Normal 4.18 2.89-6.04 
Contextual Factors   
Distance to nearest grocery store (miles) 0.53 0.25-1.15 
CT Poverty   
< 5% vs. ≥ 20% 0.92 0.49-1.71 
5-9.9% vs. ≥ 20% 1.32 0.88-1.96 
10-19.9% vs. ≥ 20% 0.79 0.59-1.06 
Bold = significant at the 0.05 level  
6.2.5 Conclusions 
Racial and ethnic disparities in T2DM remain a major public health problem. While many studies 
investigating the potential causes for these disparities have focused on variations in individual 
lifestyles and behaviours, genetics, and/or individual-level socio-demographic factors, we examined 
the added influence of neighbourhood-level factors. We found that there was a large variation in 
the prevalence of T2DM by neighbourhood that could not be explained by the composition of the 
neighbourhood (i.e. individual-level factors).  We also sought to identify specific aspects of 
neighbourhoods that were associated with variability in T2DM by race/ethnicity. However, despite 
the comprehensive list of contextual variables amassed in this study (built environment, 
neighbourhood socioeconomics, racial composition, safety, and neighbourhood disorder) we were 
unable to identify contextual elements that could explain the racial/ethnic disparities in T2DM nor 
the neighbourhood variability present in this study. While bivariate associations indicated that 
neighbourhood socioeconomic factors (SES, poverty), racial composition, and social disorder were 
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associated with higher odds of T2DM, these factors explained neither the racial/ethnic differences, 
nor the between-neighbourhood variance, in T2DM in multilevel models.  
Our finding that there was significant neighbourhood variability in T2DM is consistent with results 
reported by others.244 However, the extent to which this variability is explained by the contextual 
factors under consideration varies with the outcome of interest, the specific contextual measures 
included, the population examined, and the analytic techniques used. All of the contextual factors 
included in this study have been found to be associated with precursors to T2DM (dietary 
patterns,218-220 physical activity, 219, 221 or body mass index/obesity219, 220, 222, 516-518) in previous 
studies. However, T2DM is a more distal biological manifestation of residential conditions than 
behavioural and BMI outcomes. This indirect relationship may be one potential explanation for the 
null findings of this particular study. It is worth noting that several studies have successfully made 
the link between  neighbourhood socioeconomic factors like unemployment541, economic 
disadvantage31, 542, and racial segregation270, 271, 543 and T2DM. Astell-Burt found that individuals 
residing in neighbourhoods with greater green space had lower odds of having T2DM244 and lower 
insulin resistance.544 Therefore, the mixed results to date may largely result from the specific 
contextual factors measured and from the specific locales and populations examined.  
There are several potential explanations for our negative findings with regards to contextual factors. 
First, despite our attempts to address a comprehensive list of neighbourhood factors, it is possible 
we may be missing a key contextual factor that would explain the large between neighbourhood 
variability in T2DM. For example, we did not include a direct measure of neighbourhood 
“walkability,” but rather measured individuals’ distances to specific features of their 
135 
 
 
neighbourhoods thought to influence conduciveness to walking and linked this data to individual 
physical activity. Comprehensive measures of neighbourhood walkability have been linked to 
physical activity and body mass index,545, 546 and thus could be an area for future type 2 diabetes 
research.  Second, we recognize that we examined only one neighbourhood context, neighbourhood 
of residence. People experience and interact with multiple neighbourhood environments each day, 
known as spatial polygamy, which can influence their health and health behaviour.547 Most notably 
people’s work environment may influence their dietary and physical activity behaviours,548 thus 
influencing their risk of T2DM. Third, it is important to note that the contextual characteristics 
measured here are shaped by the macroeconomic forces of the larger community. The degree of 
economic or racial segregation of the larger community may contribute to scant variation at smaller 
units. Boston has previously ranked as one of the most residentially segregated metropolitan areas 
in the US. The racial segregation index of Boston is 67.7549 (a score of 60 and above is considered to 
be a high degree of segregation). Despite Boston being a segregated city, we found variation in 
individual versus neighbourhood racial composition. Therefore, we believe it is reasonable to expect 
co-variation between neighbourhood racial composition in relation to T2DM. Previous studies 
conducted in Boston found similarly high levels of residential segregation258 but not necessarily 
segregation in the built environment.258   
The heterogeneous findings across the literature may be attributable to differences in the 
contextual measures examined and differences in the way constructs were evaluated (e.g. distance 
to versus density of), but it is also possible that the patterning of neighbourhood social and physical 
attributes may be locale-specific. For example, in a study that examined the density of 
supermarkets, retail areas, recreational facilities, and health opportunities across three US cities, 
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neighbourhood racial/ethnic composition was significantly associated with access to facilities in both 
New York, NY and Baltimore, MD, but not in Winston-Salem, NC.550  The macro-economic influences 
of living in this urban, northeast environment may not be generalizable to other contexts or to the 
conditions in which racial/ethnic disparities in T2DM are fostered in the US at large. Nonetheless, 
the BACH cohort has been compared to other large regionally (Behavioral Risk Factor Surveillance 
System), and nationally (National Health and Nutrition Examination Survey) representative samples 
and has been shown to have a similar chronic disease profile to these survey populations with the 
exception of the exclusion of Asians (Asians comprise approximately 7.5% of the Boston, 
Massachusetts population).437 
A notable limitation of this study is the cross-sectional nature of the analyses which prevent causal 
inferences and limit our ability to determine temporality. While US Census data were available for 
previous rounds of the BACH Survey, a unique strength of the BACH III Survey was the inclusion of 
contextual data from a variety of sources such as InfoUSA (food environment), the Boston Police 
Department (crime data), and participants’ perceptions (physical and social disorder). Another 
advantage to using the BACH III data was that on-the-spot diabetes testing was conducted (this was 
not done in any other BACH study) allowing us to examine both diagnosed and undiagnosed 
diabetes which may more accurately depict the true nature of racial/ethnic disparities in T2DM. 
Finally, BACH III participants had lived at their current address, on average, for over 15 years 
(Mean=15.5, SE=0.5) and over 80% of participants lived in the same neighbourhood for all three 
rounds of the BACH Survey. These findings may mitigate concerns regarding the temporality 
between neighbourhood exposure and diabetes onset. 
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It may be argued our results are influenced by the analytic approach. Exploratory analyses using the 
residuals from the census tract poverty-T2DM regression indicated no spatial autocorrelation. 
Therefore, we did not employ spatial modelling techniques. In addition, the modelling strategy 
presented here allowed individual-level variables to enter the model first to test the contribution of 
compositional factors. However, we also built the models introducing neighbourhood-level 
contextual variables first and the results were the same. In addition, the modifiable areal unit 
problem (MAUP) is an issue. However, we note that the neighbourhood definitions used in the 
current study are common in the social epidemiology of neighbourhood literature. 
Finally, residential selection bias is a well-known limitation of many investigations of neighbourhood 
effects.551 Neighbourhood selection is the result of residential mobility choices made by individuals 
and households within a restricted set of choices that can produce residential segregation patterns. 
To reduce the potential for bias relating to residential selection, we adjusted for variables that may 
be associated with neighbourhood selection (e.g. individual income, education, and occupation). We 
recognize that this is a crude method to account for selection into neighborhoods,552, 553 but 
unfortunately there was not a variable in our dataset for neighbourhood selection. Finally, it is 
important to note that results from this study might only be generalizable to adults in similar urban 
locations to Boston. 
There are a number of strengths to this study and the analytic approaches used here. Features of 
BACH that make it uniquely suitable for this investigation include: large diverse random sample of 
community-dwelling men and women; the utilization of established survey instruments; the 
collection of fasting blood samples at BACH III allow us to examine both diagnosed and undiagnosed 
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T2DM; and collection of neighbourhood measures from a wide variety of sources including the US 
Census Bureau, InfoUSA, as well as the individual participants’ perceptions of their neighbourhood. 
We attempted to compile a list of compositional and contextual factors representative of both the 
physical (food store availability, green space) and social (socioeconomics, racial composition, safety) 
environments in which individuals live. While many studies of neighbourhood effects rely solely on 
objective assessments of neighbourhood, we included residents’ subjective characterization of their 
neighbourhood using a psychometrically validated scale.528 In addition, the racial/ethnic diversity of 
our sample allowed us to examine the impact of neighbourhood characteristics on disparities, an 
understudied potential impact of the contextual environment.  
In conclusion, using data from the BACH Survey, we have identified large, significant, neighbourhood 
variability in the prevalence of T2DM. However, the many neighbourhood factors we were able to 
examine did not explain this neighbourhood variability, nor did they appear to play a role in the 
amplification or creation of racial/ethnic disparities in T2DM. While the findings of this study overall 
suggest that neighbourhood factors are not a major contributor to racial/ethnic disparities in T2DM, 
further research is needed including data from other geographic locations, including both urban and 
rural areas and areas with both high and low residential segregation. 
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7 The Relative Contributions of Socioeconomic, Local Environmental, 
Psychosocial, Lifestyle/Behavioural, Biophysiologic, and Ancestral Factors 
to Racial/Ethnic Disparities in Type 2 Diabetes 
7.1 Introduction 
While previous papers looked at specific factors in depth, this paper aims to tie together the 
conceptual model of racial/ethnic disparities in T2DM. This paper examines the relative 
contributions of socioeconomic, local environmental, psychosocial, lifestyle/behavioural, 
biophysiologic, and genetic ancestral factors to racial/ethnic disparities in T2DM. Given the 
complexity of racial/ethnic disparities in T2DM, the conceptual model was simplified for modelling 
purposes. Two-level structural equation modelling was used to examine direct and indirect effects 
whilst accommodating the clustering of participants within their census tract of residence. 
This paper is currently under consideration for publication in the International Journal of 
Epidemiology. 
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7.2 Article Submitted 
7.2.1 Abstract 
Background: Racial/ethnic minorities in the US have a higher prevalence of type 2 diabetes mellitus 
(T2DM). While many independent risk factors for T2DM have been identified, these determinants 
are often viewed in isolation without considering the joint contributions of competing risk factors. 
The objective of this study was to assess the relative contributions of six domains of influence to 
racial/ethnic disparities in T2DM. 
Methods: Cross-sectional analyses were conducted using the Boston Area Community Health 
(BACH) III Survey (2010-12), the third wave of a random, population-based sample of men and 
women from three racial/ethnic groups (Black, Hispanic, White) living in Boston, Massachusetts 
(N=2,764). Prevalent diabetes was defined by self-report of T2DM, fasting glucose>125 mg/dL, or 
HbA1c≥6.5%.  Structural equation models (SEM) were constructed to evaluate the direct effects of 
each conceptual domain of influence on T2DM prevalence as well as their indirect effect on the 
race/ethnicity – T2DM relationship. All direct and indirect pathways were included.  
Findings: The final model indicated that 38.9% and 21.8% of total effect of Black race and Hispanic 
ethnicity, respectively, on T2DM prevalence was mediated by the socioeconomic, environmental, 
psychosocial, and lifestyle/behavioural risk scores. The largest mediating influence was the 
socioeconomic risk score, which explained 21.8% and 26.2% of the total effect of Black race and 
Hispanic ethnicity, respectively. 
Interpretation: Our study found that socioeconomic factors had the greatest impact on explaining 
the excess prevalence of T2DM among racial/ethnic minorities. 
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7.2.2 Background 
Disparities in type 2 diabetes mellitus (T2DM) by race/ethnicity are an important public health 
problem in the United States and worldwide. Compared to White adults, the prevalence of diabetes 
is 77% higher among Black and 66% higher among Hispanic adults in the US.2 Racial/ethnic 
disparities in T2DM are associated with disparities in diabetes control,6 elevated rates of diabetes-
related complications, and greater health care costs.554  
Many factors have been identified as contributing to these disparities,555 including variations in 
lifestyles and behaviours, biophysiological, psychosocial,  socio-demographic, and environmental 
factors, and biogeographic ancestry.36, 37 However, research to date has largely focused on individual 
risk factors in isolation and the relative contribution of these influences have not been identified.555  
Since racial/ethnic differences in T2DM appear to result from a broad range of influences, a more 
complete understanding requires a multilevel approach.  A multilevel risk model, reflecting the 
many factors that contribute to T2DM risk, may advance understanding, and better inform the 
design of interventions to target the most relevant domains which disproportionately contribute to 
disparities.  
The aim of this research is to develop and test a conceptual risk model that takes a multilevel 
approach to T2DM disparities (Figure 7-1). Statistical methods are available that allow us to test this 
conceptual model which includes both direct and indirect (mediating) effects. Our aim is to assess 
the relative contributions of six domains of influence to racial/ethnic disparities in T2DM: (1) 
socioeconomic, (2), local environmental, (3) psychosocial, (4) lifestyle/behavioural, (5) 
biophysiologic, and (6) biogeographic ancestry (BGA).  
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7.2.3 Methods 
Study Sample 
The Boston Area Community Health (BACH) Survey is a longitudinal, random, population-based, 
cohort of 5,502 residents (2,301 men, 3,201 women) aged 30-79 from three racial/ethnic groups in 
Boston, MA. 437  BACH has conducted total of three surveys to date (BACH I: 2002-2006; BACH II: 
2008-2010; BACH III: 2010-2012). The current analysis uses cross-sectional data from the third 
survey (BACH III, N=3,155).  Analyses were restricted to 2,764 participants still residing in Boston, 
Figure 7-1. Conceptual Model of Potential Factors Influencing Racial/Ethnic Disparities in 
T2DM  
Potential factors influencing racial/ethnic disparities in T2DM are grouped into five domains of 
influence: social structure, environmental, psychosocial, lifestyle/behavioural, Biophysiological. 
Race/ethnicity, age, gender, and genetic constructs are considered exogenous. Constructs 
operationalized in the BACH III Survey are listed in the ovals (conceptual domains). 
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Massachusetts at BACH III due to the availability of environmental parameters. Survey participants 
were interviewed in the morning after being instructed to fast overnight (≥ 8 hours) and after 
providing written informed consent. The interviews were conducted by trained, certified 
phlebotomists fluent in English and/or Spanish. The response rate, conditional on previous 
participation, was 81.4%.508 The study was approved by the New England Research Institutes’ 
Institutional Review Board.  
Measures 
The primary determinant of interest was self-identified race/ethnicity (non-Hispanic Black [Black], 
non-Hispanic White [White], and Hispanic). The primary outcome was prevalent T2DM. Fasting 
glucose (FG) was measured with a HemoCue 201 point-of-care analyzer. HbA1c was measured by 
Quest Laboratories in Cambridge, MA. Participants who (a) self-reported T2DM (“have you ever 
been told by a doctor or other health professional that you have type 2 diabetes?”), or (b) had FG > 
125 mg/dL or HbA1c ≥ 6.5% were classified as having T2DM.21 Medication inventory and age of 
diagnosis was used to further separate type 1 versus type 2 diabetes. Eight individuals younger than 
35 years at diagnosis and on continuous insulin therapy were considered to have type 1 diabetes 
and were excluded. The medication inventory also confirmed over 80% of the self-reported cases of 
diabetes.  
Our multilevel approach builds upon an earlier theoretical model419 and includes six domains of 
influence (Figure 1) which are hypothesized to directly and/or indirectly, singly and in combination 
affect T2DM. The constructs measured within each domain are described in briefly below. 
Additional details on the measures can be found in Section 7.3.  
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Socio-economic influences considered included household income, educational attainment, 
occupation, perceptions of everyday discrimination,556 immigration status, acculturation,427 health 
literacy, type of health insurance, and number of visits to a health care provider in the past year. 
ArcGIS 10.1 (ESRI, Redlands, California) was used to geocode participants’ residences and link 
participants with geographic features. Environmental influences considered included census-tract 
socioeconomic status,431 percent poverty, percent non-Hispanic Black, percent non-Hispanic White, 
violent and property crime per 1,000 population, distance to the closest grocery store, convenience 
store, and fast food (miles), percentage of recreational open space, perceived social and physical 
disorder,528 and number of years at current address. Spatial access to health care was assessed by 
distance to the closest community health centre, acute care hospital, or health care centre of either 
kind (miles). Psychosocial influences considered included hours of sleep each night, major life 
events,557 and sense of personal control.429 Lifestyle/behavioural factors assessed: dietary patterns 
(2005 Block food frequency questionnaire558 assessed average daily intake of sodium, vegetables, 
fruits, meats/beans, grains, fibre, and saturated fat comprising a “healthy eating score” which was 
adjusted for total kilocalories), physical activity,530 BMI, waist circumference, and body fat 
percentage were measured by trained field interviewers, and smoking history. Biophysiological 
influences considered included: blood pressure (average of three readings taken during the in-home 
visit), total cholesterol, HDL cholesterol, triglycerides (Quest laboratories, Cambridge, MA), reported 
high blood pressure or cardiovascular disease, and for women only menopausal status, and history 
of gestational diabetes. 
To measure BGA, we evaluated a panel of 63 ancestry informative markers, including 33 autosomal 
single nucleotide polymorphisms differentiating Native American versus European ancestry and 30 
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single nucleotide polymorphisms differentiating West African versus European ancestry. The 63 
markers combined can provide an estimate of % West African, % Native American, and % European 
ancestry for each participant.559, 560 Genotyping was conducted at the Broad Institute using the 
Sequenom iPLEX platform. Family history of diabetes was also considered as an independent risk 
factor for T2DM. Race/ethnicity, age, and gender, BGA, and family history of diabetes were 
considered exogenous factors.  
Structural Equation Modelling 
We applied two-level structural equation modelling (SEM) to assess the associations between 
race/ethnicity, confounding and mediating characteristics, and T2DM. Two-level SEM allows us to 
include both direct and indirect effects of each risk domain on T2DM as hypothesized in the 
conceptual model (Figure 7-1) while accommodating the clustering of participant observations (level 
1) within their census tract of residence (level 2). Direct effects are depicted as arrows from 
independent to dependent variables. For example, socioeconomic risk may have a direct effect on 
T2DM (depicted in Figure 7-1 by a single arrow from socioeconomic risk to T2DM, the final outcome 
variable). Indirect effects are depicted as a series of arrows operating through mediating 
construct(s). For example, socioeconomic risk may contribute to increased lifestyle/behavioural risk 
which in turn contributes to T2DM and serves as a mediating influence. We relied on published 
literature and inherent temporality to determine the direction of the effects. Correlations between 
the measurement errors of two variables are represented by bi-directional curves. Standardized 
coefficients (sβ)561 and their p-values are reported. We performed mediation analysis to assess the 
percentage of the racial/ethnic effect explained by each the five mediating domains of influence. 
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The mediated, or indirect, effect is calculated as the product of the direct effects (sβ) among the 
independent, mediating, and any subsequent dependent variables.562 The overall percent mediated 
was calculated as the indirect effect over the total effect. Descriptive statistics were estimated using 
SAS callable Sudaan Version 11 and SEMs were estimated using Mplus Version 7 (Muthen and 
Muthen, Los Angeles, CA).  
Development of the Risk Scores 
Data based on the five theoretical mediating domains of influence (socioeconomic, environmental, 
psychosocial, lifestyle/behavioural, and biophysiological) were used to create risk scores. Variables 
listed in Figure 7-1 were reduced from those in the conceptual model using race/ethnicity-, age-, 
and gender-adjusted models (Table 7-3, Section 7.3.2  Supplementary Analyses). Variables that did 
not either (1) meet a minimal criterion for association with T2DM (p < 0.10) or (2) reduce the 
race/ethnic effect (OR) by 10% were not included in the domain risk score. For categorical variables, 
we created a weighted scoring system by rounding up all regression coefficients (ln(OR)) to the 
nearest integer, using methods similar to those utilized in Bang et al563 which is the basis for the 
American Diabetes Association self-screening tool. For continuous variables, risk was based on 
clinically accepted “high risk” criteria (see Table 7-1 for citations). If clinically accepted criteria were 
not available, tertiles were used. Following the construction of the final model all variables were 
added in the model singly to ensure their effects were adequately captured by the risk scores. 
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Table 7-1. Development of the “risk score” 
 
Domain/Variable 
High Risk 
(+1) 
Very High Risk  
(+2) 
Socioeconomic   
Income $20,000 - $49,999 <$20,000 
Education High school or 
equivalent/Some college 
Less than High School 
Occupation Manual labour/Never 
worked 
 
Born in the US Yes  
Acculturation High/Bicultural (≥2.5 for 
English domain) 
 
Health Literacy Inadequate/Marginal  
Insurance Status Public  
Visits to HCP in the past year 7+  
Neighbourhood   
CT Poverty > 20%  
Psychosocial   
Sleep Duration < 6 hours > 9 hours 
Major Life Events > 1 MLE  
Sense of Control (tertiles) < 1.0  < 0.43  
Lifestyle/Behavioural   
Physical activity Low  
Smoking history Current  
BMI563 25-29 30-39 (> 40 adds 3 risk points) 
Waist circumference564 ≥ 102 cm (men) 
≥ 88 cm (women) 
 
Body fat percentage (tertiles) > 25% (men) 
> 35% (women) 
> 33% (men) 
> 42% (women) 
Biophysiological   
Blood pressure564 SBP ≥ 130 or DBP ≥ 85 or 
self-report of hypertension 
diagnosis 
 
Cholesterol (total)565 ≥ 200 mg/dL ≥ 240 mg/dL 
HDL Cholesterol564 < 40 mg/dL (men) 
< 50 mg/dL (women) 
 
Triglycerides564 ≥ 150  
Cardiovascular disease  Yes 
Menopausal status Post Surgical/Undetermined 
Gestational diabetes  Yes 
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In order to minimize reductions in precision, multiple imputation was implemented using 
the Multivariate Imputation by Chained Equations (MICE)510 algorithm in R (Vienna, Austria). Fifteen 
multiple imputation datasets were created. Imputations were conducted separately for each 
racial/ethnic by gender combination to preserve interaction effects, and the complex survey sample 
design was taken into account. DNA samples were obtained and isolated on 73.1% of participants, 
24.4% of participants were missing household income, and 25.8% were missing dietary data. The 
proportions of missing data for other variables were 10%. BACH’s sampling design requires 
weighting observations inversely proportional to their probability of selection for results to be 
generalizable to the base population.540 Sampling weights were post-stratified in order to produce 
estimates representative of the Black, Hispanic, and White Boston, MA population. 
7.2.4 Results 
The prevalence of diabetes in the BACH III study was 23.4%. The demographic characteristics of the 
2,476 participants the analytic sample are presented in Table 7-2.  The sample was comprised of 
approximately 1/3 Black (29.0%), Hispanic (32.8%), and White (34.6%) participants and the average 
age of the participants was 54. Compared with non-diabetic participants, T2DM participants were 
older, had greater West African genetic ancestry, were of lower socioeconomic status, reported 
greater discrimination, lower health literacy, lived in lower SES/greater poverty census tracts and 
neighbourhoods with more minority residents, reported greater neighbourhood disorder, short (<6 
hours) or long (>9 hours) sleep, reported a lower sense of control, less physical activity, greater BMI, 
waist circumference and body fat percentage, had higher blood pressure, total cholesterol, and 
triglycerides and lower HDL cholesterol.  
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Table 7-2. Characteristics of the BACH III study population overall by diabetes status (N=2,476)  
 Overall 
 
N=2,764 
Type 2 
Diabetes 
N=892 
No Type 2 
Diabetes 
N=1872 
P-value 
Self-Identified Race/Ethnicity     
Black 929 (27.10%) 351 (39.51%) 578 (23.42%) < 0.001 
Hispanic 937 (12.20%) 340 (12.55%) 597 (12.09%)   
White 898 (60.71%) 201 (47.94%) 697 (64.48%)   
Age1     
34-44 405 (27.54%) 61 (14.68%) 344 (31.34%) < 0.001 
45-54 739 (26.97%) 177 (23.07%) 562 (28.13%)   
55-64 812 (19.99%) 300 (24.12%) 512 (18.77%)   
65-74 536 (13.76%) 236 (21.46%) 300 (11.49%)   
75-88 272 (11.74%) 119 (16.67%) 153 (10.28%)   
Gender, % Male 1018 (46.46%) 344 (52.00%) 674 (44.82%) 0.056 
Genetic Influences     
% West African, Mean (SE) 29.84 (1.23) 39.02 (2.27) 27.12 (1.43) < 0.001 
% Native American, Mean (SE) 6.85 (0.29) 6.53 (0.56) 6.95 (0.36) 0.545 
% European, Mean (SE) 63.31 (1.27) 54.45 (2.33) 65.93 (1.49) < 0.001 
Family History of Diabetes 1483 (46.52%) 602 (62.12%) 882 (41.91%) < 0.001 
Socio-economic Influences     
Income     
<$20,000 1234 (26.68%) 524 (44.69%) 710 (21.35%) < 0.001 
$20,000 - $49,999 798 (25.10%) 234 (25.63%) 564 (24.94%)   
≥ $50,000 732 (48.22%) 134 (29.67%) 598 (53.70%)   
Education     
Less than High School 560 (8.16%) 278 (16.21%) 282 (5.78%) < 0.001 
High school or equivalent 867 (24.44%) 298 (32.72%) 569 (21.99%)   
Some college 576 (21.17%) 176 (23.79%) 400 (20.39%)   
College or advanced degree 761 (46.23%) 140 (27.28%) 620 (51.84%)   
Occupation     
Professional, Managerial, 
Sales, and Office 1324 (65.27%) 345 (52.95%) 979 (68.92%) < 0.001 
Service  715 (17.52%) 224 (19.53%) 492 (16.92%)   
Manual labour 495 (13.67%) 209 (21.83%) 286 (11.25%)   
Never worked 229 (3.54%) 114 (5.70%) 115 (2.90%)   
Discrimination (0-45), Mean 
(SE) 9.34 (0.25) 10.31 (0.57) 9.05 (0.29) 0.057 
Born in US 1645 (78.97%) 488 (77.50%) 1157 (79.41%) 0.490 
Acculturation (English not First 
language) 
 
   
Low 669 (8.53%) 253 (10.54%) 416 (7.93%) 0.178 
High/Bicultural 2095 (91.47%) 639 (89.46%) 1456 (92.07%)  
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 Overall 
 
N=2,764 
Type 2 
Diabetes 
N=892 
No Type 2 
Diabetes 
N=1872 
P-value 
Health literacy     
Inadequate 708 (13.44%) 328 (24.12%) 380 (10.27%) < 0.001 
Marginal 298 (6.25%) 120 (10.28%) 178 (5.06%)   
Adequate 1759 (80.32%) 445 (65.60%) 1313 (84.67%)   
Environmental Influences      
CT SES     
Low 1269 (25.55%) 447 (34.07%) 822 (23.03%) < 0.001 
Middle 968 (39.87%) 315 (40.65%) 653 (39.64%)   
High 527 (34.58%) 130 (25.29%) 397 (37.33%)   
CT Poverty     
< 5% 159 (10.45%) 33 (6.84%) 126 (11.52%) 0.018 
5-9.9% 280 (14.37%) 88 (12.22%) 192 (15.01%)   
10-19.9% 792 (35.78%) 210 (32.94%) 582 (36.62%)   
≥ 20% 1533 (39.40%) 561 (48.01%) 972 (36.86%)   
CT Racial Composition     
% Black, Mean (SE) 26.80 (1.07) 32.61 (1.86) 25.09 (1.18) < 0.001 
% Hispanic, Mean (SE) 16.62 (0.53) 18.25 (0.88) 16.14 (0.55) 0.017 
% White, Mean (SE) 53.75 (1.25) 47.33 (2.06) 55.65 (1.38) < 0.001 
Property crime per 1,000, Mean 
(SE) 74.05 (3.58) 77.84 (4.28) 72.93 (3.84) 0.219 
Violent crime per 1,000, Mean 
(SE) 6.35 (0.33) 6.51 (0.37) 6.30 (0.35) 0.505 
Low Access to… (> 0.5 mi)     
Supermarkets  1316 (51.01%) 415 (49.53%) 901 (51.45%)  0.529 
Grocery Stores 251 (11.58%) 69 (9.76%) 182 (12.12%) 0.370 
Convenience Stores 164 (7.94%) 52 (8.40%) 112 (7.81%) 0.616 
Fast Food 882 (33.66%) 269 (30.71%) 613 (34.53%) 0.578 
CT % Open Space, Mean (SE) 0.08 (0.01) 0.07 (0.01) 0.08 (0.01) 0.105 
Physical Disorder (6-30), Mean 
(SE) 13.55 (0.14) 13.82 (0.20) 13.48 (0.18) 0.191 
Social Disorder (6-30), Mean 
(SE) 13.86 (0.16) 14.58 (0.26) 13.65 (0.18) 0.003 
Years Lived at Current Address, 
Mean (SE) 15.51 (0.48) 17.17 (0.86) 15.02 (0.56) 0.031 
Access to/Use of health care      
Distance to Community Health 
Centre (Miles), Mean (SE) 0.60 (0.03) 0.56 (0.04) 0.61 (0.03) 0.200 
Distance to Acute Care Hospital 
(Miles), Mean (SE) 1.24 (0.04) 1.24 (0.06) 1.24 (0.05) 0.958 
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 Overall 
 
N=2,764 
Type 2 
Diabetes 
N=892 
No Type 2 
Diabetes 
N=1872 
P-value 
Distance to Any Health Care 
Centre (Miles) , Mean (SE) 0.53 (0.03) 0.49 (0.04) 0.54 (0.03) 0.326 
Usual Source of Care 2714 (98.75%) 880 (98.48%) 1834 (98.82%) 0.651 
Difficulty in Traveling to Health 
Care Provider 
 
   
Very difficult 54 (1.67%) 22 (1.96%) 32 (1.58%) 0.171 
Somewhat difficult 199 (6.62%) 79 (9.26%) 120 (5.84%)   
Not too/Not at all Difficult 477 (17.19%) 181 (19.75%) 296 (16.43%)   
Not at all difficult 2034 (74.52%) 611 (69.02%) 1423 (76.15%)   
Insurance Status     
Private 1001 (51.41%) 218 (33.84%) 783 (56.61%) < 0.001 
Public 1671 (46.03%) 654 (64.14%) 1016 (40.67%)  
None 92 (2.56%) 20 (2.02%) 73 (2.72%)  
Visits to Health Care Provider in 
the past year     
0-1 times 395 (16.71%) 74 (9.49%) 321 (18.85%) < 0.001 
2-6 times 1459 (51.96%) 411 (49.12%) 1048 (52.81%)  
7+ times 910 (31.32%) 407 (41.39%) 503 (28.35%)  
Psychosocial     
Sleep Duration     
< 6 hours 622 (17.53%) 259 (27.98%) 363 (14.44%) < 0.001 
6-9 hours 2097 (81.28%) 617 (69.96%) 1480 (84.62%)   
> 9 hours 45 (1.19%) 17 (2.06%) 28 (0.93%)   
Major Life Events (0 to 10), 
Mean (SE) 0.60 (0.03) 0.68 (0.05) 0.57 (0.03) 0.080 
Sense of Control (-16 to 16), 
Mean (SE) 0.72 (0.02) 0.61 (0.03) 0.76 (0.02) < 0.001 
Lifestyle/Behavioural 
Influences 
 
   
Dietary Influences     
< 1500 mg Sodium 615 (15.16%) 216 (18.03%) 399 (14.31%) 0.144 
3-4 Servings of Vegetables 276 (12.47%) 83 (9.84%) 194 (13.25%) 0.239 
2-3 Servings of Fruit 382 (18.09%) 114 (15.60%) 268 (18.83%) 0.299 
2-3 Servings of Meat/Beans 588 (23.07%) 187 (19.96%) 401 (23.98%) 0.204 
6-11 Servings of Grain 400 (18.99%) 111 (14.22%) 289 (20.39%) 0.051 
25-30 g of Fibre 171 (7.17%) 51 (5.28%) 120 (7.73%) 0.172 
< 14 g Saturated Fat 1040 (29.19%) 352 (31.29%) 688 (28.58%) 0.435 
FFQ Score (0-7), Mean (SE) 1.24 (0.03) 1.14 (0.07) 1.27 (0.04) 0.092 
Total Kcal, Mean (SE) 1745.4 (32.02) 1685.1 (79.47) 1763.2 (34.47) 0.370 
Physical activity     
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 Overall 
 
N=2,764 
Type 2 
Diabetes 
N=892 
No Type 2 
Diabetes 
N=1872 
P-value 
Low 1132 (33.21%) 480 (47.31%) 652 (29.03%) < 0.001 
Medium 1286 (50.51%) 337 (39.80%) 949 (53.68%)   
High 346 (16.28%) 76 (12.89%) 270 (17.29%)   
BMI, Mean (SE) 29.42 (0.22) 32.63 (0.42) 28.47 (0.22) < 0.001 
Waist Circumference (cm), 
Mean (SE) 97.05 (0.54) 106.58 (1.09) 94.23 (0.55) < 0.001 
Body Fat %, Mean (SE) 33.96 (0.32) 36.74 (0.57) 33.13 (0.37) < 0.001 
Smoking History     
Never 1220 (44.25%) 373 (37.55%) 847 (46.22%) 0.014 
Former 1015 (38.80%) 346 (39.62%) 669 (38.56%)   
Current 529 (16.95%) 173 (22.83%) 356 (15.21%)   
Biophysiological Influences     
SBP, Mean (SE) 130.57 (0.61) 138.83 (1.32) 128.13 (0.66) < 0.001 
DBP, Mean (SE) 80.38 (0.37) 81.86 (0.79) 79.94 (0.43) 0.034 
Total Cholesterol, Mean (SE) 187.03 (1.29) 176.10 (2.31) 190.26 (1.45) < 0.001 
HDL Cholesterol, Mean (SE) 54.89 (0.68) 50.39 (1.00) 56.22 (0.82) < 0.001 
Triglycerides, Mean (SE) 129.05 (3.88) 148.94 (5.87) 123.17 (4.67) < 0.001 
Hypertension 2110 (70.16%) 805 (89.44%) 1305 (64.46%) < 0.001 
Cardiovascular Disease 604 (16.09%) 315 (32.66%) 289 (11.19%) < 0.001 
Women Only     
Menopausal Status     
Pre/Peri- menopause 437 (36.63%) 67 (16.14%) 370 (41.90%) < 0.001 
Post-menopause 740 (36.79%) 241 (40.54%) 499 (35.83%)   
Undetermined/Other 569 (26.57%) 240 (43.33%) 329 (22.27%)   
Gestational Diabetes 125 (5.93%) 72 (17.07%) 54 (3.07%) < 0.001 
     
1 n and column percent presented for categorical variables, P-value from a chi-squared test 
2 Mean and standard error presented for continuous variables, P-value from a t-test 
CT= Census Tract 
 
Using the results of the race/ethnic-, gender-, and age-adjusted models (Table 7-3), we identified 24 
variables within the 5 mediating domains that were associated with T2DM prevalence and/or 
racial/ethnic disparities in T2DM (Table 7-1). This produced risk scores with the following ranges and 
means: socioeconomic (0-10, 4.3), environmental (0-1, 41.2%), psychosocial (0-5, 1.7), 
lifestyle/behavioural (0-8, 3.2), and biophysiological (0-11, 2.7).  
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The SEM specified in Figure 7-1 fit the data well. Age and gender had direct effects on almost all 
factors with the exception of environmental risk. For simplicity, age and gender effects and non-
significant pathways (p≥0.05) are not presented in Figure 2 (full results are available in eTable 2). 
The lifestyle/behavioural domain was the largest direct predictor of T2DM status (sβ=0.25, p<0.001) 
followed by biophysiologic factors (0.19, p<0.001), socioeconomic factors (0.13, p=0.003), and family 
history of diabetes (0.10, p=0.005). There was a marginal direct effect of self-identified 
race/ethnicity on T2DM prevalence (Black, 0.18, p=0.054; Hispanic, 0.10, p=0.069). The standardized 
coefficients represented in Figure 7-2 can be interpreted as a one standard deviation difference in 
the predictor (i.e. lifestyle/behavioural risk) is associated with a 0.25 standard deviation difference 
in the outcome (i.e. T2DM). Unstandardized coefficients are available online (Standardized 
coefficients (StdYX and StdY) are presented in the main body of the paper. However, unstandardized 
coefficients may be useful as well.  All standardized and unstandardized coefficients are available in 
Table 7-4, below. The unstandardized coefficients may be interpreted in the typical manner: as a 
logistic regression coefficient for a binary outcome (environmental risk and T2DM) or as a linear 
regression coefficient for a continuous outcome (all other outcomes). For example, the 
unstandardized coefficients suggest that for every one unit increase in the lifestyle/behavioural risk 
score the odds of T2DM increase 35% (OR=1.35) and for every one unit increase in the 
biophysiological risk score the odds increase 29% (OR=1.29).  
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Figure 7-2. Final Structural Equation Model of Factors in the Pathway from Race/Ethnicity to 
T2DM 
 
 
 Total 
Effect of 
Race/ 
Ethnicity 
Direct 
Effect of 
Race/ 
Ethnicity 
% Mediated by 
Socio-
economic 
Factors 
Environ-
mental 
Factors 
Psycho-
social 
Factors 
Lifestyle/ 
Behavioural 
Factors 
Bio-
physiological 
Factors 
Black 0.29 0.18 21.8% 1.3% 0.0% 11.21% 4.6% 
Hispanic 0.18 0.10 26.2% 4.3% 5.0% 5.77% 4.6% 
 
 
Self-identified Black race had a significant direct effect on socioeconomic risk (sβ=0.23, p=0.003) and 
environmental risk (0.14, p=0.001) only. There was no direct effect of self-identified Black race on 
psychosocial, lifestyle/behavioural, biophysiological risk, or T2DM. However, Black race has an 
indirect effect on these outcomes through socioeconomic factors. Socioeconomic risk is 43.3% 
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mediated by lifestyle/behavioural risk. The mediation analysis (Figure 7-2) indicate that 38.9% of 
total effect of Black race was mediated by the socioeconomic, environmental, psychosocial, 
lifestyle/behavioural risk scores with 21.8% of the total effect of Black race being explained by 
socioeconomic risk.  
Self-identified Hispanic ethnicity had a significant direct effect on socioeconomic risk (0.17, 
p<0.001), environmental risk (0.29, p<0.001), and psychosocial risk (0.17, p=0.04). There was no 
significant direct effect of Hispanic ethnicity on lifestyle/behavioural risk, biophysiological risk, or 
T2DM. Mediation analyses indicate that 45.7% of total effect of Hispanic ethnicity was explained by 
the calculated risk scores. Again, the largest mediator, 26.2%, was the socioeconomic risk score. 
Despite the considerable differences in BGA among type 2 diabetics versus non-diabetics in the 
bivariate results (Table 7-2), neither West African Ancestry (OR=1.02, p=0.658) nor Native American 
ancestry (OR=0.94, p=0.428) contributed to T2DM once self-identified race/ethnicity was included in 
the model (Table 7-3). The final SEM also indicated that there was no significant direct effect of 
West African (-0.003, p=0.069) or Native American ancestry (-0.016, p=0.725) on T2DM once self-
identified race/ethnicity was accounted for. 
7.2.5 Conclusions 
To our knowledge, this study presents the first examination of a multilevel risk model aimed at 
explaining racial/ethnic disparities in T2DM. While many authors have proposed similar conceptual 
frameworks with the aim of understanding and eliminating health disparities,419, 555, 566 to our 
knowledge the BACH study is the first survey to amass this data and test this model of health 
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disparities in T2DM in a community-based population with adequate numbers of Black, Hispanic, 
and White participants. 
Under our conceptual framework, biophysiological and individual lifestyle/behavioural factors were 
considered more proximate to T2DM. The data supported this temporality as individual 
lifestyle/behavioural risk had the largest direct effect on T2DM and biophysiological risk the second 
largest direct effect. However, the mediation analyses indicate that only 5% and 11% of the total 
effect of Black race can be explained by excess biophysiological and lifestyle/behavioural risk, 
respectively. Among Hispanic participants, the % mediated was even lower. The mediation analyses 
indicate that the largest explainable proportion of the excess proportion of T2DM among Black and 
Hispanic participants is attributable to socioeconomic risk. The socioeconomic risk score developed, 
which is a composite of household income, education, occupation, immigration status, 
acculturation, health literacy, insurance status and utilization of health care explains 22% of the 
excess odds of T2DM among Black and 26% of the excess odds among Hispanic participants. The 
statistical analyses indicate that while much of the excess odds of T2DM among Blacks and Hispanics 
remains unexplained (61% and 54%, respectively), adverse socioeconomic conditions explains the 
largest explainable proportion of racial/ethnic disparities in T2DM. 
Our data, supported by our previous findings,567 suggest that the effects of BGA on T2DM are 
attenuated with further adjustment for self-identified race/ethnicity and nearly eliminated when 
socioeconomic and lifestyle/behavioural pathways are considered.  This finding is supported by 
several studies.36, 37, 79 However, other studies have found the effect of BGA on T2DM to be more 
robust to adjustment,37, 80, 81 including research from the BACH study which demonstrate that the 
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effect of BGA on prediabetic illness may be robust to adjustment for social factors.82 Race and 
ethnicity are complex multidimensional constructs reflecting biogeographic origin, biological factors, 
as well as social, cultural, and economic factors. 69 Our findings suggest that while BGA may be 
associated with T2DM, it is likely that the social, cultural, and economic facets of race/ethnicity may 
better explain T2DM disparities in the BACH study. 
Family history of diabetes, which may have a genetic component, but may also be the result of 
similar socioeconomic, environmental, psychosocial, lifestyle, and biophysiological risk profiles 
between parent and offspring, had a modest direct effect of T2DM prevalence (0.10, p=0.005) and 
was highly associated with race/ethnicity. 
While race/ethnicity had no direct effect on lifestyle/behavioural risk, it is important to note that 
socioeconomic risk, which was highly associated with race/ethnicity, did have a significant direct 
effect on lifestyle/behavioural risk. Overall, lifestyle/behavioural risk explained 43.3% of the 
socioeconomic effect on T2DM. Studies that aim to assess the role of lifestyle and behavioural 
factors on the socioeconomic gradient of health in T2DM have found similar results. For example, 
the Whitehall II cohort study found that lifestyle/behavioural factors accounted for 33-45% of the 
socioeconomic gradient in T2DM.373  
Each domain of the conceptual model presented here suggests a particular structural intervention. 
Increased socioeconomic risk suggests policy interventions affecting social conditions; 
environmental risk--community intervention; psychosocial risk--primary prevention aimed at 
reducing psychological strain and increasing coping mechanisms; lifestyle/behavioural risk--primary 
prevention directed at increasing healthy behaviours and decreasing unhealthy behaviours; and 
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biophysiological risk--secondary prevention efforts aimed at stopping/slowing the progression of 
disease. The results of these analyses, as well as the results of several trials,568 suggest that 
interventions targeting lifestyle/behavioural and biophysiologic risk may reduce T2DM risk overall. 
However, the results presented here demonstrate that interventions aimed at reducing disparities 
may need to target socioeconomic risk factors in order to lessen the racial/ethnic divide.  
Strengths and limitations 
A substantial limitation to this analysis is the cross-sectional design.  One-time measurement of 
health behaviours may underestimate their contribution. Life-course and repeated measures 
designs have shown to increase the proportion of social inequalities that can be explained by 
potential modifiable risk factors. 
Second, although the sample is geographically limited to Boston, Massachusetts, the BACH Survey 
sample has been compared to other large regional (Behavioral Risk Factor Surveillance System) and 
national (the National Health and Nutrition Examination Survey) on a number of socio-demographic 
and health-related variables. The results suggest that the BACH Survey estimates of key health 
conditions are comparable with national trends.437 
Third, although we measured BGA markers, which are thought to estimate the genetic contribution 
to increased diabetes prevalence in certain populations, we do not have comprehensive markers of 
genetic risk. We therefore cannot make conclusions regarding genetic contributors to racial/ethnic 
disparities in T2DM.  
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The key strengths of this study stem from the community-based, stratified, random sample design 
of the BACH Survey which provided a large cohort of Black, Hispanic, and White men and women. 
Since this study was designed to test this specific conceptual model of disparities, validated scales 
with published metrics measuring the constructs of interest were used wherever available (Section 
7.3.1).  Finally, unlike many studies of T2DM, we did not rely solely on self-report for T2DM status. 
Participants were contacted in the morning in their home, giving a more accurate prevalence of 
T2DM. 
Conclusions 
Our study found that while lifestyle/behavioural and biophysiologic risk factors had the greatest 
direct effect on T2DM risk, socioeconomic factors had the greatest impact on explaining 
racial/ethnic disparities in T2DM.  
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7.3 Supplementary Materials 
7.3.1 Measures 
7.3.1.1 Race/ethnicity 
Race/ethnicity was self-reported by survey participants according to two separate survey questions: 
“Do you consider yourself to be Spanish, Hispanic, or Latino (Latina)?” and “What do you consider 
yourself to be? Select one or more of the following” with response categories of American Indian or 
Alaska Native, Asian, Black or African American, Native Hawaiian or other Pacific Islander, White or 
Caucasian, and Other (Specify). These questions are the standard used in the United States as 
recommended by the Office of Management and Budget.423 The racial/ethnic labels used in this 
research are 1) non-Hispanic Black (Black), 2) Hispanic of any race (Hispanic), and 3) non-Hispanic 
White (White). 
7.3.1.2 Socio-economic Influences 
As mentioned in Section 2.6, in this thesis social determinants are defined as factors that involve a 
person’s relationships to other people. This includes social and economic structures of society (i.e. 
socioeconomic status) as well as acculturation, discrimination, health literacy, and access to health 
care. In the conceptual model of this thesis (Figure 3-1) acculturation and discrimination were 
separated from SES. Higher levels of acculturation have been associated with T2DM and it is 
hypothesized that higher SES may be a key mediator of this pathway. Poverty, low SES and lower 
social capitol may be causes for everyday discrimination in addition to, or independent of, 
race/ethnicity.  In the development of the latent constructs (see Section 7.3.2.3), acculturation and 
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discrimination were captured as part of the socioeconomic domain although the exploratory factor 
analysis indicated they could considered as individual factors. Nonetheless, when the risk scores 
were developed, these constructs were captured within the socioeconomic risk score. Despite their 
temporality and complex interplay with SES, these factors are socio-economic constructs defined by 
relationships with other people and within one’s culture. 
Socioeconomic Status (SES) 
The individual SES indicators considered were: household income, educational attainment and 
occupation. Household income, originally grouped into 12 ordinal categories, was collapsed into the 
following three categories of US dollars: <20,000, 20-49,999, and ≥50,000. Educational attainment 
was categorized as less than high school, high school graduate or equivalent, some college, and 
college or advanced degree were combined due to smaller numbers.  Current or former occupation 
was categorized into four groups: (1) management, professional, sales and office occupations; (2) 
service occupations; (3) manual labour which includes construction, maintenance, farming, 
production, and transportation occupations; and (4) never worked. We use the broader term ‘SES’ 
when referring to these three distinct socioeconomic factors in the aggregate, all of which are 
strongly related to overall health.529 
Discrimination 
We measured perceptions of everyday discrimination using the Every Discrimination Scale (Short 
Version), a five item scale that attempts to measure chronic and/or routine experiences of unfair 
treatment without direct reference to the influence of race and a four item scale that measures the 
influence .556 Metrics on this scale have been published previously.556 The five items capture the 
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frequency of the following experiences in the day-to-day lives of the participants: being treated with 
less courtesy than others; less respect than others; receiving poorer service than others in 
restaurants or stores; people acting as if you are not smart; they are afraid of you; and being 
threatened or harassed. Scores for each item ranged from 0 to 5 with 0 indicating the event never 
occurred and 5 indicating an almost every day occurrence. Scores for the total scale ranged from 0 
to 45, with a high score indicating greater perceived discrimination.  
Acculturation 
The Bidimensional Acculturation Scale (BAS) was used to assess the extent to which the individuals 
participate in the cultural domains of both their original culture and the culture of contact. The 
domains assessed are language use, language proficiency, and electronic media. The BAS has been 
tested in several Hispanic populations (Central and Mexican Americans populations) and correlates 
well with generational status, length of residence in the US, and ethnic self-identification.427 
Health Literacy 
To measure health literacy, we used the abbreviated form of the s-TOFHLA, Spanish or English 
version.569 The abbreviated s-TOFHLA is a 36-item, timed reading comprehension test. Every fifth to 
seventh word in a reading passage is omitted, and 4 multiple-choice options are provided. The 
abbreviated s-TOFHLA contains two health care passages. The abbreviated s-TOFHLA is scored on a 
scale of 0 to 36. Using established convention, we categorized patients 
as having inadequate health literacy if the s-TOFHLA score was 0 to 16, marginal health literacy if it 
was 17 to 22, and adequate health literacy if it was 23 to 36. 
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Access to Health Care 
Type of health insurance (public or private), number of visits to a health care provider in the past 
year and spatial access to health care (assessed by distance to the closest community health centre, 
acute care hospital, or health care centre of either kind (miles)) were considered to be 
socioeconomic and environmental factors, respectively. While most would argue that number of 
visits to a health care provider in the past year would be influenced by the diagnosis of T2DM, rather 
than vice-versa, the case can be made that visits to a provider could influence the diagnosis of 
T2DM. Limited access to health care as measured by lack of insurance, visits to a health care 
provider in the past year, and routine patterns of health care utilization are associated with 
undiagnosed diabetes.390 Diabetes may be identified anywhere along the spectrum from a “low-risk” 
individual who has a random glucose test, to a higher-risk individual who is tested due to suspicion 
of diabetes, to the symptomatic individual.21 Essentially, the greater the visits to a health care 
provider, the greater the chance that a “missed patient” may be caught. Furthermore, data from a 
factorial experiment examining the effect of patient race/ethnicity on diabetes diagnosis 
demonstrated that even when presenting with the same signs and symptoms, a “missed diagnosis” 
of diabetes was patterned on race/ethnicity.434  
7.3.1.3 Environmental Influences 
Neighbourhood Socioeconomic Status (SES) 
Census-tract (neighbourhood) SES was based on methods used by Diez-Roux. 431  A composite index 
Z-score was created for census tract based on six measures including: log median household income; 
log median value of owner occupied housing; percent of household receiving interest, dividend or 
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net rental income; percent of adults 25 and over with high school degree; percent of adults 25 and 
over with a college degree; and percent of individuals ages 16 and over in management and 
professional occupations. An increasing score signifies increasing neighbourhood socioeconomic 
advantage. Census tracts were designated as low, middle, or high SES according to the tertiles of the 
z-score.263  
Safety 
Crime incident reports provided by the Boston Police Department were downloaded from the City of 
Boston website at https://data.cityofboston.gov/. Data was coded using conventions described by 
others.525 The property crime rates in 2010-2011 were calculated as the number of offenses of 
burglary, larceny, and motor vehicle theft per 1,000 population. Violent crime was calculated as 
murder, robbery, and assault (including sexual assault) per 1,000 population. 
Built Environment 
We used ArcGIS (Environmental Systems Research Institute, Redlands, CA) to draw circular buffers 
with 3 different radii (0.25mi, 0.5mi, and 1.0 miles) centred at each research participant’s residence.  
A distance of 0.25 mi is approximately a 5 minute walk which has been estimated to be the average 
distance walked to a grocery store in large metropolitan cities with available public transit.570 The 
food stores within each radius were categorized as supermarkets, grocery stores, fast food, and 
convenience stores.  Information on food establishments located in the Boston metro area were 
purchased from InfoUSA Inc., a proprietary information service. Supermarkets and grocery stores 
were identified by a primary SIC code of 541105. Following precedents set by previous work,526 
supermarkets were differentiated from grocery stores on the basis of chain name recognition or 
annual payroll of greater than 50 employees.  Convenience stores were identified as businesses with 
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a primary or secondary SIC code of 541102 or 541103. Following standards set by other 
researchers527 fast food restaurants including restaurants, delicatessens, pizza shops and coffee 
shops (SIC codes: 581206,07,08,09,14,19,22,24,28) had to meet the following criteria: 1) be a 
franchised vendor, 2) ability to purchase food without wait staff, and 3) sale of both food and 
beverage. To ensure that our database was both comprehensive and appropriate for Boston, we 
gathered information on fast-food restaurants in the city from several other sources. In addition to 
the InfoUSA list, we also referred to a privately run Web site, Fast Food Source 
(http://www.fastfoodsource.com), to identify fast-food restaurants in Boston. We thus defined food 
environment exposures into three category measures defined as high access (<0.25 miles), medium 
(0.25-0.50 miles), and low access (>0.50 miles) to convenience stores, grocery stores, supermarkets, 
and fast food.    
Neighbourhood disorder 
Social and physical neighbourhood order and disorder were measured using the “Perceived 
Neighbourhood Disorder” scale developed by Ross and Mirowsky.528 Social disorder refers to people 
hanging around on the streets, drug and alcohol use, trouble with neighbours, and a general 
perception of lack of safety. Physical disorder refers to graffiti, vandalism, abandoned buildings, 
cleanliness, and maintenance of homes and apartments. The physical and social disorder indices 
were created by reverse coding “order” items and summing the six items in each subscale with 
higher scores indicating higher perceived disorder.182, 430 Number of years at current address was 
used to assess residential mobility and was considered as a potential mediator between 
neighbourhood determinants and downstream health effects. 
Access to health care 
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The locations of community health centres and acute care hospitals were obtained from the 
Massachusetts Office of Geographic Information (MassGIS).571  Distance to the closest community 
health centre, acute care hospital, and community health centre or hospital were calculated in 
miles. In addition, we assessed whether the participants had a usual source of care (Yes/No) and 
their perceived difficulty in getting to their primary care provider (Very/Somewhat/Not too/Not at 
all difficult).  
7.3.1.4 Psychosocial Influences 
Sleep 
Hours of sleep each night was captured continuously and categorized as <6, 6-9, >9 hours over the 
referent period of the past month. 
Sense of Control 
The Mirowsky and Ross sense of control index429 contains 8 items that assess internal sense of 
control over positive and negative outcomes (e.g. “I am responsible for my own successes” [positive] 
and “I am responsible for my failures” [negative]) as well as a sense of powerlessness over positive 
and negative outcomes (e.g. “the really good things that happen to me are mostly luck” [positive] 
and “most of my problems are due to bad breaks” [negative]). This 2x2 design eliminates defence 
and agreement bias from the measure. All items are coded -2 to 2 (external items are reverse 
coded). The sense of control score is calculated as the sum of the responses to the 8 items, and 
ranges from maximally denying (−16) to maximally claiming control (+16). Metrics for this scale on 
Black and White populations indicate high test-retest reliability and robust confirmatory factor 
analysis validation. 182, 572 
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7.3.1.5 Lifestyle/behavioural influences 
Dietary patterns 
Participants completed the self-administered Block Food Frequency Questionnaire (FFQ) in English 
or Spanish. This FFQ has been validated to obtain data on usual dietary intake over the past year.558 
Based upon the USDA and AHA guidelines for healthy eating,535 we calculated a healthy eating score 
composed of FFQ data on average daily intake of sodium, vegetables, fruits, meats/beans, grains, 
fibre and saturated fat. The healthy eating score was adjusted for total kilocalories.  
7.3.2 Supplementary Analyses 
7.3.2.1 Risk Score Creation 
Table 7-3, below, presents the race/ethnicity-, age-, and gender-adjusted models. These results 
were used to create the weighted scoring system presented in the paper above. Variables that did 
not either (1) meet a minimal criterion for association with T2DM (p < 0.10) or (2) reduce the 
race/ethnic effect (OR) by 10% were not included in the domain risk score. For categorical variables, 
we created a weighted scoring system by rounding up all regression coefficients (ln(OR)) to the 
nearest integer. For continuous variables, risk was based on clinically accepted “high risk” criteria 
(see Table 7-1 for citations). If clinically accepted criteria were not available, tertiles were used. 
Following the construction of the final model all variables were added in the model singly to ensure 
their effects were adequately captured by the risk scores. 
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Table 7-3. Results from logistic regression models (each potential variable added one at a time to race/ethnicity, age, and gender model) 
 Odds Ratio (OR) 
(95% CI) 
p-value Black vs. White 
OR (95% CI)1 
Hispanic vs. White 
OR (95% CI)1 
Score Assigned 
Base Model (age, gender adjusted)   2.86 (1.96, 4.19) 1.98 (1.34, 2.94)  
Genetic Influences      
West African Ancestry  1.02 (0.92, 1.14) 0.658 2.44 (1.09, 5.46) 2.10 (1.18, 3.76) N/A2 
Native American Ancestry  0.94 (0.79, 1.10) 0.428 2.44 (1.09, 5.46) 2.10 (1.18, 3.76) N/A2 
Family History of Diabetes 2.11 (1.54, 2.90) <0.001 2.51 (1.71, 3.69) 1.80 (1.21, 2.69) N/A2 
Socio-economic Influences      
Income   2.30 (1.56, 3.39) 1.34 (0.87, 2.06)  
<$20,000 3.13 (2.08, 4.71) < 0.001   2 
$20,000-$49,999 1.63 (1.06, 2.51)     1 
≥ $50,000 Reference    0 
Education   1.94 (1.30, 2.88) 1.06 (0.68, 1.65)  
Less than high school 4.56 (2.74, 7.61) < 0.001   2 
High school or GED 2.60 (1.75, 3.86)     1 
Some college 1.93 (1.22, 3.05)     1 
College or advanced degree Reference    0 
Occupation   2.59 (1.77, 3.80) 1.54 (1.01, 2.35)  
Professional Reference 0.005   0 
Service 1.34 (0.91, 1.99)     0 
Manual labour 1.78 (1.15, 2.76)     1 
Never worked 2.23 (1.28, 3.89)     1 
Discrimination (log transformed) 1.03 (0.89, 1.21) 0.667 2.82 (1.92, 4.16) 2.00 (1.35, 2.96) -- 
Born in US (Yes vs. No) 1.10 (0.68, 1.76) 0.705 2.89 (1.95, 4.27) 2.14 (1.20, 3.79) 1* 
Acculturation    2.88 (1.96, 4.21) 1.68 (0.94, 2.99)  
Low Ref 0.396   0 
High/Bicultural 1.35 (0.67, 2.72)     1* 
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 Odds Ratio (OR) 
(95% CI) 
p-value Black vs. White 
OR (95% CI)1 
Hispanic vs. White 
OR (95% CI)1 
Score Assigned 
Health Literacy   2.46 (1.67, 3.63) 1.40 (0.90, 2.18)  
Inadequate 2.06 (1.33, 3.19) 0.002   1 
Marginal 1.81 (1.10, 2.96)     1 
Adequate Ref     0 
Access to/Use of health care      
Insurance Status   2.56 (1.74, 3.77) 1.71 (1.14, 2.56)  
Private 0.87 (0.33, 2.29) 0.004   0 
Public 1.69 (0.63, 4.54)     1 
Other Ref     0 
Visits to HCP in the past year   2.94 (2.00, 4.33) 2.06 (1.39, 3.06)  
0-1 0.37 (0.23, 0.62) < 0.001   0 
2-6 0.62 (0.45, 0.86)     0 
7+ Ref     1 
Environmental Influences (random 
intercept models) 
  
2.89 (2.08, 4.01) 2.53 (1.86, 3.45) 
 
CT SES   2.71 (1.91, 3.83) 2.39 (1.72, 3.30)  
Low 1.27 (0.89, 1.82) 0.193   -- 
Middle 1.18 (0.83, 1.68) 0.356   -- 
High Reference    -- 
CT Poverty   2.63 (1.84, 3.75) 2.29 (1.65, 3.19)  
< 5% Reference    0 
5-9.9% 1.73 (0.88, 3.39) 0.109   0 
10-19.9% 1.15 (0.62, 2.13) 0.648   0 
≥ 20% 1.72 (0.93, 3.18) 0.086   1 
CT Racial Composition      
% Black (log transformed) 1.04 (0.92, 1.18) 0.494 2.73 (1.86, 4.02) 2.45 (1.76, 3.41) -- 
% White (log transformed) 0.95 (0.82, 1.10) 0.484 2.74 (1.87, 4.00) 2.45 (1.77, 3.40) -- 
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 Odds Ratio (OR) 
(95% CI) 
p-value Black vs. White 
OR (95% CI)1 
Hispanic vs. White 
OR (95% CI)1 
Score Assigned 
% Hispanic (log transformed) 1.09 (0.92, 1.29) 0.324 2.82 (2.02, 3.92) 2.42 (1.75, 3.35) -- 
Property crime (log transformed) 1.11 (0.86, 1.43) 0.419 2.82 (2.02, 3.94) 2.48 (1.81, 3.40) -- 
Violent crime (log transformed) 1.16 (0.94, 1.43) 0.169 2.72 (1.93, 3.82) 2.42 (1.76, 3.33) -- 
Access to Supermarkets   2.91 (2.10, 4.03) 2.53 (1.86, 3.45) -- 
Low Access (> 0.5 miles) 0.76 (0.53, 1.08) 0.169   -- 
Medium Access (0.25-0.5 miles) 0.77 (0.52, 1.12) 0.169   -- 
High Access (< 0.25 miles) Reference    -- 
Access to Grocery Stores   2.90 (2.09, 4.03) 2.50 (1.83, 3.41) -- 
Low Access (> 0.5 miles) 0.69 (0.43, 1.10) 0.121   -- 
Medium Access (0.25-0.5 miles) 0.88 (0.68, 1.14) 0.331   -- 
High Access (< 0.25 miles) Reference    -- 
Access to Convenience Stores   2.89 (2.08, 4.01) 2.50 (1.83, 3.42) -- 
Low Access (> 0.5 miles) 0.94 (0.56, 1.56) 0.804   -- 
Medium Access (0.25-0.5 miles) 0.81 (0.60, 1.09) 0.159   -- 
High Access (< 0.25 miles) Reference    -- 
Access to Fast Food   2.93 (2.11, 4.06) 2.54 (1.87, 3.45) -- 
Low Access (> 0.5 miles) 0.80 (0.59, 1.08) 0.15   -- 
Medium Access (0.25-0.5 miles) 0.95 (0.72, 1.26) 0.739   -- 
High Access (< 0.25 miles) Reference    -- 
CT % Open Space   2.85 (2.05, 3.95) 2.52 (1.85, 3.43) -- 
≤ 5% 1.14 (0.73, 1.78) 0.57   -- 
5.1-10% 0.94 (0.57, 1.53) 0.798   -- 
10.1-20% 1.11 (0.67, 1.85) 0.678   -- 
> 20% Reference    -- 
Neighbourhood Disorder   2.78 (2.00, 3.87) 2.45 (1.80, 3.35)  
Social (log transformed) 1.09 (0.58, 2.05) 0.79   -- 
Physical (log transformed) 1.37 (0.79, 2.38) 0.26   -- 
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 Odds Ratio (OR) 
(95% CI) 
p-value Black vs. White 
OR (95% CI)1 
Hispanic vs. White 
OR (95% CI)1 
Score Assigned 
Years Lived at Current Address (log 
transformed) 
0.90 (0.78, 1.04) 0.16 
2.79 (2.01, 3.88) 2.39 (1.74, 3.29) 
-- 
Access to Community Health Centre 
(miles) 0.96 (0.66, 1.41) 0.851 2.84 (1.94, 4.15) 1.97 (1.32, 2.93) 
-- 
Psychosocial Influences      
Sleep Duration   2.57 (1.74, 3.80) 1.83 (1.21, 2.76)  
< 6 2.07 (1.45, 2.96) < 0.001   1 
6-9 Ref     0 
> 9 3.32 (0.92, 11.95)     2 
Major Life Events (log transformed) 1.18 (0.83, 1.69) 0.349 2.82 (1.93, 4.11) 1.97 (1.32, 2.92) 1 (> 1 MLE) 
Sense of Control  
0.63 (0.45, 0.87) 0.006 2.83 (1.93, 4.14) 1.68 (1.10, 2.56) 
1 (< 1.0), 2 (< 
0.43) 
Lifestyle/Behavioural Influences      
Dietary Influences2      
< 1500 mg Sodium 0.91 (0.55, 1.51) 0.702 2.84 (1.93, 4.17) 1.94 (1.30, 2.88) -- 
3-4 Servings of Vegetables 0.72 (0.39, 1.33) 0.293 2.80 (1.91, 4.12) 1.87 (1.25, 2.79) -- 
2-3 Servings of Fruit 0.96 (0.61, 1.51) 0.845 2.81 (1.90, 4.14) 1.91 (1.28, 2.84) -- 
2-3 Servings of Meat/Beans 0.87 (0.58, 1.28) 0.470 2.81 (1.91, 4.13) 1.92 (1.30, 2.85) -- 
6-11 Servings of Grain 0.77 (0.47, 1.27) 0.301 2.78 (1.88, 4.10) 1.91 (1.28, 2.85) -- 
25-30 g of Fibre 0.82 (0.44, 1.53) 0.529 2.80 (1.91, 4.11) 1.92 (1.29, 2.85) -- 
< 14 g Saturated Fat 0.84 (0.55, 1.28) 0.422 2.84 (1.93, 4.18) 1.96 (1.33, 2.90) -- 
FFQ Score (log) 0.70 (0.48, 1.03) 0.068 2.80 (1.90, 4.11) 1.97 (1.33, 2.91) -- 
Total Kcal (log) 0.87 (0.65, 1.17) 0.357 2.82 (1.92, 4.14) 1.92 (1.29, 2.85) -- 
Physical activity   2.83 (1.92, 4.15) 1.91 (1.28, 2.84)  
Low 1.77 (0.99, 3.17) 0.004   1 
Medium 1.00 (0.59, 1.72)     0 
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 Odds Ratio (OR) 
(95% CI) 
p-value Black vs. White 
OR (95% CI)1 
Hispanic vs. White 
OR (95% CI)1 
Score Assigned 
High Ref     0 
Smoking status   2.73 (1.87, 3.99) 1.96 (1.32, 2.91)  
Never Ref 0.014   0 
Former 1.03 (0.73, 1.47)     0 
Current 1.81 (1.19, 2.75)     1 
BMI (log transformed) 
31.42 (14.07, 70.15) < 0.001 2.51 (1.68, 3.77) 1.88 (1.25, 2.84) 
1 (25-29), 2 (30-
39), 3 (> 40) 
Waist Circumference  
1.05 (1.04, 1.06) < 0.001 2.78 (1.86, 4.15) 2.54 (1.66, 3.87) 
1 (≥ 102 cm, 
men; ≥ 88 cm, 
women) 
Body Fat % 
1.06 (1.04, 1.09) < 0.001 2.54 (1.70, 3.80) 1.91 (1.28, 2.87) 
1 (> 25%, men; > 
35% women), 2 
(> 33%, men; > 
42%, women) 
Biophysiological Influences      
SBP 1.02 (1.01, 1.03) < 0.001 2.50 (1.70, 3.70) 1.92 (1.29, 2.87) 1 (SBP ≥ 130) 
DBP 1.01 (1.00, 1.03) 0.101 2.73 (1.86, 4.00) 1.97 (1.33, 2.93) 1 (DBP ≥ 85) 
Total Cholesterol 0.99 (0.98, 0.99) < 0.001 3.01 (2.05, 4.41) 2.05 (1.37, 3.06) 1 (≥ 200 mg/dL) 
HDL Cholesterol 
0.97 (0.96, 0.99) < 0.001 3.00 (2.04, 4.41) 1.83 (1.22, 2.75) 
1 (< 40 mg/dL, 
men; < 50 
mg/dL women) 
Triglycerides 1.00 (1.00, 1.00) < 0.001 3.12 (2.14, 4.55) 1.97 (1.31, 2.95) 1 (≥ 150) 
Hypertension 3.21 (1.98, 5.19) < 0.001 2.41 (1.64, 3.55) 1.90 (1.26, 2.85) 1 
Cardiovascular Disease 2.86 (1.99, 4.12) < 0.001 2.72 (1.84, 4.01) 1.92 (1.28, 2.88) 2 
Women Only   3.09 (1.88, 5.09) 2.46 (1.48, 4.10)  
Menopausal Status   2.83 (1.71, 4.70) 2.34 (1.39, 3.93)  
Pre/Peri Reference 0.017   0 
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 Odds Ratio (OR) 
(95% CI) 
p-value Black vs. White 
OR (95% CI)1 
Hispanic vs. White 
OR (95% CI)1 
Score Assigned 
Post 2.14 (0.95-4.81)    1 
Undetermined/Unknown 3.11 (1.36-7.11)    2 
Gestational Diabetes 8.46 (4.03-17.74) <0.001 3.34 (1.99, 5.62) 2.28 (1.32, 3.93) 2 
1 Bold indicates racial/ethnic effect was reduced by ≥ 10% 
2 Genetic factors were treated as exogenous (not predicted by any other variables in the model) variables and therefore not incorporated into the 
mediating risk scores 
3 All dietary influences are also adjusted for total kcal 
* Point was added to risk score due to mediation of the effect of race/ethnicity rather than a direct effect on T2DM 
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7.3.2.2 Structural Equation Model – Full Results 
Standardized coefficients (StdYX and StdY) are presented in the main body of the paper. 
However, unstandardized coefficients may be useful as well.  All standardized and 
unstandardized coefficients are available in Table 7-4, below. The unstandardized coefficients 
may be interpreted in the typical manner: as a logistic regression coefficient for a binary 
outcome (environmental risk and T2DM) or as a linear regression coefficient for a continuous 
outcome (all other outcomes). For example, the unstandardized coefficients suggest that for 
every one unit increase in the lifestyle/behavioural risk score the odds of T2DM increase 35% 
(OR=1.35) and for every one unit increase in the biophysiological risk score the odds increase 
29% (OR=1.29). 
Table 7-4 Final Structural Equation Model of Factors in the Pathway from Race/Ethnicity to 
T2DM (full standardized and non-standardized results) 
Predictor Outcome Standardized 
Coefficient 
Unstandardized 
Coefficient 
p-value 
Black vs. White Socioeconomic Risk 0.226 0.969 0.003 
Hispanic vs. White Socioeconomic Risk 0.173 0.900 <0.001 
West African 
ancestry 
Socioeconomic Risk 0.105 0.057 0.135 
Native American 
ancestry 
Socioeconomic Risk 0.008 0.013 0.801 
% Black 
participants1 
Environmental Risk 0.140 0.269 0.001 
% Hispanic 
participants1 
Environmental Risk 0.289 0.689 <0.001 
West African 
ancestry 
Environmental Risk ND2   
Native American 
ancestry 
Environmental Risk ND2   
Socioeconomic Risk Environmental Risk 0.410 0.225  <0.001 
Black vs. White Psychosocial Risk 0.003 0.006 0.965 
Hispanic vs. White Psychosocial Risk 0.173 0.496 <0.001 
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Predictor Outcome Standardized 
Coefficient 
Unstandardized 
Coefficient 
p-value 
West African 
ancestry 
Psychosocial Risk 0.031 0.009 0.653 
Native American 
ancestry 
Psychosocial Risk 0.023 0.019 0.477 
Socioeconomic Risk Psychosocial Risk 0.391 0.207 <0.001 
Environmental Risk Psychosocial Risk 0.009 0.008 0.903 
Black vs. White Lifestyle/behavioural Risk 0.113 0.451 0.081 
Hispanic vs. White Lifestyle/behavioural Risk 0.037 0.178 0.369 
West African 
ancestry 
Lifestyle/behavioural Risk -0.034 -0.017 0.605 
Native American 
ancestry 
Lifestyle/behavioural Risk -0.034 -0.051 0.312 
Socioeconomic Risk Lifestyle/behavioural Risk 0.312 0.291 <0.001 
Environmental Risk Lifestyle/behavioural Risk 0.114 0.165 0.178 
Psychosocial Risk Lifestyle/behavioural Risk 0.008 0.014 0.785 
Black vs. White Biophysiologic Risk 0.069 0.259 0.264 
Hispanic vs. White Biophysiologic Risk 0.044 0.200 0.283 
West African 
ancestry 
Biophysiologic Risk -0.072 -0.034 0.218 
Native American 
ancestry 
Biophysiologic Risk 0.015 0.021 0.602 
Socioeconomic Risk Biophysiologic Risk 0.136 0.120 <0.001 
Environmental Risk Biophysiologic Risk 0.083 0.116 0.297 
Psychosocial Risk Biophysiologic Risk 0.049 0.082 0.069 
Lifestyle/behaviour
al risk 
Biophysiologic Risk 0.205 0.194 <0.001 
Family history Biophysiologic Risk 0.047 0.169 0.056 
Black vs. White T2DM 0.177 0.875 0.054 
Hispanic vs. White T2DM 0.100 0.600 0.069 
West African 
ancestry 
T2DM -0.003 -0.002 0.976 
Native American 
ancestry 
T2DM -0.016 -0.029 0.725 
Socioeconomic Risk T2DM 0.132 0.152 0.003 
Environmental Risk T2DM -0.022 -0.037 0.861 
Psychosocial Risk T2DM 0.039 0.085 0.283 
Lifestyle/behaviour
al risk 
T2DM 0.248 0.306 <0.001 
Family history T2DM 0.102 0.485 0.005 
Biophysiologic Risk T2DM 0.192 0.251 <0.001 
1 The % of Black and Hispanic participants within each census tract were used to predict neighbourhood-
level outcomes 
2 ND = Not determined, model would not converge with this path present 
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7.3.2.3 Alternative Modelling Techniques 
The conceptual model presented in Figure 7-1 would ideally be modelled as a structural 
equation model using latent constructs to represent the conceptual mediating domains.  
The latent variable specification in SEM is typically based on a confirmatory factor analysis 
(CFA).573 The use of CFA modelling in SEM encourages the use of validated instruments with 
simple measurement structures in an a priori specified model. Despite the use of validated 
instruments an a priori conceptual model, it was unknown how the measures included in this 
study would harmonize. For example, could the measures included in the socioeconomic domain 
be summarized by a single latent factor?  
Despite the fact that CFA procedures are often used for exploratory purposes, there are a 
number of critiques of using these techniques.574 Therefore, rather than relying on traditional 
CFA models, we used the exploratory structural equation modelling (ESEM) approach. In the 
ESEM approach, exploratory factor measurement models with factor loading matrix rotations 
can be used.573 
In order to optimize the number of latent constructs within each mediating domain of interest, 
ESEMs were formulated for a measurement model. Each domain was explored separately, with 
varying factor sizes, and using geomin rotation.   
For the socioeconomic domain ESEMs with one, two, or three latent constructs were explored. 
The analyses indicated a three-factor exploratory structure fit the data well (Table 7-5). The 
comparative fit index (CFI) = 1.000 and the root mean squared error of approximation (RMSEA) = 
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0.005. As described in Section 5.3, models are said to fit the data well if the RMSEA is 0.08 or 
less. 
Table 7-5. Exploratory Factor Analysis Estimates for the Socioeconomic Domain 
Items 
Factor 1 
“Socio-economic” 
Factor 2 
“Immigration” 
Factor 3 
“Discrimination” 
Income 0.729 -0.064 0.026 
Education 0.868 -0.068 -0.031 
Occupation* 0.698 0.021 0.041 
Discrimination 0.000 0.294 1.150 
Immigration Status 0.000 1.439 -0.660 
Acculturation* 0.591 0.453 0.017 
Health Literacy 0.687 0.111 -0.093 
* Reverse coded 
The factor loadings presented in Table 7-5 suggest potential interpretation of the factors in 
terms of socioeconomic-, immigration-, and discrimination related factors. There was only one 
notable cross-loading. Acculturation could factor with either the socioeconomic or the 
immigration domains. In an ESEM the loading estimates are not standardized to item variances 
and the variances are allowed to vary across items.  
The factor loadings and model indices across the other domains indicated: a one factor model 
for the psychosocial domain (two or higher factor models would not converge), a three factor 
model for the lifestyle/behavioural domain, a three factor model for the biophysiological domain 
for women, and a two factor model for men. Given these results the model was revised to 
accommodate these findings (Figure 7-3). 
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Figure 7-3. Revised Conceptual Model 
 
 
The full conceptual model as presented in Figure 7-3 would not converge using structural 
equation modelling with latent constructs predicted by our measured mediating influences. The 
following models were attempted in order of decreasing complexity: 
 1-level model removing the environmental influences 
 Constructs with low factor loadings were removed 
 Psychosocial domain was removed 
 SEM with just the socioeconomic and lifestyle/behavioural domains (converged) 
 SEM with just the socioeconomic and biophysiologic domains (converged) 
 SEM with just the lifestyle/behavioural domains and biophysiologic domains (did not 
converge) 
 SEM with one latent factor for each remaining domain of influence (socioeconomic, 
lifestyle/behavioural, and biophysiologic) (did not converge) 
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In conclusion, even greatly simplified models would not converge. This limited the ability to 
make conclusions regarding the relative contributions of the relevant domains of interest. 
Therefore, my co-author S.V. Subramanian and I developed the risk score model approach 
presented in the paper (Section 7.2). 
There are limitations to the risk score method we developed. The largest limitation is that the 
risk score approach likely introduces measurement error into the mediating domains in our 
model. Non-differential measurement error (for a mediator non-differential measurement error 
is defined as error that is neither associated with the outcome of interest nor the exposure of 
interest)575 typically biases estimates towards the null (no association). Therefore, it is likely that 
the risk score method underestimates the true degree of mediation by the socioeconomic, 
environmental, psychosocial, lifestyle/behavioural, and biophysiologic domains of interest.  
Despite this limitation, there are also benefits to using the risk score approach. The risk scores 
developed could prove to be useful and intuitive to clinicians. The method used to develop the 
risk scores mirrors the construction of the American Diabetes Association self-assessment tool563 
and the  American Diabetes Association’s criteria for testing for diabetes in asymptomatic 
adults.21 
To examine the potential impact of our risk score development, I conducted several sensitivity 
analyses. The outcomes of these sensitivity analyses are presented in Table 7-6. Sub-table A 
demonstrates the standardized coefficient of our risk scores (as described and used in the 
manuscript) on T2DM directly (each modelled singly) in the column titled StdYX on T2DM. The 
direct effect of Black race and Hispanic race on each risk score, each modelled singly, are 
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presented in the columns StdY Black on Domain and StdY Hispanic on Domain. Finally, the 
direct effect of Black race and Hispanic race on T2DM while the mediating pathway for that risk 
score, each modelled singly, was controlled are presented (StdY Black on T2DM and StdY 
Hispanic on T2DM).  
In Sub-table B, I developed greatly simplified structural equation models, using only one 
mediating latent construct at a time. I used the StdY and StdYX for each measured construct on 
the latent variable (e.g. socioeconomic risk) to create a “risk score.” These resulting risk scores 
were then used in a full structural equation model similar to the model presented in Figure 7-2. 
This allowed for a head-to-head comparison with our results presented in the paper (Table 7-7).   
The greatest differences seen between the risk scores developed in the paper and those 
developed for the sensitivity analyses are for the psychosocial domain. The latent variable/risk 
score hybrid approach indicates a greater role for psychosocial influences. This may indicate that 
our model as presented in the paper may underestimate the true influence of psychosocial risk 
factors. Despite these results, we proceeded with our initial risk score methodology, as the 
development of these risk scores may be more valuable to clinicians, since they were based on 
clinically accepted criteria, and may be more readily interpretable. 
In Sub-table c, I again developed greatly simplified structural equation models, using only one 
mediating latent construct at a time. However, no risk construct was created. The results 
presented indicate the findings using a single latent variable to represent the domain of interest. 
The results were similar to those demonstrated in Sub-table B. And the overall direction and 
significance of the estimates were in line with Sub-table A. The full model would not converge 
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using latent constructs to represent all domains of interest. Therefore these results are not 
directly compared to those in Figure 7-2. 
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Table 7-6. Sensitivity analyses comparing risk score methodology to latent variable 
methodology 
a. Method 1 for the development of the risk scores (as described in the manuscript) 
 StdYX on 
T2DM 
(p-value) 
StdY Black on 
Domain 
(p-value) 
StdY Black 
on T2DM 
(p-value) 
StdY Hispanic 
on Domain 
(p-value) 
StdY Hispanic 
on T2DM 
(p-value) 
R2 
Socioeconomic 0.24 (< 0.001) 0.22 (0.002) 
 
0.24 (0.01) 0.41 (<0.001) 
 
0.08 (0.18) 0.27 
Environmental1 0.17 (0.09) 0.412 (<0.001) 0.24 (0.009) 0.482 (<0.001) 0.14 (0.01) 0.24 
Psychosocial 0.14 (0.001) 0.09 (0.22) 0.29 (0.001) 0.26 (<0.001) 0.15 (0.006) 0.26 
Lifestyle/ 
Behaviour 
0.40 (<0.001) 0.21 (0.001) 
 
0.25 (0.005) 0.12 (0.004) 
 
0.15 (0.003) 0.38 
Biophysiologic 0.31 (<0.001) 0.15 (0.02) 0.22 (0.01) 0.11 (0.004) 0.13 (0.02) 0.33 
b. Method 2 for the development of the risk scores (hybrid method uses the results of 
factor analysis of underlying latent construct to create the risk score) 
 StdYX on 
T2DM 
(p-value) 
StdY Black on 
Domain 
(p-value) 
StdY Black 
on T2DM 
(p-value) 
StdY Hispanic 
on Domain 
(p-value) 
StdY Hispanic 
on T2DM 
(p-value) 
R2 
Socioeconomic 0.25 (< 0.001) 0.18 (0.02) 
 
0.21 (0.01) 0.64 (<0.001) 
 
-0.01 (0.88) 0.28 
Environmental1 0.17 (0.09) 0.412 (<0.001) 0.24 (0.009) 0.482 (<0.001) 0.14 (0.01) 0.24 
Psychosocial 0.14 (0.001) 0.13 (0.07) 0.24 (0.007) 0.23 (<0.001) 0.13 (0.02) 0.27 
Lifestyle/ 
Behaviour 
0.34 (<0.001) 0.18 (0.01) 
 
0.24 (0.008) 0.03 (0.55) 
 
0.17 (0.001) 0.37 
Biophysiologic       
Men 0.12 (0.01) 0.15 (0.13) 0.19 (0.14) 0.05 (0.45) 0.13 (0.10) 0.24 
Women 0.22 (<0.001) 0.12 (0.26) 0.30 (0.004) 0.15 (0.01) 0.17 (0.02) 0.33 
c. Method 3 latent variable method  
 StdYX on 
T2DM 
(p-value) 
StdY Black on 
Domain 
(p-value) 
StdY Black 
on T2DM 
(p-value) 
StdY Hispanic 
on Domain 
(p-value) 
StdY Hispanic 
on T2DM 
(p-value) 
R2 
Socioeconomic 0.45 (<0.001) 0.26 (<0.001) 
 
0.14 (0.15) 0.71 (<0.001) 
 
-0.16 (0.11) 0.31 
Environmental1 0.17 (0.09) 0.412 (<0.001) 0.24 (0.009) 0.482 (<0.001) 0.14 (0.01) 0.24 
Psychosocial 0.27 (0.20) 0.07 (0.69) 0.25 (0.02) 0.47 (<0.001) 0.04 (0.78) 0.30 
Lifestyle/ 
Behaviour 
0.39 (<0.001) 0.21 (0.002) 
 
0.20 (0.11) 0.08 (0.07) 
 
0.13 (0.03) 0.34 
Biophysiologic       
Men 0.02 (0.86) 0.18 (0.29) 0.21 (0.12) -0.01 (0.95) 0.12 (0.14) 0.23 
Women 0.39 (0.36) 0.38 (0.05) 0.19 (0.42) 0.20 (0.08) 0.14 (0.37) 0.38 
1 Estimates for environmental domain are the same because they are parameterized the same. Only one variable 
predicted this domain. 
2 Estimate for cluster level mean of Black/Hispanic race/ethnicity 
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Table 7-7. Final Structural Equation Model of Factors in the Pathway from Race/Ethnicity to 
T2DM (full standardized and non-standardized results) – Compare risk models 
  Risk scores based on 
standard method  
(Method a) 
Risk scores based on 
latent variable results 
(Method b) 
Predictor Outcome Standard-
ized 
Coefficient 
p-value Standard-
ized 
Coefficient 
p-value 
Black vs. White Socioeconomic 
Risk 
0.22 0.002 0.177 0.003 
Hispanic vs. White Socioeconomic 
Risk 
0.41 <0.001 0.641 <0.001 
West African 
ancestry 
Socioeconomic 
Risk 
-0.003 0.977 0.075  0.224 
Native American 
ancestry 
Socioeconomic 
Risk 
-0.018 0.693 0.044 0.109 
Black vs. White Environmental 
Risk 
0.149 <0.001 0.168 <0.001 
Hispanic vs. White Environmental 
Risk 
0.153 0.004 0.040 0.609 
West African 
ancestry 
Environmental 
Risk 
ND1  ND1  
Native American 
ancestry 
Environmental 
Risk 
ND1  ND1  
Socioeconomic Risk Environmental 
Risk 
0.448 <0.001 0.498 <0.001 
Black vs. White Psychosocial Risk 0.001 0.992 0.055 0.424 
Hispanic vs. White Psychosocial Risk 0.082 0.044 -0.030 0.552 
West African 
ancestry 
Psychosocial Risk 0.031 0.665 0.02 0.783 
Native American 
ancestry 
Psychosocial Risk 0.015 0.624 -0.001 0.968 
Socioeconomic Risk Psychosocial Risk 0.402 <0.001 0.377 <0.001 
Environmental Risk Psychosocial Risk 0.050 0.505 0.065 0.415 
Black vs. White Lifestyle/ 
behavioural Risk 
0.120 0.065 0.114 0.121 
Hispanic vs. White Lifestyle/ 
behavioural Risk 
-0.028 0.516 -0.049 0.405 
West African 
ancestry 
Lifestyle/ 
behavioural Risk 
-0.032 0.621 -0.024 0.752 
Native American 
ancestry 
Lifestyle/ 
behavioural Risk 
-0.040 0.259 -0.025 0.471 
Socioeconomic Risk Lifestyle/ 
behavioural Risk 
0.268 0.000 0.009 0.858 
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  Risk scores based on 
standard method  
(Method a) 
Risk scores based on 
latent variable results 
(Method b) 
Predictor Outcome Standard-
ized 
Coefficient 
p-value Standard-
ized 
Coefficient 
p-value 
Environmental Risk Lifestyle/ 
behavioural Risk 
0.164 0.041 0.172 0.018 
Psychosocial Risk Lifestyle/ 
behavioural Risk 
0.026 0.392 0.087 0.003 
Black vs. White Biophysiologic 
Risk 
0.067 0.274 0.029 0.532 
Hispanic vs. White Biophysiologic 
Risk 
0.010 0.803 0.007 0.857 
West African 
ancestry 
Biophysiologic 
Risk 
-0.071 0.221 -0.124 0.012 
Native American 
ancestry 
Biophysiologic 
Risk 
0.013 0.654 0.023 0.311 
Socioeconomic Risk Biophysiologic 
Risk 
0.131 0.000 0.055 0.070 
Environmental Risk Biophysiologic 
Risk 
0.117 0.142 0.078 0.209 
Psychosocial Risk Biophysiologic 
Risk 
0.054 0.050 0.019 0.394 
Lifestyle/behaviour
al risk 
Biophysiologic 
Risk 
0.211 <0.001 0.159 <0.001 
Family history Biophysiologic 
Risk 
0.050 0.032 0.012 0.588 
Black vs. White T2DM 0.181 0.049 0.19 0.045 
Hispanic vs. White T2DM 0.075 0.201 0.024 0.721 
West African 
ancestry 
T2DM -0.003 0.977 -0.009 0.924 
Native American 
ancestry 
T2DM -0.018 0.693 -0.020 0.655 
Socioeconomic Risk T2DM 0.100 0.029 0.200 <0.001 
Environmental Risk T2DM 0.001 0.993 0.047 0.661 
Psychosocial Risk T2DM 0.048 0.197 0.072 0.042 
Lifestyle/behaviour
al risk 
T2DM 0.257 0.000 0.283 <0.001 
Family history T2DM 0.098 0.003 0.119 <0.001 
Biophysiologic Risk T2DM 0.197 <0.001 0.105 0.007 
1 ND = Not determined, model would not converge with this path present 
2 N/A = Not applicable, cluster means were used to predict neighbourhood-level outcomes, 
unstandardized outcome is not directly interpretable 
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8 Discussion 
The purpose of this thesis was to quantify the relative contribution of (i) social and economic, (ii) 
contextual/neighbourhood, (iii) psychosocial, (iv) lifestyle/behavioural, (v) biophysiologic, and 
(vi) genetic/ancestral factors to racial/ethnic disparities in T2DM. This aim was addressed 
through a series of papers with the following objectives: 
1. To quantify the contributions of genetic biogeographic ancestry versus socioeconomic 
factors to racial/ethnic disparities in T2DM incidence. 
2. To identify and estimate the contributions of specific aspects of contextual 
environments/neighbourhoods to racial/ethnic disparities in T2DM prevalence.  
3. To quantify the relative contributions of (i) social and economic, (ii) 
contextual/neighbourhood, (iii) psychosocial, (iv) lifestyle/behavioural, (v) 
biophysiologic, and (vi) genetic/ancestral factors to racial/ethnic disparities in 
prevalent T2DM. 
In the following section (Section 8.1), the results from each manuscript will be discussed briefly 
and then the findings of these different papers will be synthesized. The strengths and limitations 
of my overall research findings will then be briefly discussed in Section 8.2. The strengths and 
limitations of each paper have been presented in the submitted papers presented in previous 
chapters. Therefore, those details will not be repeated here. The implications of my research 
findings for policy and practice are discussed in Section 8.3 followed by recommendations for 
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future research in Section 8.4.  Finally, an overview of my dissemination activities is provided in 
Section 8.5. 
8.1 Summary and synthesis of the research findings 
The objective of the first paper with substantive findings (Chapter 5) was to quantify the 
contribution of genetic biogeographic ancestry versus socioeconomic factors to racial/ethnic 
disparities in T2DM incidence. In these analyses I used longitudinal data from the BACH Study to 
examine the effects of race/ethnicity, biogeographic ancestry, and socioeconomic factors on the 
cumulative incidence of diagnosed T2DM. These analyses were supplemented with cross-
sectional data examining the prevalence of both diagnosed and undiagnosed T2DM. The results 
demonstrated that racial/ethnic disparities in the incidence of T2DM were potentially mediated 
by SES, whereas biogeographic ancestry appeared to have no effect on this association. The 
results also demonstrated that while African ancestry is significantly associated with T2DM 
incidence, a large proportion of this association was mediated by self-identified race/ethnicity 
and socioeconomic factors.  
The findings from the supplementary cross-sectional analyses (Section 5.4) were similar. 
However, the association between biogeographic ancestry and T2DM was not eliminated when 
self-identified race/ethnicity and socioeconomic factors were taken into account. 
The objective of the second paper with substantive findings (Chapter 6) was to identify and 
estimate the contribution of specific aspects of contextual environments/neighbourhoods to 
racial/ethnic disparities in T2DM prevalence. There was a large variation in the prevalence of 
T2DM by neighbourhood. This geographic variation was not explained by the composition of the 
neighbourhood (i.e. individual-level factors) in the BACH Study.  This geographic variation was 
also not explained by the contextual variables collected in this study including measures of: (1) 
built environment (proximity to supermarkets, grocery stores, convenience stores, fast food 
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outlets, and open recreational space), (2) neighbourhood socioeconomics (composite SES 
measure, poverty), (3) racial composition, (4) safety (property and violent crime), or 
neighbourhood disorder (physical and social).  More importantly, none of these contextual 
elements, singly or in combination, attenuated the measured racial/ethnic disparities in T2DM.  
The objective of the third paper with substantive findings (Chapter 7) was to quantify the 
relative contribution of (i) social and economic, (ii) contextual/neighbourhood, (iii) psychosocial, 
(iv) lifestyle/behavioural, (v) biophysiologic, and (vi) genetic/ancestral factors to racial/ethnic 
disparities in prevalent T2DM. The results indicated that that much of the excess odds of T2DM 
among Black (61%) and Hispanic (54%) participants could not be explained by the constructs 
measured in the BACH Study. The socioeconomic risk score developed, which was a composite 
of household income, education, occupation, immigration status, acculturation, health literacy, 
insurance status and utilization of health care, explained 22% of the excess odds of T2DM among 
Black and 26% of the excess odds among Hispanic participants. The environmental risk score 
explained only 1% and 4% of the excess odds of diabetes among Black and Hispanic participants, 
respectively; psychosocial factors explained 0% and 5%; lifestyle/behavioural 11% and 6%; and 
biophysiologic factors 5% and 5%. Finally biogeographic ancestry was included in the final model 
as a confounder and significant associations with neither T2DM nor with any of the mediating 
risk domains were found.  
The latter result further bolsters the results from the first results-driven paper on biogeographic 
ancestry. Both the longitudinal and cross-sectional findings demonstrated that self-identified 
race/ethnicity and socioeconomic factors may explain much of the excess risk of T2DM thought 
to be associated with biogeographic ancestry.  These analyses indicate that while genetic factors, 
including biogeographic ancestry, may play a role in T2DM, it is likely that the social, cultural, 
and economic facets of race/ethnicity better explain T2DM disparities in the US. Specifically, the 
Page 189 of 317 
 
lower average SES of Blacks and Hispanics in the US, compared with that of Whites, provides a 
plausible explanation for a large proportion of the excess risk of T2DM. 
General conclusions regarding the total contribution of “genetic factors” to racial/ethnic 
disparities in T2DM cannot be made, since the BACH Study only collected markers relating to 
biogeographic ancestry. However, review of the literature indicates that genetic variation does 
not explain a substantial proportion of variation in T2DM risk, even though genetic 
polymorphisms linked to T2DM have been identified. This suggests that other contributors, 
including gene-environment interactions, are more likely to play a major role. 576 Furthermore, 
the presence of disparities in multiple unrelated health outcomes as well as the presence of 
heterogeneity in racial/ethnic differences over time and across contexts suggests that genetic 
factors alone are unlikely to explain racial/ethnic disparities in T2DM.  
The findings from all three papers underscore the importance of social and economic factors in 
racial/ethnic disparities in T2DM. The results from the biogeographic ancestry analyses, as well 
as the relative contributions analyses, indicate that social and economic factors, particularly 
income, education, and occupation are mediators in the relationship between self-identified 
race/ethnicity and T2DM incidence and prevalence. Estimates of this indirect effect ranged from 
64% and 100% of the total effect for Blacks and Hispanics in the longitudinal analyses to 46% and 
100% in the cross-sectional analyses. The cross-sectional findings from both manuscripts indicate 
that social and economic factors may have an indirect effect on T2DM through 
lifestyle/behavioural risk factors and body mass. Even after accounting for environmental, 
psychosocial, lifestyle/behavioural, and biophysiologic risk factors, social and economic risk 
factors were estimated to account for 22% and 26% of the total relationship between Black race 
and Hispanic ethnicity and the odds of T2DM. 
Lifestyle/behavioural factors also appear to play an important role in development of disparities 
in T2DM. There is a plethora of research on the impact of diet and exercise on T2DM and these 
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findings also demonstrate a significant direct effect of lifestyle/behavioural risk factors on T2DM. 
In the final structural equation model (Figure 7-2), the lifestyle/behavioural risk domain had the 
largest direct effect on T2DM prevalence. However, it is important to note that the results 
indicated no direct effect between race/ethnicity and lifestyle/behavioural risk. Furthermore, 
lifestyle/behavioural risk factors (i.e. physical activity, smoking history, BMI, waist 
circumference, and body fat percentage) appeared to explain only 11% and 6% of the excess 
odds of T2DM among Blacks and Hispanics, respectively. 
Although race/ethnicity had no direct effect on lifestyle/behavioural risk, it is important to note 
that socioeconomic risk, which was highly associated with race/ethnicity, did have a significant 
direct effect on lifestyle/behavioural risk. Overall, lifestyle/behavioural risk explained 43.3% of 
the association between socioeconomic status and T2DM. Other studies have found similar 
results.373 These results indicate a complex relationship between race/ethnicity, adverse 
socioeconomic conditions and lifestyle/behavioural risk factors.  While there are many pathways 
and mechanisms by which race/ethnicity and SES can combine to affect the development of 
diabetes (see Section 2.6) including early life exposures, environmental conditions and 
opportunities, as well as psychosocial stress, these results appear to emphasize the contribution 
of adult lifestyle/behavioural risk factors. However, it is important to note that early life 
exposures were not captured in this study. 
Contextual features of residential neighbourhood are one potential pathway by which 
race/ethnicity and socioeconomic factors may influence lifestyle/behavioural factors and 
subsequent T2DM risk. People with limited socioeconomic means are more likely to live in 
neighbourhoods that are more segregated, have fewer places to purchase healthy food, more 
places to purchase unhealthy food, are less walkable, have less open space, have higher crime 
and that have a greater perceived lack of safety. Several studies have demonstrated that the 
contextual elements of the local environment may affect obesity and T2DM.54129,524 244, 270, 271, 543 
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Furthermore, the largest randomized experiment examining the effect of spatial mobility found 
that offering vouchers to move to a lower poverty neighbourhood had a significant impact on 
the prevalence of obesity and diabetes.273 However, researchers could not attribute the 
reduction in obesity to specific environmental factors.577 My analyses also could not identify 
specific contextual factors responsible for the neighbourhood variability in T2DM.  In addition, I 
found that racial/ethnic disparities could not be explained by the contextual factors examined. 
For this particular result, it is very important to note the limitation of this study region to the city 
of Boston, Massachusetts.  
In summary, these research papers indicate that socioeconomic factors contribute to the 
development and/or amplification of racial/ethnic disparities in T2DM. According to the 
conceptual model, socioeconomic factors were considered distal to lifestyle/behavioural and 
biophysiologic risk factors.  While these proximal risk factors were found to be direct risk factors 
for T2DM, they only impacted racial/ethnic disparities through social and economic influences. 
As highlighted in the study’s conceptual framework (Figure 3-1), the pathways by which race and 
ethnicity may impact T2DM risk are complex. Considering these complex pathways, and how 
they influence each other, can help to identify interventions that might promise reductions in 
racial/ethnic disparities. 
8.2 Strengths and Limitations 
Individual limitations of the methodologies used in each manuscript were noted. In addition, 
there are further considerations that are presented below. 
8.2.1 General Strengths 
The strengths of this study stem from the BACH Study’s community-based stratified random 
sample design. The BACH Study, by design, includes both sexes, a wide age range (30–79 years) 
and includes a large number of minority participants, representative of Black and Hispanic 
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populations. Key strengths of the BACH Survey that were utilized in these analyses include: (1) 
the wide range of measurements covering six theoretical domains, that (2) allow for both 
individual-level and neighbourhood-level (multi-level) analyses  and (3) the multi-disciplinary 
approach measures the prevalence of disease through both self-report and physiologic 
measurements (i.e. fasting glucose and HbA1c to capture undiagnosed cases).  
8.2.2 General Weaknesses 
A notable limitation of this study is the cross-sectional nature of the majority of the analyses 
which prevent causal inferences and limit the ability to determine temporality. The bulk of the 
analyses used BACH III data only. This was done for several reasons. First, the objective 
measures of diabetes status (fasting glucose, HbA1c and fasting insulin) were only captured at 
BACH III. This limited potential longitudinal analyses to the cumulative incidence of diagnosed 
T2DM which affects study power (small number of events) and is also a more subjective 
measure of diabetes status that may underestimate the true magnitude of racial/ethnic 
disparities. This was demonstrated in Section 5.4. Second, while some measures addressing the 
six domains of interest were captured at BACH I and BACH II, many were not (see Table 4-3 for a 
full list of available measures). This limited the ability to examine the full contribution of certain 
domains of interest, particularly the environmental and psychosocial domains, longitudinally. A 
further limitation to using cross-sectional data is that it is likely that one-time measurement of 
health behaviours may underestimate their contribution. Sensitivity analyses conducted by 
others have indicated that life-course331, 332 and repeated measures373 designs increase the 
proportion of social inequalities that can be explained by potential mediating risk factors. 
Another limitation of this study is that it is geographically limited to Boston, Massachusetts. The 
BACH Survey sample has been compared to other large regional (Behavioral Risk Factor 
Surveillance System) and national (the National Health and Nutrition Examination Survey) on a 
number of socio-demographic and health-related variables437 and the results indicate that the 
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BACH Survey estimates of key health conditions are comparable with national trends. However, 
the macro-economic influences of living in this urban, northeast environment may not be 
generalizable to other contexts or to the conditions in which racial/ethnic disparities in T2DM 
are fostered in the US at large. This limitation particularly affects the estimates regarding the 
neighbourhood/environmental contributors to racial/ethnic disparities in T2DM. 
Finally, although biogeographic ancestry markers were measured, which are thought to estimate 
the genetic contribution to increased diabetes prevalence in certain populations, the BACH 
Survey did not include comprehensive markers of genetic risk. Therefore conclusions regarding 
genetic contributors to racial/ethnic disparities in T2DM cannot be made.  
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8.3 Implications/Recommendations for Policy and Practice 
 
Each domain of the conceptual framework for this research evokes a particular structural 
intervention (Figure 8-1). The roles of adverse social and economic conditions suggest policy 
interventions affecting social conditions. Unfavourable built and social environment 
characteristics suggest community level intervention. Increased psychosocial stressors could be 
alleviated with primary prevention tactics aimed at reducing psychological strain and increasing 
coping mechanisms. Unhealthy lifestyles would suggest primary prevention directed at 
increasing healthy behaviours and decreasing unhealthy behaviours. Secondary prevention 
efforts aimed at stopping/slowing the progression of disease would be the proposed 
intervention for individuals with unfavourable biophysiologic profiles.  
Figure 8-1. Each domain of influence suggests a specific level of intervention 
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In many of these analyses and indeed in the following sections we adopted this simplified 
framework that suggests each domain of has its own specific proposed intervention. However, 
this may be overly simplistic given the complex interplay between these potential causes as is 
shown in the conceptual model, (Figure 3-1, p. 53). For example, there are situations in which a 
genetic cause may have an environmental solution and vice-versa.578, 579 
Finally, it is important to note that the risk factors identified as the main causes of T2DM may 
not necessarily be causes of racial/ethnic disparities.580 It follows that interventions that may 
reduce the incidence of T2DM may not necessarily reduce disparities. While many overlaps may 
exist it is an important epidemiologic distinction to note.579 
8.3.1 Lifestyle/Behavioural Interventions 
One of the most common interventions to prevent or delay the onset of type 2 diabetes is to 
prescribe physical activity and/or dietary intervention. The results of trials examining 
lifestyle/behaviour interventions have proved promising. A meta-analysis of nine randomized 
controlled trials demonstrated that lifestyle modification based on physical activity, dietary 
interventions, or both is associated with improvements in glucose levels and tolerance levels in 
participants at risk for T2DM.581 The Diabetes Prevention Program, the largest major randomized 
controlled trial of prediabetic adults to date, found that lifestyle modification was just as 
efficacious in preventing or delaying T2DM as metformin.582 The results indicated that the 
lifestyle intervention prevented one case of diabetes per each three treated person-years. 
However, it is important to note that the efficacy of this lifestyle intervention was a 
consequence of an intensive regimen. The goal was to attain a weight loss of at least 7% using a 
low-calorie diet, and increasing physical activity to at least 150 minutes per week. These lifestyle 
changes were guided by a case manager who provided monthly support sessions and a 16-lesson 
curriculum. 
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There are challenges to replicating these types of prevention programs in a widespread setting 
and particularly in underserved areas. The infrastructure necessary to establish these programs 
including a suitable setting, and staffing that would be available for the requisite period of time, 
are difficult to obtain and sustain. Disadvantaged communities in particular lack the requisite 
resources and community organization necessary to develop such T2DM prevention programs. 
However, it has been established that these disadvantaged communities have the highest rates 
of T2DM, thus having the greatest needs for such programs. Accordingly, a major public health 
challenge for many minority and underserved communities is to acquire resources and the 
supportive infrastructure to implement intensive diabetes prevention programs.403 
In addition to these challenges, it is worth mentioning that concentrating on individual 
behavioural risk factors may not result in change to racial/ethnic and socio-economic 
inequalities in health outcomes.  It is critical to consider how people come to be exposed to 
individually-based risk factors such as poor diet and lack of exercise, for example by living in a 
neighbourhood with few healthy food options with low walkability/low greenspace.324 If the 
upstream generators of these inequalities are not considered, population-wide intervention to 
improve health behaviours may result in greater uptake of the message in socially advantaged 
groups, potentially increasing social inequalities in health.583 Therefore, solutions to redressing 
racial/ethnic disparities in T2DM may also lie outside the health sector (see Section 8.3.3).  
The results of these analyses indicated that lifestyle/behavioural factors contributed to 
racial/ethnic disparities in T2DM indirectly. Socioeconomic factors were identified as a more 
fundamental cause of these disparities. As a fundamental cause of disparities, adverse 
socioeconomic conditions were associated with T2DM through a variety of mechanisms (directly 
and indirectly). This indicates that even if one effectively modifies an intervening mechanism, 
such as lifestyle/behaviour, an association between a fundamental cause and disease will likely 
re-emerge.212 Therefore, focusing solely on lifestyle/behaviour as a mediating mechanism may 
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fail to eliminate racial and ethnic disparities because the fundamental cause, social and 
economic disparities, is not being addressed.  
In conclusion, the results of these analyses, as well as the results of several trials,568 suggest that 
interventions targeting lifestyle/behavioural and biophysiologic risk may reduce T2DM risk 
overall. However, the results presented here demonstrate that interventions aimed at reducing 
disparities may need to target socioeconomic risk factors in order to lessen the racial/ethnic 
divide.  
8.3.2 Contextual/Neighbourhood Interventions 
Community-based nutritional health and activity interventions have the potential to make a 
modest public health impact.584, 585 Examples of these types of interventions include opening 
farmers’ markets, promoting safe bike and walking paths, community gardens, and community 
shared agriculture programs. Many of these programs are gaining traction nationally, and 
several have been implemented in the BACH study area under the Urban Agriculture program 
initiated in 2010.586 
However, these initiatives do not address the underlying inequitable distribution of certain 
neighbourhood amenities. The liberalization of urban and density zoning laws and the 
investment of business in disadvantaged communities may influence disparities in the built 
environment. 587 Such infrastructure developments in communities can also improve population 
health, in addition to reducing disparities.588  
The implementation of health impact assessments (HIAs) have been promising in minimizing the 
adverse health impacts of residential segregation.589, 590 HIAs are used to evaluate the impact of 
policies and projects in community design and other areas (i.e. transportation planning) on 
public health.591 However, there is still a need for rigorous evaluation of the impact of various 
interventions.  
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It is important to note that disparities in neighbourhoods or across areas result from specific 
policies, or absence of policies. Neighbourhood contexts are mutable and can be responsive to 
economic and social policy interventions. This makes the local social and built environmental 
policy a particularly suitable target for disparities reduction.304  
Interventions like the MTO initiative, which provided vouchers for individuals and families to 
move to lower poverty, lower crime neighbourhoods, offer the potential to diminish racial and 
ethnic disparities in obesity and T2DM.273 The increase in US residential segregation, both 
racially and socioeconomically, in recent decades may expose populations to concentrated 
poverty.592 Mobility programs, like the MTO, result in families living in lower poverty 
neighbourhoods and having better health outcomes. Housing mobility is a platform for positive 
outcomes. However, it is likely that a more comprehensive approach is needed to reduce T2DM 
disparities.  
8.3.3 Social and Economic Interventions 
The results of this study, and others, indicate that lower socioeconomic status is central to 
explaining why racial/ethnic minorities have a higher prevalence and incidence of T2DM. 
Variations in the distribution of income are associated with disparities in the distribution of a 
large number of health outcomes including mortality. These disparities parallel relative 
investments in human and social capital. Social and economic policies that influence income and 
wealth inequality may have an important impact on health outcomes.310 
Despite abundant work describing health disparities, little progress has been made in identifying 
or implementing policies or interventions to eliminate inequalities. One possible explanation is 
that the underlying and structural causes of disparities have not been identified.  A fast-growing 
body of research is investigating the many potential causes of socioeconomic disparities in 
health and are attempting to disentangle multiple potential causal pathways.15 A primary focus 
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is investigating how adverse socioeconomic conditions shape exposure to T2DM across the 
lifespan. The research presented in this thesis contributes to this knowledge base. We 
attempted to disentangle several potential causes of racial/ethnic disparities in T2DM. The 
findings indicate that social conditions are a fundamental cause that exerts both direct and 
indirect effects on T2DM.  
Another reason why interventions on macroeconomic, cultural, and environmental conditions 
have rarely been used to date is that the macroeconomic, cultural, and environmental causes for 
health disparities are distal and may be quite distant in space and time from health outcomes. 593 
The consequences of intervening on these distal and structural causes can be very difficult to 
convincingly identify in observational or experimental studies. Social and economic factors affect 
disease outcomes through multiple mechanisms and therefore may maintain an association with 
disease even when intervening mechanisms change.  
The political climate of the US and other Western cultures also shapes the focus on proximate 
risk factors for targeted intervention (e.g. lifestyles/behaviours Section 8.3.1). US culture 
emphasizes the ability of the individual to control his or her own personal fate and the 
importance of doing so (i.e. “personal responsibility”).211, 212 These cultural values contribute to 
the level of public and policy interest in T2DM research findings, and influence funding priorities 
as well.   
Nonetheless, action at the federal level in the US is starting to occur. The Centers for Disease 
Control and Prevention (CDC) have partnered with the Federal Bureau of Primary Care and 
Institute for Healthcare Improvement to engage with community health centres. The resulting 
Health Disparities Collaborative, which focuses on diabetes and several other conditions, work to 
link patients with community resources to promote health education and lifestyle changes to 
diet and exercise.11, 594, 595  However, these collaboratives tend to focus on downstream health 
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outcomes of already diagnosed disease and early results appear to be disappointing for diabetes 
outcomes.596 
Focusing on risk factors further upstream, childhood obesity is also a target for this model. 
Obesity experts have long advocated for the development and application of multi-level, multi-
sector prevention strategies that invoke change at the environment and policy level.597 Evidence 
for the effectiveness of some of these obesity prevention interventions is mounting, with the 
most promising approaches being changes in environments and policies.598  A recent national 
effort to prevent childhood obesity is the Let’s Move! campaign. Let’s Move! focuses on early 
childhood obesity prevention, parent and caregiver empowerment, healthier food in schools, 
access to healthy, affordable foods, and increased physical activity. Despite these promising 
strides towards structural and policy intervention, resistance towards policy changes remain, 
and strategies to overcome such resistance are elusive.  
As mentioned in the section above, one of the most promising social and environmental 
interventions to date was the “Moving to Opportunity” program in the U.S.273 Implemented 
under the U.S. Department of Housing and Urban Development, this social experiment offered 
more than 4,000 low-income families the chance to move to a low-poverty neighbourhood. 
Long-term results indicated that the mobility program resulted in families living in lower poverty, 
safer neighbourhoods. The study demonstrated that participants who moved to lower poverty 
neighbourhoods had better health outcomes including extreme obesity and diabetes, as well as 
decreased psychological distress and major depression. However, families in the experimental 
group did not experience better employment or income outcomes, nor did their children 
experience better educational achievement. 
In summary a comprehensive public health perspective is likely needed to reduce racial/ethnic 
disparities in T2DM addressing the multiple levels of influence and the complex pathways that 
were demonstrated in these findings. Coordinated interventions presented at two or more 
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ecological levels are likely needed to produce, population-wide, comprehensive, and efficacious 
reductions in any given health disparity.403 Such interventions can range from the macrolevel 
(e.g., changing social policy, social institutions, cultural norms and practices) to the microlevel 
(e.g. individualized lifestyle/behavioural diabetes prevention interventions).  
8.4 Research Recommendations 
This study has drawn attention to the complex interplay of factors leading to the racial/ethnic 
disparities manifest in T2DM.  
As discussed in Section 8.2.2, there were several limitations to this research that should be 
remediated in future research. First, a true longitudinal design with repeated measures of 
objective diabetes status are needed and over a longer follow-up period. It is likely that the one-
time measurement of health behaviours may underestimate their contribution. Other 
longitudinal studies indicate that life-course331, 332 and repeated measures373 designs have shown 
to increase the proportion of social inequalities that can be explained by potential mediating risk 
factors. 
Second, future studies should include comprehensive measures of not just adult, but also pre-
natal and childhood, exposures. While there are several cohort studies that have generational 
data in addition to T2DM measures,599 studies that are driven by a comprehensive conceptual 
framework are generally lacking. 
Racial/ethnic disparities in T2DM arise from a complex interplay of social and economic, local 
environmental, psychosocial, lifestyle/behavioural, biophysiologic, and genetic factors. Given 
this complexity, it is likely that conclusive evidence will not necessarily flow from a single study 
or with increasing methodological sophistication within a single type of study. Rather, consensus 
will likely emerge from the work of multiple disciplines, often with diverse methodological 
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approaches. Partnership between health researchers, communities, and policy experts, will be 
crucial. 
8.5 Dissemination 
Research of this nature carries a responsibility to disseminate findings to try to create positive 
change. Dissemination efforts to date have focused on (1) the scientific community, (2) local and 
national policy leaders, and (3) the Boston community. 
8.5.1 Scientific Community 
My findings from this research have been published in several top tier epidemiology journals 
including: the International Journal of Epidemiology, Annals of Epidemiology, and Social Science 
and Medicine. In addition, I applied the methodological techniques I mastered over the course 
of my doctoral training to several other manuscripts published in peer reviewed journals. A 
complete list of publications relevant to this thesis is provided below. 
1. Goonesekera SD, Fang SC, Piccolo RS, Florez JC, McKinlay JB. Biogeographic ancestry is 
associated with higher total body adiposity among African-American females: the Boston 
Area Community Health Survey. PLoS ONE. In press. 
2. Piccolo RS, Duncan D, Pearce N, McKinlay, JB. The role of neighborhood characteristics 
in racial/ethnic disparities in type 2 diabetes: Results from the Boston Area Community 
Health (BACH) Survey. Social Science in Medicine, Apr 2015; 130: 79-90. 
3. Yang MH, Hall SA, Piccolo RS, Maserejian NN, McKinlay JB. Do Behavioral Risk Factors for 
Prediabetes and Insulin Resistance Differ Across the Socioeconomic Gradient? Results 
from a Community-Based Epidemiologic Survey. International Journal of Endocrinology, 
in press. 
4. Piccolo RS, Pearce N, Araujo AB, McKinlay, JB. The contribution of biogeographic 
ancestry and socioeconomic status to racial/ethnic disparities in type 2 diabetes: Results 
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from the Boston Area Community Health (BACH) Survey. Annals of Epidemiology, Sep 
2014; 24(9): 648-654. 
5. Meigs JB, Grant RW, Piccolo R, Lopez L, Florez JC, Porneala B, Marceau L, McKinlay JB. 
Association of African Genetic Ancestry with Fasting Glucose and Hemoglobin A1c Levels 
in Non-Diabetic Individuals: The Boston Area Community Health (BACH) Prediabetes 
Study. Diabetologia, Sept 2014; 57 (9): 1850-1858.  
6. Piccolo RS, Araujo AB, Pearce, N, McKinlay JB. Cohort Profile: The Boston Area 
Community Health (BACH) Survey. International Journal of Epidemiology. Feb 2014; 43 
(1): 42-51. 
 
Preliminary and final findings were presented at a number of scientific conferences from June 
2012- November 2013. 
 
American Public Health Association (Boston, MA) November 2013 
 Does Genetic Ancestry Explain Racial/Ethnic Disparities in Diabetes? Results from a 
Longitudinal Study (Piccolo RS) 
 Racial/Ethnic Disparities in Type 2 Diabetes: The Role of Neighborhood (Piccolo RS) 
 
AcademyHealth (Baltimore, MD) June 2013 
 Are Racial/Ethnic Disparities in Diabetes Explained by Ancestry or by Socioeconomic 
Differences? Results from a Longitudinal Study (Piccolo RS) 
 The Role of Neighborhood Socioeconomic Status in Racial/Ethnic Disparities in Type 2 
Diabetes (Piccolo RS) 
 
American Diabetes Association (Chicago, IL) June 2013 
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 The Role of Neighborhood Socioeconomic Status in Racial/Ethnic Disparities in Type 2 
Diabetes (Piccolo RS) 
 Is Genetic Ancestry Associated with Incident Type 2 Diabetes? (Piccolo RS) 
 
Society for Social Medicine (London, UK) September 2012 
 A Profile of Undiagnosed Diabetics in the Community: Results from the Boston Area 
Community Health (BACH) Pre-Diabetes Survey (Piccolo RS) 
 
American Diabetes Association (Philadelphia, PA) June 2012 
 A Profile of Undiagnosed Diabetics in the Community: Results from the Boston Area 
Community Health (BACH) Pre-Diabetes Survey (Piccolo RS) 
 Does Limited Health Literacy Explain Racial/Ethnic Disparities in Diabetes Control? 
(Piccolo RS) 
 
AcademyHealth (Orlando, FL) June 2012 
 Does Limited Health Literacy Explain Racial/Ethnic Disparities in Diabetes Control? 
(Piccolo RS) 
8.5.2 Policy Leaders 
In an effort to reach relevant local and national policy leaders, I presented my findings at two 
summits focusing on racial/ethnic disparities. While attending and presenting at these national 
summits, I took the opportunity to meet and discuss with National Institutes of Health officials, 
including program officers. 
2013 Reducing Health Disparities in Type 2 Diabetes Mellitus Summit (Baltimore, MD) March 
2013 
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 The Role of Neighborhood Socioeconomic Status in Racial/Ethnic Disparities in Type 2 
Diabetes (Piccolo RS) 
 
2012 Science of Eliminating Health Disparities Summit (Washington D.C.) December 2012 
 Does Limited Health Literacy Explain Racial/Ethnic Disparities in Diabetes Control? 
(Piccolo RS) 
In addition, I provided the BACH funding organization, the National Institute of Diabetes and 
Digestive and Kidney Diseases, with regular updates on our findings through official progress 
reports and personal emails. 
Finally, new results are posted regularly the New England Research Institutes (NERI) website and 
twitter accounts. 
8.5.3 Boston Community 
The BACH research team regularly reaches out to the Boston area and the BACH participants, 
specifically, with updates on the study findings. We compiled a one page summary of the 
findings summarizing the major findings from the study including findings from this research. 
This summary is sent to all BACH participants and to several community leaders within the 
Boston area. 
8.6 Conclusion 
This study presents, to my knowledge, the first examination of a multidisciplinary, multilevel risk 
model aimed at explaining racial/ethnic disparities in T2DM. This research highlighted the 
complexity in the causation and amplification of racial/ethnic disparities in T2DM.  Guided by the 
conceptual model, I conclude that social and economic factors are fundamental in the creation 
and amplification of these disparities. The evidence did not indicate a fundamental role of 
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biogeographic ancestry, contextual environmental factors, or psychosocial factors in the 
manifestation of these disparities. Lifestyle/behavioural and biophysiologic risk factors appeared 
to be heavily influenced by socioeconomic parameters. These results have national and local 
policy implications as they suggest that in order to reduce disparities, either wide-scale social 
and economic policy shifts need to occur, or interventions need to be targeted toward 
racial/ethnic minorities and the socially and economically disadvantaged. 
 
 
  
It is inaction that cannot be afforded, for the 
human and economic costs are too high 
Sir Michael Marmot,1 p. 35 
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Appendix B: Study Questionnaires 
9.1 Physical Measures 
SECTION A:  KEY IDENTIFYING INFORMATION 
   
A1. Subject identification number       
 
A2.  Date of physical measurements   /   /     
  M M / D D / Y Y Y Y 
 
A3. Start time (24 hour clock)   :   
  H H : M M 
 
A4. Data collector ID number     
   
SECTION B:  BODY MEASUREMENTS 
   
SCRIPT: Now I’d like to take some measurements of your body. These should not cause 
you any pain and will take only a few seconds each.   
 
INSTRUCTION: ASK SUBJECT TO TAKE OFF SHOES FOR HEIGHT AND WEIGHT 
MEASUREMENT. 
 
B1. Height (cm)    .  
   
 a. 
Self-reported height 1. Feet   
2. 
Inches 
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B2. Do you have a pacemaker, implanted cardiac defibrillator, other implanted 
electrical medical devices or an artificial limb? 
 
 YES ............................................ 1 (B4) 
 
 NO .................................................... 2 
 
 NOT SURE ................................. 3 (B4) 
   
INSTRUCTION: THE TANITA ULTIMA SCALE PASSES A LOW-LEVEL ELECTRICAL CURRENT 
THROUGH THE BODY THAT MAY INTERFERE WITH THE OPERATION OF MEDICAL DEVICES.  
IF THE SUBJECT HAS, OR MAY HAVE, SUCH A DEVICE, SKIP THE BODY FAT ASSESSMENT 
(B3) AND USE THE WEIGHT-ONLY PROTOCOL 
 
B3. Body fat percentage    
   
B4. Weight (kg)    .  
   
 a. Self-reported weight (lbs)     
 
B5. What was your approximate birth weight? 
  a. 
Pounds 
  
b. 
Ounces 
  
 
  
Page 243 of 317 
 
 
B6. Waist circumference (cm)    .  
   
 a. Measurement taken in LIGHT CLOTHING .......................... 1 
 
 UNDERGARMENTS ....................... 2 
 
B7. Hip circumference (cm)    .  
   
 a. Measurement taken in LIGHT CLOTHING .......................... 1 
 
 UNDERGARMENTS ....................... 2 
 
SECTION C:  PULSE AND BLOOD PRESSURE 
   
SCRIPT: I am now going to begin taking your pulse and blood pressure.  Please keep 
your legs uncrossed while I check your blood pressure. 
 
INSTRUCTION: ENCOURAGE SUBJECT TO SIT QUIETLY DURING MEASUREMENTS AND 
REFRAIN FROM TALKING. 
 
C1. Arm circumference (cm)    .  
   
 a. Arm LEFT .................... 1 RIGHT ......... 2 
 
C2. Cuff size PEDIATRIC .................................... 1 
 
 ADULT .......................................... 2 
 
 LARGE ADULT ............................... 3 
 
 THIGH ........................................... 4 
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C3. Heart rate (beats/60 seconds)      
   
C4. Systolic blood pressure (mmHg)      
   
C5. Diastolic blood pressure (mmHg)      
   
C6. End time (24 hour clock)   :   
  H H : M M 
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9.2 Phlebotomy Form 
SECTION A:  KEY IDENTIFYING INFORMATION 
   
A1. Subject identification number       
 
A2.  Date of phlebotomy   /   /     
  M M / D D / Y Y Y Y 
 
A3. Start time (24 hour clock)   :   
  H H : M M 
 
 
A4. Phlebotomist ID number     
   
SECTION B:  INTERVIEW 
   
SCRIPT: Now I am going to draw your blood. First I need to ask you some questions: 
 
B1. Do you currently take blood thinners (Warfarin or Coumadin) or do you have 
hemophilia? 
    
  YES ............ 1 (END) NO ...................... 2 
 
B2. What time did you wake up? (24 hour clock) 
       
    :   
  H H : M M 
   
B3. Have you fasted for at least 8 hours? YES ...................... 1 NO ...................... 2 
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B4. Have you had anything alcoholic in the past 8 hours? 
    
  YES ...................... 1 NO ...................... 2 
 
B5. Have you had anything with caffeine in the past 8 hours? 
    
  YES ...................... 1 NO ...................... 2 
 
B6. At what time did you last have any food or beverage? 
       
    :   
  H H : M M 
   
SECTION C:  BLOOD DRAW 
   
C1. Time of 1st attempt (24 hour clock)   :   
  H H : M M 
   
 a. Arm for first attempt LEFT .................... 1 RIGHT ................. 2 
   
 b. Was first attempt successful? YES ...............1 (C3) NO ...................... 2 
 
C2. Time of 2nd attempt (24 hour clock)   :   
  H H : M M 
   
 a. Arm for second attempt LEFT .................... 1 RIGHT ................. 2 
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C3. List the specimens collected Response 1. 
   YES NO Volume drawn 
 a. SST 1 1 2    .  
m
L 
 b. SST 2 1 2    .  
m
L 
 c. Red Top 1 1 2    .  
m
L 
 d. Lavender Top 1 1 2    .  
m
L 
 e. Lavender Top 2 1 2    .  
m
L 
 
C4. Was draw completed? 
    
  YES……………………….1 NO              2(C4a) 
 
 a. Why was draw not completed? 
 
 UNSUCCESSFUL ATTEMPTS………………….1 
 
 SUBJECT REFUSAL………………………………..2 
 
 OTHER………………………………………99 (C4a1) 
 
  a1. Specify other reason why blood draw was not completed: 
    
    
    
   
SECTION D:  RESULTS 
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D1. HemoCue 201 (mg/dL)    
   
 a. 
Was the HemoCue measurement taken using venous blood (from blood draw) or 
capillary blood (finger stick)? 
 
 VENOUS BLOOD ....................................... 1 
 
 CAPILLARY BLOOD.................................... 2 
 
D2. VeraLight (mg/dL)    
   
D3. Comments: please note if there were any unusual circumstances: 
  
  
  
   
D4. End time (24 hour clock)   :   
  H H : M M 
   
SECTION E: FOLLOW-UP 
   
E1. Is a blood re-draw needed? YES………………………..1 NO…………2 (END) 
   
E2. Did subject consent to a blood re-draw? YES………………………..1 NO…………2 
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9.3 Interviewer Administered Questionnaire 
SECTION A: INTERVIEW SUMMARY 
 
 
A1. SUBJECT ID: 
  
 
A2.  BACHSUBS SURVEY EVENT      
   
 
A3.  FORM COMPLETION DATE:   /   /     
  M M  D D  Y Y Y Y 
   
   
A4. DATA COLLECTOR ID:     
   
   
A5. SEX OF SUBJECT: MALE ........................................ 1 
  FEMALE .................................... 2 
   
   
A6. LANGUAGE: ENGLISH.................................... 1 
  SPANISH ................................... 2 
   
A7. START TIME OF INTERVIEW:   :   24 HR CLOCK 
  H H  M M   
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SECTION B: Self Assessed Health Status 
 
This interview will ask questions about your overall health, some specific health conditions, your 
lifestyle, and your typical daily activities. Remember, we are interested in how you feel about 
your health. Many of these questions may seem familiar to you.  We are interested in how your 
health may or may not have changed since we last spoke with you. Today I am also going to ask 
you some questions about things that may or may not have an affect on your day-to-day life, 
such as work, friends and family and how you feel about certain situations. Finally I will give you 
a short form to fill out yourself. 
 
Once again, I would like to remind you that all the information you provide is completely 
confidential. If you feel uncomfortable answering a question, you should feel free to tell me and 
we can skip it. Also, there are no right or wrong answers. If you don’t know the answer to 
something, just tell me and we’ll move on.   
 
If you need to take a break at any time, just let me know. Are you ready? Let’s begin.  
 
B1. In general, would you say your health is: 
  
 Excellent ................................................................................. 1  
 Very good ............................................................................... 2  
 Good ....................................................................................... 3  
 Fair .......................................................................................... 4  
 Poor ........................................................................................ 5  
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SECTION C: HEALTH AND HEALTH CARE 
Now I have some questions about whether a health care provider has ever told you that you 
have a particular health condition.  As you consider your answer, please keep in mind that a 
health care provider can be a general doctor, a specialist doctor, a nurse practitioner, a physician 
assistant, a nurse or anyone else you would see for health care. 
C1 
*Have you ever been told by 
a health care provider that 
you now have or previously 
had: 
 
 
 
 
YES 
 
 
NO 
 
 
RF 
 
 
DK 
i: IF YES: How old 
were you when you 
were first told OR 
at the time of the 
first event OR 
when you had 
surgery? 
*a. Insulin-dependent or 
juvenile-onset diabetes  
Type I 
1 
2 
(C1b) 
-7 -8 
    
    
    
 a1. IF YES: Are you treating your diabetes by…..  
 i. No treatment 1 (C1a2) 2 -7 -8  
 ii. Modifying your diet 1 2 -7 -8 
iii. 
Medications taken by 
mouth 
1 2 -7 -8 
iv. Insulin injection 1 2 -7 -8 
 
a2. 
IF YES: Has the 
diabetes caused: 
 
 
i. 
Problems with your 
kidneys 
1 
 
2 
 
-7 -8 
    
     
    
 
ii. 
Problems with your 
eyes treated by an 
ophthalmologist? 
1 
 
2 
 
-7 -8 
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C1 
*Have you ever been told by a 
health care provider that you 
now have or previously had: 
 
 
 
 
YES 
 
 
NO 
 
 
RF 
 
 
DK 
i: IF YES: How old 
were you when 
you were first 
told OR at the 
time of the first 
event OR when 
you had surgery? 
*b. Non-insulin dependent or 
adult-onset diabetes Type II 
1 
2 
(C1c) 
-7 -8 
    
    
    
 b1 IF YES: Are you treating your diabetes by…..  
 
i. No treatment  
1 
(C1b2) 
2 -7 -8 
 
 ii. Modifying your diet 1 2 -7 -8 
iii. 
Medications taken by 
mouth 
1 2 -7 -8 
iv. Insulin injection 1 2 -7 -8 
 b2. IF YES: Has the diabetes caused:  
 
i. 
Problems with your 
kidneys 
1 2 -7 -8 
    
     
    
 
ii. 
Problems with your eyes 
treated by an 
ophthalmologist or 
optometrist? 
1 2 -7 -8 
    
     
    
*c
. 
Elevated blood sugar 
(hyperglycemia) 
 
IF FEMALE: excluding when you 
were pregnant  (gestational 
diabetes) 
1 
 
2 
 
-7 -8 
    
  
 
   
    
d. WOMEN ONLY: Gestational 
diabetes 1 2 -7 -8 
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C1 
*Have you ever been told by a 
health care provider that you 
now have or previously had: 
 
 
 
 
YES 
 
 
NO 
 
 
RF 
 
 
DK 
i: IF YES: How old 
were you when 
you were first 
told OR at the 
time of the first 
event OR when 
you had surgery? 
 
e. Kidney disease or poor kidney 
function (blood tests show high 
creatinine) 1 
2 
(C1f) 
-7 -8 
    
    
    
 
e1. IF YES: Have you ever 
used hemodialysis or 
peritoneal dialysis? 
 
1 
2 
(C1f) 
-7 -8 
    
     
    
 e2. IF YES: Have you ever 
received kidney 
transplantation? 1 2 -7 -8 
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C1. * Have you ever been told by a 
health care provider that you 
now have or previously had: 
 
 
 
YES 
 
 
NO 
 
 
RF 
 
 
DK 
i: IF YES: How old were 
you when you were 
first told OR at the time 
of the first event OR 
when you had surgery? 
*f. 
A heart attack (myocardial 
infarction or MI) 
 
1 2 -7 -8 
    
    
    
*g. Congestive heart failure (CHF) 
(you may have been short of 
breath and the doctor may 
have told you that you had 
fluid in your lungs or that your 
heart was not pumping well) 
1 
2 
(C1h) 
-7 -8 
 
     
 
 g1. 
IF YES: Were you treated 
for this? 
1 2 -7 -8 
 
*h. Surgery or angioplasty for 
arterial disease of the leg (an 
operation to unclog or bypass 
arteries in your leg) 
1 2 -7 -8 
    
    
    
i. A TIA or mild stroke (Transient 
Ischemic Attack, mini stroke) 
 
1 2 -7 -8 
    
    
    
j. A Stroke (CVA, 
cerebrovascular accident, 
blood clot or bleeding in the 
brain) 
 
1 
2 
(C1k) 
-7 -8 
    
    
    
 j1. IF YES: Do you have 
difficulty moving an arm 
or leg as a result of the 
stroke or cerebrovascular 
accident? 
1 2 -7 -8 
 
*k. Angina pectoris, chest pain 
 
1 
 
2 
-7 -8 
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C1. * Have you ever been told by a 
health care provider that you 
now have or previously had: 
 
 
 
YES 
 
 
NO 
 
 
RF 
 
 
DK 
i: IF YES: How old were 
you when you were 
first told OR at the time 
of the first event OR 
when you had surgery? 
  
    
l. Carotid artery surgery (on 
artery in neck) 
 1 
 
2 
 
-7 -8 
    
  
 
   
    
*m. Heart-rhythm disturbance 
 
1 
 
2 
 
-7 -8 
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C1 *Have you ever been told by a 
health care provider that you 
now have or previously had: 
 
 
 
YES 
 
 
NO 
 
 
RF 
 
 
DK 
i: IF YES: How old were 
you when you were 
first told OR at the time 
of the first event OR 
when you had surgery? 
n. Peripheral vascular disease 
1 2 -7 -8 
 
     
 
o. High cholesterol 
 1 2 -7 -8 
    
     
    
p. High blood pressure 
(hypertension) 
 
1 2 -7 -8 
    
     
    
q. Surgery of the stomach for 
weight loss purposes (i.e. 
stomach band, gastric bypass) 
 
1 
 
2 
 
-7 -8 
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WOMEN ONLY.  MALE SUBJECTS SKIP TO C6. 
 
Now I have some questions about your reproductive health history.  I know that these may be 
quite personal, but we ask them of everyone. Please remember that all information you provide 
is confidential. 
   
C2. *Have you ever had: 
   YES NO  
 *a. A hysterectomy, an operation to remove your uterus or 
womb? 1 2 (C2b)  
      
  a1. IF YES: Was this surgery 
done through the 
abdomen or vagina 
(birth canal)? 
ABDOMINALLY ........................ 1 
VAGINALLY .............................. 2 
DK ........................................... -8 
      
 *b An ovary removed? 1 2  
      
  b1. IF YESWere one or two 
ovaries removed? 
ONE ......................................... 1 
TWO ........................................ 2 
DK ........................................... -8 
      
 
C3. Have you had a menstrual period in the past 12 months? 
 
YES………………………………….………….1 (C4) RF………………………………………………….-7 (C4) 
NO………………………………………………2  DK………………………………………………….-8 (C4) 
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 a. Did they stop because of: 
    YES NO RF DK 
  1. Medication, chemotherapy or radiation 
treatment 
1 2 -7 -8 
        
  2. Pregnancy or breastfeeding 1 2 -7 -8 
        
  3. Menopause 1 2 -7 -8 
        
  4. Severe weight loss or another reason 1 2 -7 -8 
 
 b. Can you tell me approximately what year 
your periods stopped? 
    RF ............................ -7 
DK ............................ -8 
(C6) 
(C6) 
   Y Y Y Y  
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C4. 
 
Compared to a year ago, has the number of days between the start of one menstrual period and the start 
of your next menstrual period become less predictable? 
  
 YES ..................................................................... 1   
 NO ...................................................................... 2   
 
 
C5. Have you had a menstrual period in the past 3 months? 
  
 YES .......................................................... 1   
 NO ........................................................... 2   
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SECTION C3.  FAMILY MEDICAL HISTORY 
 
Next, I am going to ask you a question about the health of your primary blood relatives, including your parents, siblings and any children you might have.   
 
[ IF MORE THAN ONE SISTER/BROTHER/CHILD HAS DIABETES RECORD AGES FOR EACH SISTER/BROTHER/CHILD UNTIL ALL ARE ACCOUNTED FOR] 
 
C6 * Please tell me if any of the following 
people has or had Diabetes: 
Do not include adopted, step or half 
relatives. 
 
 
YES 
 
 
NO 
 
 
N/A 
 
 
RF 
 
 
DK 
i: IF YES: At 
what age was 
___ diagnosed 
with diabetes? 
a. Your biological mother? 
1 2 -1 -7 -8 
    
  
 
   
    
b. Your biological father? 
1 2 -1 -7 -8 
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C6 * Please tell me if any of the following 
people has or had Diabetes: 
Do not include adopted, step or half 
relatives. 
 
 
YES 
 
 
NO 
 
 
N/A 
 
 
RF 
 
 
DK 
i: IF YES: At 
what age was 
___ diagnosed 
with diabetes? 
 
    
c. Your biological sister? 
 
1 
 
2 
 
-1 -7 -8 
    
  
 
   
    
d. Your biological brother? 
 1 
 
2 
 
-1 -7 -8 
 
     
 
e. Your biological child? 
1 2 -1 -7 -8 
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SECTION C4: MEDICATIONS 
  
Now I am going to ask you questions about your medications.  Think about the pills or medicines you are currently taking or have taken within the last 4 weeks, 
which are prescribed by your health care provider.  I will read off a list of medications, please let me know if you are taking any in the groups I mention.                         
 
IF YES, GO ACROSS. IF NO, GO TO NEXT ITEM 
C7 i. *In the last four 
weeks have you 
taken:  
 
YES NO RF DK ii. What is 
the name 
of that 
medication
? Any 
others? 
iii. What 
do you 
take it 
for? 
iv. Amount 
per dose 
(include 
units) 
v. 
Doses 
per day 
vi. How long have 
you been on this 
medicine? 
 
 
vi_i. MONTHS 
YEARS 
               
*a.  Insulin or pills for 
sugar in your 
blood? (NPH, 
regular insulin, 
1 2 -7 -8          
1
 
2 
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C7 i. *In the last four 
weeks have you 
taken:  
 
YES NO RF DK ii. What is 
the name 
of that 
medication
? Any 
others? 
iii. What 
do you 
take it 
for? 
iv. Amount 
per dose 
(include 
units) 
v. 
Doses 
per day 
vi. How long have 
you been on this 
medicine? 
 
 
vi_i. MONTHS 
YEARS 
 Glucophage, 
Micronase, 
Glucotrol, Avandia) 
             
1
 
2 
              
               
*b.  Anything for your 
heart or heart beat 
including pills, 
paste or patches? 
(Digoxin, Nitrodur, 
1 2 -7 -8          
1
 
2 
              
1
Page 264 of 317 
 
C7 i. *In the last four 
weeks have you 
taken:  
 
YES NO RF DK ii. What is 
the name 
of that 
medication
? Any 
others? 
iii. What 
do you 
take it 
for? 
iv. Amount 
per dose 
(include 
units) 
v. 
Doses 
per day 
vi. How long have 
you been on this 
medicine? 
 
 
vi_i. MONTHS 
YEARS 
Nitroglycerin, 
Inderal) 
 
2 
              
               
*c.  Any medications 
for cholesterol or 
fats in your blood? 
(Lipitor, Zocor, 
Mevacor, 
Pravachol) 
1 2 -7 -8          
1
 
2 
              
1
 
2 
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C7 i. *In the last four 
weeks have you 
taken:  
 
YES NO RF DK ii. What is 
the name 
of that 
medication
? Any 
others? 
iii. What 
do you 
take it 
for? 
iv. Amount 
per dose 
(include 
units) 
v. 
Doses 
per day 
vi. How long have 
you been on this 
medicine? 
 
 
vi_i. MONTHS 
YEARS 
              
 
 
 
C7. Continued 
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C7 i. *In the last four 
weeks have you 
taken:  
 
YES NO RF DK ii. What is 
the name of 
that 
medication? 
Any others? 
iii. What do 
you take it 
for? 
iv. 
Amount 
per dose 
(include 
units) 
v. Doses 
per day 
vi. How long have 
you been on this 
medicine? 
 
 
vi_i. MONTHS YEARS 
               
d.  Blood pressure or 
fluid pills (Norvasc, 
Vasotec, Aldomet, 
Nifedipine, 
Captopril, 
Atenolol, Lasix, 
HCTZ, 
Spironolactone)? 
1 2 -7 -8          
1
 
2 
              
1
 
2 
              
               
*e.  IF FEMALE: Any 
female hormones 
1 2 -7 -8          
1
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C7 i. *In the last four 
weeks have you 
taken:  
 
YES NO RF DK ii. What is 
the name of 
that 
medication? 
Any others? 
iii. What do 
you take it 
for? 
iv. 
Amount 
per dose 
(include 
units) 
v. Doses 
per day 
vi. How long have 
you been on this 
medicine? 
 
 
vi_i. MONTHS YEARS 
including for birth 
control, including 
pills, creams, 
patches, implants 
or injectables? 
(Premarin, 
Provera, Prempro, 
Estrace) 
 
2 
              
1
 
2 
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SECTION D. HEALTH CARE 
 
Now I am going to ask you a few questions about your use of health care services. 
 
D1. In the last year, how many times did you go to see a health care provider for yourself? (This 
would include visits for routine health care, emergency, mental health care, dental, vision, 
physical therapy, etc).  
 
    
 
# VISITS         IF ZERO, GO TO D3. 
 
     
 
  
 
D2.  What was (were) the major reason(s) for your visit(s)? Was it 
(Were they) for: 
YES NO 
a. An urgent (acute) problem 1 2 
b. A routine visit for an ongoing problem 1 2 
c. A flare-up of an ongoing problem 1 2 
d. Pre- or post-surgery/injury care 1 2 
e. Non-illness care (e.g., routine prenatal, general exam) 1 2 
 
D3. When did you last see a health care provider for your own health?  Was it… 
 6 months ago or less ..................................................  1  
 More than 6 months ago, but less than a year ago ...  2  
 More than 1 year ago, but less than 2 years ago .......  3  
 More than 2 years ago, but less than 5 years ago .....  4  
 5 years ago or more ...................................................  5  
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Now I’d like to find out more about your usual health care.  By usual we mean whatever it means 
to you. 
 
D4. Is there a particular doctor’s office, clinic, health center, or other place that you 
usually go if you are sick or need advice about your health? 
Would you say… 
 Yes ..........................................................................................  1 (D6) 
 No, or  .....................................................................................  2  
 More than one place ..............................................................  3 (D6) 
 
 
D5. What is the main reason you do not have a usual source of health care? 
(Pick only one) 
 
 You seldom or never get sick ................................................  1 (D14) 
 You recently moved into area ..............................................  2 (D14) 
 You don’t know where to go for care  ..................................  3 (D14) 
 Your usual source of medical care in this area is no longer 
available ................................................................................  
4 (D14) 
 You can’t find a provider who speaks your language ...........  5 (D14) 
 You like to go to different places for different health needs 6 (D14) 
 You just changed insurance plans ........................................  7 (D14) 
 You don’t use doctors/ you treat yourself ...........................  8 (D14) 
 The cost of medical care, or .................................................  9 (D14) 
 Another reason .....................................................................  99  
 
Can you tell me more? __________________________ 
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D6.  Where do you usually go for health care?   
 
YES NO 
 a. An outpatient clinic or doctor’s office 1 2 
 b. A hospital emergency room 1 2 
 c. A hospital outpatient clinic 1 2 
 d. A health center 1 2 
 e. A free clinic  1 2 
 f.  Retail clinic i.e. CVS Minute Clinic 1 2 
 
 
 
D7.  How do you usually get to your usual provider? 
PROBE: Whatever a usual provider means to 
you. 
YES NO 
 a. Drive 1 2 
 b. Someone drives you 1 2 
 c. Taxi, cab, The Ride, bus, train, other 
public transportation  
1 2 
 d. Walk 1 2 
 
 
 
 
D8. How long does it take you to get to your usual provider? (From wherever you usually  
leave from whether it is home, work, or some place else.) 
    
 
 MINUTES..................1 
 HOURS......................2 
 DAYS.........................3 
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D9. How difficult is it for you to get to your usual provider? 
Would you say it is…. 
 Very difficult .........................................................................  1  
 Somewhat difficult ...............................................................  2  
 Not too difficult or ................................................................  3  
 Not at all difficult ..................................................................  4  
 
 
 
D10. Using any number from 0 to 10, where 0 is the worst doctor possible and 10 is 
the best doctor possible, what number would you use to rate your usual 
provider? 
 
0         1           2          3          4          5          6         7          8          9        10 
Worst                                                                                                         Best 
Doctor                                                                                                     Doctor 
Possible                                                                                               Possible 
 
D11.  In the last 12 months, were the explanations your usual 
provider gave you about each of the following hard to 
understand? 
*Was the explanation of [ITEM] hard to understand? 
YES NO DOES 
NOT 
APPLY 
*a. What was wrong with you? 1 2 3 
*b. The reason for a treatment? 1 2 3 
c. What a medicine was for? 1 2 3 
d. How to take a medicine? 1 2 3 
*e. Results of a blood test, x-ray or other test? 1 2 3 
f. What to do if a condition got worse or came back? 1 2 3 
*g. Something else?  1 2 3 
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 D11g1. Please specify: ________________________________ 
 
 
D12. What language do you speak to your usual health care provider in? 
 SPECIFY: ____________________________ 
 
 
D13. In the last 12 months, were any of the explanations your usual provider gave you 
hard to understand because of an accent or the way the doctor spoke 
[LANGUAGE ABOVE]? 
 YES ..........................................................................................  1  
 NO ...........................................................................................  2  
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Now I am going to ask you a few questions about your health insurance. 
 
D14. What is your current health insurance?  You might have 
more than one type of insurance.  
*Do you have… 
YES NO 
 
*a. Private insurance from your or your partner’s 
employer 
1 2 
 
*b. Private insurance that you purchased (you pay the 
entire premium) 
1 2 
 c. Medicare  1 2 
 d. Medicaid or Mass Health 1 2 
 e. TriCare Military Health (Champus or ChampVA) 1 2 
 
f. Worker’s compensation (a current injury is covered 
by worker's comp.) 
1 2 
 g. Free care at a particular clinic or hospital 1 2 
 h. COBRA 1 2 
 i. Some other type of insurance 1 2 
      i1. SPECIFY:   
 
*j. IF NO TO ALL: Do you currently have any type of 
health insurance? 
1 
2  
      i1. SPECIFY:   
 
D15. IF NONE: 
How long have you been uninsured? 
   
MONTHS 1 
YEARS  2 
 
 
 
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I am going to ask you a few more questions about health care, particularly the cost of care. 
When answering the next few questions, do not include dental care, vision care, and 
prescription medicines. 
 
D16. In the last 12 months, did you or a doctor believe you needed any medical care, 
tests, or treatment? 
 Yes ...........................................................................................  1  
 No............................................................................................  2 (D20) 
 
D17. In the last 12 months, were you unable to get medical care, tests, or treatments 
you or a doctor believed necessary? 
 Yes ...........................................................................................  1  
 No............................................................................................  2 (D20) 
 
D18. In the last 12 months, why were you unable to get 
medical care, tests, or treatments you or a doctor 
believed necessary? 
Was it because…. YES NO 
a. You couldn’t afford care ......................................................  1 2 
b. The insurance company wouldn’t approve, cover, or pay 
for care..... 
1 2 
c. The doctor refused to accept family’s insurance plan ........  1 2 
d. Problems getting to doctor’s office .....................................  1 2 
e. Different language ...............................................................  1 2 
f. You couldn’t get time off work ............................................  1 2 
g. You didn’t know where to go to get care ............................  1 2 
h. You were refused services ...................................................  1 2 
i. You couldn’t get child care ..................................................  1 2 
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D18. In the last 12 months, why were you unable to get 
medical care, tests, or treatments you or a doctor 
believed necessary? 
Was it because…. YES NO 
j. You didn’t have time or took too long .................................  1 2 
k. Another reason ....................................................................  1    2 
 k.i. SPECIFY:         
 
D19. How much of a problem was it that you did not get medical care, tests, or 
treatments you or a doctor believed necessary? 
Would you say… 
 A big problem, ......................................................................  1  
 A small problem, or ..............................................................  2  
 Not a problem? .....................................................................  3  
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 INCLINATION TO SEEK CARE  
 
People seek medical care for many different reasons.  An important reason for one person may 
be not at all important for another.  We are interested in what would cause you to seek medical 
care.  For these questions we are interested in chronic experiences, that is, experiences that 
occur over a period of 3 months or more. 
 
D20.  [SHOW RESPONSE CARD ‘D20’] 
*How important to you would it be for 
you to seek medical care if / to (USE 
EITHER WORK AS APPLICABLE)….  
EX
TR
EM
EL
Y
  
U
N
IM
P
O
R
TA
N
T 
U
N
IN
M
O
R
TA
N
T 
N
EI
TH
ER
 U
N
-I
M
P
O
R
TA
N
T 
 N
O
R
 IM
P
O
R
TA
N
T 
IM
P
O
R
TA
N
T 
EX
TR
EM
EL
Y
  
IM
P
O
R
TA
N
T 
*a. you had a suspicious mole/growth on your 
skin 1  2 3 4 5 
       
*b.  you were told that a sibling (brother or 
sister) had been diagnosed with diabetes 1 2 3 4 5 
       
*c.  you had chest pains  1 2 3 4 5 
       
d. get a flu shot 1 2 3 4 5 
       
e. get your blood pressure or cholesterol 
checked 1  2 3 4 5 
       
 
TAKE BACK RESPONSE CARD
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E. DIABETES RISK 
 
Now I would like to ask you a few questions about Diabetes.  
 
E1. Please answer this question as true or false. Diabetes is an illness in which you 
have more than normal sugar in your blood. 
 
TRUE
 ..............................................................................................  
1  
 FALSE ....................................................................................  2  
 
E2. Do you consider diabetes to be: 
 
Not a serious 
disease
 ..............................................................................................  
1  
 A moderately serious disease ...............................................  2  
 A serious disease ..................................................................  3  
 A very serious disease ..........................................................  4  
 No 
Opinion
 ..............................................................................................  
5  
 
E3. Do you think your personal risk for diabetes is: 
 
I have 
diabetes
 ..............................................................................................  
1 (F1) 
 
Almost no 
risk
 ..............................................................................................  
2  
 Slight risk ..............................................................................  3  
 Moderate risk .......................................................................  4  
 High risk ................................................................................  5  
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E4.  
*In the past month, did you ever have: 
YES NO 
*a. Increased thirst? 1 2 
b. Increased need to urinate? 1 2 
*c. Increased fatigue? 1 2 
*d. 
Weight loss without decreasing your food intake or increasing 
exercise? 
1 2 
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F. SLEEP (Sleep Quality Questionnaire and Berlin Sleep Questionnaire ) 
 
The following questions relate to your usual sleep habits during the past month only.  Your answers 
should indicate the most accurate reply for the majority of days and nights in the past month.   
 
 [SHOW RESPONSE CARD ‘F1’] 
 
 
F1. 
 
*Thinking about the past month… 
Almost 
never or 
never 
A few 
times 
Sometimes 
Most 
times 
Almost 
always 
or 
always 
*a. Do you have difficulties falling 
asleep?      1 2 3 4 5 
*b. After getting up in the morning, 
can you fall asleep again? 
1 2 3 4 5 
*c. Do you use sleeping pills? 1 2 3 4 5 
d. Are you tired during wake time? 1 2 3 4 5 
e. Are you tired after sleeping? 1 2 3 4 5 
f. Are you restless during the night 
(moving your legs and arms)? 
1 2 3 4 5 
g. Do you get up during the night? 1 2 3 4 5 
*h. Do you suffer from headaches 
first thing in the morning? 1 2 3 4 5 
i. Do you feel exhausted for no 
obvious reasons? 1 2 3 4 5 
*j. How often have you been told 
that you quit breathing during 
your sleep? 1 2 3 4 5 
k. How often have you nodded off 
or fallen asleep while driving a 
vehicle? 1 2 3 4 5 
*l. How frequently have you been 
told that you snore? 
1 
 
2 
 
3 
 
4 
 
5 
 
 
[TAKE BACK RESPONSE CARD]   
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F2. How many hours of actual sleep do you usually get during the night?   
(This may be different than the number of hours you spend in bed) 
  
    
. 
 
HOURS 
 
 
F3. How long does it usually take you to fall asleep at bedtime? 
  
     MINUTES  
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SECTION G:  PHYSICAL ACTIVITY (PASE) 
 
Now I am going to ask you about your activities in the last seven days not including today.  Your 
answers should reflect how you actually behaved.  There are no right or wrong responses.  
 
G1. 
[SHOW RESPONSE CARD ‘G1’] 
 
*In the last 7 days, how often did you:  
 
[SHOW RESPONSE CARD ‘G1i’] 
i. IF EVER: On average, how 
many hours per day did you 
engage in these activities?   
*a. Participate in sitting 
activities such as 
reading, watching TV 
or doing handcrafts. 
Would you say: 
Never .................................... 0  Less than 1 hour ...................... 1  
Seldom (1-2 days) ................. 1 1 but less than 2 hours ............ 2 
Sometimes (3-4 days) ........... 2 2-4 hours ................................. 3 
Often (5-7 days) .................... 3 More than 4 hours................... 4 
   
*b. Take a walk outside 
your home or yard for 
any reason? For 
example, for fun or 
exercise, walking to 
work, walking the 
dog, etc.  Would you 
say:  
  
  
Never .................................... 0  Less than 1 hour ...................... 1  
Seldom (1-2 days) ................. 1 1 but less than 2 hours ............ 2 
Sometimes (3-4 days) ........... 2 2-4 hours ................................. 3 
Often (5-7 days) .................... 3 More than 4 hours................... 4 
   
*c. Engage in light sport 
or recreational 
activities such as 
catch, darts, bocci, 
golf with a cart, 
fishing from a boat or 
pier or other similar 
activities. Would you 
say: 
  
  
Never .................................... 0  Less than 1 hour ...................... 1  
Seldom (1-2 days) ................. 1 1 but less than 2 hours ............ 2 
Sometimes (3-4 days) ........... 2 2-4 hours ................................. 3 
Often (5-7 days) .................... 3 More than 4 hours................... 4 
   
*d. Engage in moderate 
sport and 
recreational activities 
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G1. 
[SHOW RESPONSE CARD ‘G1’] 
 
*In the last 7 days, how often did you:  
 
[SHOW RESPONSE CARD ‘G1i’] 
i. IF EVER: On average, how 
many hours per day did you 
engage in these activities?   
such as doubles 
tennis, dancing, 
hunting, ice skating, 
golf w/o a cart, 
softball, skating or 
other similar 
activities. Would you 
say: 
  
Never .................................... 0  Less than 1 hour ...................... 1  
Seldom (1-2 days) ................. 1 1 but less than 2 hours ............ 2 
Sometimes (3-4 days) ........... 2 2-4 hours ................................. 3 
Often (5-7 days) .................... 3 More than 4 hours................... 4 
   
*e. Engage in strenuous 
sport and 
recreational 
activities such as 
jogging, swimming, 
cycling, singles 
tennis, basketball, 
skiing or other 
activities. Would 
you say: 
  
  
  
Never .................................... 0  Less than 1 hour ...................... 1  
Seldom (1-2 days) ................. 1 1 but less than 2 hours ............ 2 
Sometimes (3-4 days) ........... 2 2-4 hours ................................. 3 
Often (5-7 days) .................... 3 More than 4 hours................... 4 
   
*f. Do any exercises 
specifically to 
increase muscle 
strength and 
endurance, such as 
lifting weights or 
push-ups, etc.  
Would you say: 
  
  
Never ................................... 0  Less than 1 hour ..................... 1  
Seldom (1-2 days) ................. 1 1 but less than 2 hours ............ 2 
Sometimes (3-4 days) ........... 2 2-4 hours ................................. 3 
Often (5-7 days) .................... 3 More than 4 hours................... 4 
   
[TAKE BACK RESPONSE CARD FOR ‘G1’ AND ‘G1i’] 
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 *In the last 7 days, have you done any:  YES NO 
  G2.  Light housework, such as dusting or washing dishes? 1 2 
*G3. Heavy housework or chores, such as vacuuming, scrubbing floors, 
washing windows, or carrying wood? 
1 2 
G4a.  
Home repairs like painting, wallpapering, electrical work, etc. 1 2 
*b.  
Lawn work or yard care, including snow or leaf removal, wood 
chopping, etc.  
1 2 
c.  
Outdoor gardening 1 2 
*d.  
Caretaking of another person, such as children, dependent spouse, 
or another adult 
1 2 
 
 
G5. In the last 7 days, did you work, including work as a volunteer? 
  
 
YES ..................................................................... 1  
 
NO ..................................................................... 2 (SECTION G6) 
  
 
 
 a. How many hours per week did you work, including work as a volunteer,  
in the last 7 days? 
 
     HOURS  
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b. Which of the following categories best describes the amount of physical activity 
required on your job or in your volunteer work? 
  
 Mainly sitting with slight arm movements ................................................ 1  
 Sitting or standing with some walking ...................................................... 2  
 Walking, with some handling of materials weighing less than 50 
pounds ....................................................................................................... 
3  
 Walking and heavy manual work often requiring handling of materials 
weighing over 50 pounds .......................................................................... 4 
 
 
G6. In the last year, did you work, including work as a volunteer? 
  
 
YES ..................................................................... 1  
 
NO ..................................................................... 2 (SECTION H) 
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ASK OF SUBJECTS WHO HAVE WORKED IN THE LAST 12 MONTHS ONLY 
 
At this point in the interview, the style of the questions changes; up until now, the questions 
have been more specifically health related (your health history, health care, etc.).  Now I want to 
find out more about different feelings and social situations that you may or may not experience, 
as sometimes these can affect a person’s health.  Please be patient as we go through these next 
few sections.  We ask everyone the same questions so that we can get an overall idea of the lives 
of our study participants. 
 
Since we were just talking about work, I’m going to start with that.  Here are some situations 
that might arise at work.  Please tell me how often you have had these things happen to you 
during the past 12 months.   
 
[ IF SUBJECT IS SELF-EMPLOYMED INSTRUCT THEM TO THINK ABOUT THEIR CLIENTS OR PEOPLE 
THEY WORK WITH ON A REGULAR BASIS ] 
 
[SHOW RESPONSE CARD G7] 
 
 
G7. 
 
*During the past 12 
months... 
 
Almost 
everyday 
At least 
once a 
week 
A few 
times a 
month 
A few 
times a 
year 
Less 
than 
once a 
year 
Never 
*a. How often do you 
feel that you have 
to work twice as 
hard as others to 
get the same 
treatment or 
evaluation? 1 2 3 4 5 6 
*b. How often are you 
watched more 
closely than other 
workers? 
1 2 3 4 5 6 
c. How often are you 
unfairly humiliated 
in front of others at 
work?  
 
1 2 3 4 5 6 
*d. How often does 
your supervisor or 
coworkers make 
slurs or jokes about 
1 2 3 4 5 6 
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G7. 
 
*During the past 12 
months... 
 
Almost 
everyday 
At least 
once a 
week 
A few 
times a 
month 
A few 
times a 
year 
Less 
than 
once a 
year 
Never 
racial or ethnic 
groups? 
e. How often does 
your supervisor or 
coworkers make 
slurs or jokes about 
women?  
 
1 2 3 4 5 6 
f. How often does 
your supervisor or 
co-workers make 
slurs or jokes about 
gays or lesbians? 
1 2 3 4 5 6 
 
 
TAKE BACK RESPONSE CARD.  
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SECTION H. DISCRIMINATION  
 
Next please tell me how often, in your day-to-day life the following things have happened to 
you. 
 
[SHOW RESPONSE CARD H1 / H3.] 
 
 
H1. 
 
*In your day-to-
day life how 
often ... 
 
Almost 
everyday 
At least 
once a 
week 
A few 
times a 
month 
A few 
times a 
year 
Less than 
once a 
year 
Never 
*a. are you treated 
with less 
courtesy or 
respect than 
other people 
1 2 3 4 5 6 
*b. Do you receive 
poorer service 
than other 
people at 
restaurants or 
stores. 
1 2 3 4 5 6 
c. Do people act as 
if they think you 
are not smart. 
1 2 3 4 5 6 
d. Do people act as 
if they are afraid 
of you. 
1 2 3 4 5 6 
e. Are you 
threatened or 
harassed. 
1 2 3 4 5 6 
 
 
IF NEVER TO ALL GO TO H3. 
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H2. Thinking about the experiences we just discussed [PROBE  AS NECESSARY TO 
REMEMBER WHICH.], what do you think was the main reason why these 
happened to you?  Please choose only one response. 
 Your ancestry or national origin ...........................................  1  
 Your gender ..........................................................................  2  
 Your race ..............................................................................  3  
 Your age ................................................................................  4  
 Your height ...........................................................................  5  
 Your weight ..........................................................................  6  
 Some other aspect of your physical appearance .................  7  
 Your sexual orientation ........................................................  8  
 Something else?  ..................................................................  9  
 Can you tell me more? _____________________________  
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Vigilance 
 
Next please tell me how often, in your day-to-day life you do the following things. 
 
[SHOW RESPONSE CARD H1 / H3.] 
 
 
H3. 
 
*In your day-
to-day life, 
how often do 
you … 
  
Almost 
everyday 
At least 
once a 
week 
A few 
times a 
month 
A few 
times a 
year 
Less than 
once a 
year 
Never 
*a. try to prepare 
for possible 
insults from 
other people 
before 
leaving home 1 2 3 4 5 6 
*b. feel that you 
always have 
to be very 
careful about 
your 
appearance 
to get good 
service or 
avoid being 
harassed. 
1 2 3 4 5 6 
c. watch 
carefully 
what you say 
and how you 
say it.  
1 2 3 4 5 6 
d. try to avoid 
certain social 
situations 
and places  
1 2 3 4 5 6 
 
 
TAKE BACK RESPONSE CARD. 
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SECTION I:  PSYCHOSOCIAL FACTORS  
 
Major Life Events 557  
 
Next, I’m going to read you events that may or may not have happened to you over the past 
year. Think about the last year and the events that have happened in your life.  Please answer 
Yes, it happened to me or No, it did not happen to me to each statement that I read. 
 
I1. *In the past year have you…? YES NO 
*a. Experienced the death of a spouse? 1 2 
*b. Gone through a divorce? 1 2 
*c. Gone through a marital separation? 1 2 
d. 
Been detained in jail or in another 
institution? 1 2 
*e. 
Experienced the death of a close family 
member (other than a spouse)? 
1 2 
f. Had a major injury or illness? 1 2 
g. Gotten married? 1 2 
*h. Been fired at work?  1 2 
i. Had a marital reconciliation? 1 2 
j. Retired from work? 1 2 
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SECTION J. SENSE OF CONTROL AND ALIENATION  182 
 
Next, I’m going to read you several statements describing how people sometimes feel. Think 
about yourself and the feelings you may have experienced.  Please tell me how much you agree 
or disagree with each statement that I read, keeping in mind that the “I” in each statement 
refers to you.   
 [ SHOW RESPONSE CARD J1] 
J1. 
*How much do you agree or 
disagree…. 
 
Strongly 
Disagree 
Disagree Neither 
Agree nor 
Disagree 
Agree Strongly 
Agree 
*a. 
 
I am responsible for my own 
successes. 
1 2 3 4 5 
*b. 
  
I can do just about anything 
I really set my mind to. 
1 2 3 4 5 
*c. 
  
My misfortunes are the 
result of mistakes I have 
made 
1 2 3 4 5 
d. 
  
I am responsible for my 
failures. 
1 2 3 4 5 
e.  The really good things that 
happen to me are mostly 
luck 
1 2 3 4 5 
*f. 
  
There is no sense in 
planning a lot—if something 
good is going to happen it 
will. 
1 2 3 4 5 
g. 
  
Most of my problems are 
due to bad breaks 
1 2 3 4 5 
*h.  I have little control over the 
bad things that happen to 
me 
1 2 3 4 5 
i. 
  
Most people are honest 
because they are afraid of 
being caught. 
1 2 3 4 5 
j. 
  
In order to get ahead people 
don’t always do what’s right 
1 2 3 4 5 
*k. 
  
In order to get ahead you 
have to take everything you 
can get. 
1 2 3 4 5 
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J1. 
*How much do you agree or 
disagree…. 
 
Strongly 
Disagree 
Disagree Neither 
Agree nor 
Disagree 
Agree Strongly 
Agree 
l.  For some people to succeed 
others must fail 
1 2 3 4 5 
*m. I feel it is not safe to trust 
anyone 
1 2 3 4 5 
n.  I feel suspicious 1 2 3 4 5 
*o.  I feel sure that everyone is 
against me. 
1 2 3 4 5 
p. 
  
I have someone I can turn to 
for support and 
understanding when things 
get rough 
1 2 3 4 5 
q. I have someone I can really 
talk to 
1 2 3 4 5 
r. I have someone who would 
help me out with things like 
give me a ride, watch the 
kids or house, or fix 
something 
1 2 3 4 5 
s. I have someone who would 
take care of me if I were sick 
1 2 3 4 5 
 
TAKE BACK RESPONSE CARD.
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SECTION K: TOBACCO AND ALCOHOL CONSUMPTION (NHANES III) 
 
Now I’d like to ask you about any past or present tobacco and alcohol use.   
 
K1.   For the purposes of this question we consider a “smoker” as someone  
who has smoked at least 100 cigarettes (about 5 packs) in their entire life. 
Are you now or have you ever been a smoker (smoked at least 100 cigarettes  
in your entire life)? 
 
 YES CURRENT .............................................................................  1  
 YES PAST .....................................................................................  2  
 NO I HAVE NOT SMOKED 100 OR MORE CIGARETTES ...............  3  
 
Now I would like to ask you a few questions about drinking alcoholic beverages. 
 
K2.   Have you ever had an alcoholic drink? 
 YES ..............................................................................................  1  
 NO ..............................................................................................  2 (L1) 
 
 
K3.   Have you had an alcoholic drink in the last 30 days? 
 YES ..............................................................................................  1  
 NO ..............................................................................................  2 (K6) 
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K4. 
 
Considering all the types of alcoholic beverages, how many times during the  
last 30 days did you have 5 or more drinks within a 24-hour period?  
 
   
# TIMES 
 
 
 
K5.  Now, thinking about the occasions or days that you drink, how many drinks on  
average do you have during those occasions (at one sitting or session)? 
 
   
# DRINKS 
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K6.   In the past 10 years, has your use of alcoholic beverages……. 
 Increased  ...................................................................................  1  
 Decreased...................................................................................  2  
 Not changed ...............................................................................  3  
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SECTION L: LANGUAGE AND ACCULTURATION 
Now I’d like to ask you questions about the languages that you might speak since some survey 
participants speak more than one language. 
 
L1. Can you please tell me which language was the first you learned to speak? 
 English .............................................................. 1 (L5) 
 Spanish ............................................................. 2  
 Portuguese ....................................................... 3  
 French............................................................. ..4  
 Italian.............................................................. ..5  
 Russian ........................................................... ..6  
 German........................................................... ..7  
 Or something else .......................................... 99  
 a. SPECIFY:   
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Language Use Subscale 
 
[ SHOW RESPONSE CARD L2/L4 ] 
 
 
L2 
 
 
Almost never  Sometimes Often Almost 
Always 
a. How often do you speak 
English? 1 2 3 4 
b. How often do you speak in 
English with your friends? 
1 2 3 4 
c. How often do you think in 
English? 
1 2 3 4 
d. How often do you speak 
[FIRST LANGUAGE]? 
1 2 3 4 
e. How often do you speak in 
[FIRST LANGUAGE] with 
your friends? 1 2 3 4 
f. How often do you think in 
[FIRST LANGUAGE]? 
1 2 3 4 
 
TAKE BACK RESPONSE CARD.
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Language Use Subscale 
[ SHOW RESPONSE CARD L3 ] 
 
 
L3 
 
 
Very Poorly  Poorly Well Very Well 
a. How well do you speak 
English? 1 2 3 4 
b. How well do you read in 
English? 
1 2 3 4 
c. How well do you 
understand television 
programs in English? 
1 2 3 4 
d. How well do you 
understand radio programs 
in English? 
1 2 3 4 
e. How well do you write in 
English? 1 2 3 4 
f. How well do you 
understand music in 
English? 
1 2 3 4 
g. How well do you speak 
[FIRST LANGUAGE]? 1 2 3 4 
h. How well do you read in 
[FIRST LANGUAGE]? 
1 2 3 4 
i. How well do you 
understand television 
programs in [FIRST 
LANGUAGE]? 
1 2 3 4 
j. How well do you 
understand radio programs 
in [FIRST LANGUAGE]? 
1 2 3 4 
k. How well do you write in 
[FIRST LANGUAGE]? 1 2 3 4 
l. How well do you 
understand music in [FIRST 
LANGUAGE]?? 
1 2 3 4 
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Electronic Media Subscale 
 
[ SHOW RESPONSE CARD L2/L4 ] 
 
 
L4 
 
 
Almost never  Sometimes Often Almost 
Always 
a. How often do you watch 
television programs in 
English? 1 2 3 4 
b. How often do you listen to 
radio programs in English? 
1 2 3 4 
c. How often do you listen to 
music in English? 
1 2 3 4 
d. How often do you watch 
television programs in 
[FIRST LANGUAGE]?? 
1 2 3 4 
e. How often do you listen to 
radio programs in [FIRST 
LANGUAGE]? 1 2 3 4 
f. How often do you listen to 
music in [FIRST 
LANGUAGE]? 
1 2 3 4 
 
TAKE BACK RESPONSE CARD.
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Let’s talk a little about technology and items you may or may not have. 
 
L5 As I read the following list of items, please tell 
me if you happen to have each one, or not.  
 
YES NO 
*Do you have... 
  
*a. A desktop computer? 1  2 
*b.  A laptop computer? 1  2 
*c. A cell phone? 1  2 
d. A Blackberry, iPhone or other similar 
device? 
1  2 
e. A PDA or other personal data device 1 2 
IF NO TO A AND B GO TO L7. 
IF NO TO ALL, GO TO L8. 
 
L6. 
Do you have an internet connection on your home computer? For example, 
dial-up, cable, or DSL? 
 YES ..........................................................................................  1  
 NO ..........................................................................................  2 (L7) 
 
L6a. 
How are you connected to the internet 
YES NO 
a. Dial-up 1  2 
b.  Fiber Optic 1  2 
c. DSL 1  2 
d. Cable 1  2 
e. Satellite Wireless 1 2 
f. Other 1 2 
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L7 *Do you ever use your cell phone, Blackberry 
or other device to [ITEM]? 
YES NO 
*a. Send or receive email? 1 2 
b.  Send or receive text messages? 1 2 
*c. Access the internet? 1 2 
 
 
L8. Do you have access to a computer somewhere other than home ? 
      
  YES ........... 1  
  NO ........... 2 (SECTION M) 
 
  
 
L9. Other than home, where do you use a computer? YES NO 
a. Work 1 2 
b.  Local Library 1 2 
c.  Friends 1 2 
d. Family outside household 1 2 
e. Other 1 2 
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SECTION M: SOCIO-DEMOGRAPHIC INFORMATION 
 
Now I am going to ask you some questions about your background and about where you live. 
 
M1. What is your current marital status? 
 
 Married .............................................................................  1  
 Living with a partner ........................................................  2  
 Divorced/separated..........................................................  3  
 Widowed ..........................................................................  4  
 Single, never married .......................................................  5  
 OTHER ...............................................................................  99  
[SHOW RESPONSE CARD M2] 
 
M2. What is the highest grade/degree you have completed? 
 LESS THAN 8TH GRADE ................................................. 1  
 8TH GRADE .................................................................... 2  
 9TH THROUGH 11TH GRADE .......................................... 3  
 HIGH SCHOOL DIPLOMA/GED ..................................... 4  
 TECHNICAL TRAINING .................................................. 5  
 ASSOCIATES DEGREE ................................................... 6  
 BACHELORS DEGREE.................................................... 7  
 MASTERS DEGREE ....................................................... 8  
 DOCTORATE DEGREE (E.G. MD, PHD, JD) .................... 9  
 TAKE BACK RESPONSE CARD.   
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M3.  How many years of school have you completed altogether? 
 
 
   
YEARS 
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Now I would like to ask you a few questions about your current work situation. 
 
M4. Which of the following categories best describes your current work situation?  
  
 Working for pay ...........................................................................  1  
 Unemployed and looking for work ..............................................  2 (M8) 
 Temporarily laid off; On sick or other leave ................................  3 (M8) 
 Disabled .......................................................................................  4 (M8) 
 Retired .........................................................................................  5 (M8) 
 Homemaker .................................................................................  6 (M8) 
 Full-Time Student ........................................................................  7 (M8) 
 Other (INCLUDING VOLUNTEER) .................................................  99  
 a. SPECIFY:    
 
M5.  How many jobs do you currently have?       NUMBER: ____ 
 
 
M6. Are you currently working 35 hours or more each week (full time) or less than 35 
hours? 
 35 HRS OR MORE/WK .......................................................  1  
 LESS THAN 35 HRS/WK .....................................................  2  
 
M7.  How many days per week do you work?      NUMBER:  
 
 
  
M8.  What is (was) your usual occupation?          SPECIFY:  
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[SHOW RESPONSE CARD M9] 
M9. Income is important in analyzing the health information we collect. Including income from 
wages, salaries, Social Security or retirement benefits, help from relatives, veteran’s 
benefits, real estate, investments, and other sources, about how much was your total 
household income in the last 12 months?  Please look at this card and tell me which 
category best describes the amount. 
 LESS THAN $5,000 ....................................................................  
1  
 $5,000 - $9,999 ........................................................................  
2  
 $10,000 - $19,999 ....................................................................  
3  
 $20,000 - $29,999 ....................................................................  
4  
 $30,000 - $39,999 ....................................................................  
5  
 $40,000 - $49,999 ....................................................................  
6  
 $50,000 - $59,999 ....................................................................  
7  
 $60,000 - $69,999 ....................................................................  
8  
 $70,000 - $79,999 ....................................................................  
9  
 $80,000 - $89,999 ....................................................................  
10  
 $90,000 - $99,999 ....................................................................  
11  
 $100,000 - $109,999 ................................................................  
12  
 $110,000 - $119,999 ................................................................  
13  
 $120,000 - $149,999 ................................................................  
14  
 $150,000 - $199,999 ................................................................  
15  
 $200,000 - $299,999 ................................................................  
16  
 $300,000 - $499,999 ................................................................  
17  
 $500,000 - $999,999 ................................................................  
18  
 $1,000,000 OR MORE ..............................................................  
19  
 RF .............................................................................................  
-7  
 DK .............................................................................................  
-8  
 TAKE BACK RESPONSE CARD. 
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SECTION N: NEIGHBORHOOD 
Now I am going to ask about your neighborhood. Please think about the area that you currently 
live in and answer how much you agree or disagree.  The word neighborhood in these questions 
is whatever it means to you. 
[ SHOW RESPONSE CARD N1. ] 
N1. *How much do you agree 
or disagree... 
Strongly 
Disagree 
Disagree Neither 
Agree 
nor 
Disagree 
Agree Strongly 
Agree 
*a. There is a lot of graffiti in 
my neighborhood 
1 2 3 4 5 
*b. My neighborhood is noisy 1 2 3 4 5 
*c. Vandalism is common in 
my neighborhood 
1 2 3 4 5 
d. There are a lot of 
abandoned buildings in 
my neighborhood 
 
1 2 3 4 5 
e. My neighborhood is clean 1 2 3 4 5 
*f. People in my 
neighborhood take good 
care of their houses and 
apartments. 
1 2 3 4 5 
g. There are too many 
people hanging around on 
the streets near my home. 
1 2 3 4 5 
*h. There is a lot of crime in 
my neighborhood. 
1 2 3 4 5 
i. There is too much drug 
use in my neighborhood. 
1 2 3 4 5 
j. There is too much alcohol 
use in my neighborhood. 
1 2 3 4 5 
*k. I’m always having trouble 
with my neighbors. 
1 2 3 4 5 
l. My neighborhood is safe. 1 2 3 4 5 
 
[ TAKE BACK RESPONSE CARD ]
SECTION O: CONTACT INFORMATION 
 
I am going to ask you several questions about where you live. Please tell me about where you 
currently live. 
 
O1. Do you own or rent your home? 
 Own ....................................................................................... 1  
 Rent ....................................................................................... 2  
 Other ..................................................................................... 99  
 
SPECIFY______________________ 
 
 
 
O2. Which of the following best describes your home. Please choose only one. 
 Single Family House ............................................................  1  
 Multi-Family House or unit in a Multi-Family House .........  2  
 Unit in an Apartment Building ............................................  
3 
 
 Townhouse/Brownstone ....................................................  
4 
 
 Other ...................................................................................  99  
 
SPECIFY______________________ 
 
 
 
 
O3.  How long have you lived at your current address? 
 
   DAYS…………………..1 
MONTHS………………2 
YEARS…………….......3 
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BEGIN TEAR OFF SHEET – PRIVATE PROTECTED INFORMATION 
 
O4. What is your current primary address? # AND STREET  
  APT #  
  CITY, STATE  
  ZIPCODE  
   
O5. 
What are the two nearest cross streets to 
your home? 
STREET 1  
  STREET 2  
 
 
O6.  In how many different places have you lived in the past 5 years? 
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THE FOLLOWING SECTION WILL BE PULLED FROM BACH II 
 
PROMPT THE PARTICIPANT TO CONFIRM THE FOLLOWING INFORMATION 
 
   
P1. 
What is your home telephone number? 
 
   
P2. What is your work telephone number?  
   
P3. What is your cell phone number?  
   
P4. Do you have an email address where we could  
contact you? 
 
 
P5. IF MARRIED/PARTNERED:  What is your spouse/partner’s first and last name? 
a. 
 
FIRST NAME: 
  
b. 
 
LAST NAME: 
  
 
Before I give you the last form to complete it would also be helpful to have the name and phone 
number of a contact person for you.  This would be someone who does not live in your 
household but who would know how to contact you.  We will only contact this person if we 
cannot contact you. This information, as with all of the other information that you have 
provided, will remain strictly confidential. 
 
P6. What is the name of a reliable contact person for you? Can you spell the first and last name? 
a. 
FIRST NAME: 
  
b. LAST NAME:   
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c. What is (his/her) address? 
 c1. ADDRESS   
 c2. CITY   
 c3. STATE   
 c4. ZIP   
 
d. What is (his/her) home, work, and cell phone numbers? 
 d1. HOME:   
 d2. WORK:   
 d3. CELL:   
 
P7. What is the name of a second reliable contact person for you? Can you spell the first and last name? 
a. 
FIRST NAME: 
  
b. LAST NAME:   
 
c. What is (his/her) address? 
 c1. ADDRESS   
 c2. CITY   
 c3. STATE   
 c4. ZIP   
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d. What is (his/her) home, work, and cell phone numbers? 
 d1. HOME:   
 d2. WORK:   
 d3. CELL:   
 
P9. END TIME OF INTERVIEW:   :    24 HR CLOCK 
  H H  M M   
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SECTION Q. HEALTH LITERACY 
 
Here are some medical instructions that people sometimes see around a hospital. 
Each instruction has some of the words missing.  There are four possible choices that might work 
with each sentence.  TURN PAGES TO SHOW EXAMPLES. 
For each instruction, please look at each of the four choices and decide which makes the most 
sense to fill in the blank.  Then circle the letter and go on to the next until you have finished all 
the questions. 
 
GIVE THE PARTICIPANT THE HEALTH LITERACY PACKET. ALLOW THE PARTICIPANT 7 MINUTES TO 
COMPLETE THE SURVEY. DO NOT TELL THEM IT IS TIMED. WHEN SEVEN MINUTES HAVE 
ELAPSED TELL THE PARTICIPANT THAT “THAT SHOULD GIVE US WHAT WE ARE LOOKING FOR. 
THANK YOU FOR YOUR COOPERATION” AND REMOVE THE TEST MATERIAL. 
 
 
Q1.  WHAT IS THE SUBJECT’S HEALTH LITERACY SCORE?  
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Appendix C: Relevant Presentations and Publications 
9.4 Publications 
Publications relevant to this thesis that I have either produced or contributed to over the course 
of my education are listed below: 
7. Goonesekera SD, Fang SC, Piccolo RS, Florez JC, McKinlay JB. Biogeographic ancestry is 
associated with higher total body adiposity among African-American females: the Boston 
Area Community Health Survey. PLoS ONE. In press. 
8. Piccolo RS, Duncan D, Pearce N, McKinlay, JB. The role of neighborhood characteristics 
in racial/ethnic disparities in type 2 diabetes: Results from the Boston Area Community 
Health (BACH) Survey. Social Science in Medicine, Apr 2015; 130: 79-90. 
9. Yang MH, Hall SA, Piccolo RS, Maserejian NN, McKinlay JB. Do Behavioral Risk Factors for 
Prediabetes and Insulin Resistance Differ Across the Socioeconomic Gradient? Results 
from a Community-Based Epidemiologic Survey. International Journal of Endocrinology, 
In press. 
10. Piccolo RS, Pearce N, Araujo AB, McKinlay, JB. The contribution of biogeographic 
ancestry and socioeconomic status to racial/ethnic disparities in type 2 diabetes: Results 
from the Boston Area Community Health (BACH) Survey. Annals of Epidemiology, Sep 
2014; 24(9): 648-654. 
11. Meigs JB, Grant RW, Piccolo R, Lopez L, Florez JC, Porneala B, Marceau L, McKinlay JB. 
Association of African Genetic Ancestry with Fasting Glucose and Hemoglobin A1c Levels 
in Non-Diabetic Individuals: The Boston Area Community Health (BACH) Prediabetes 
Study. Diabetologia, Sept 2014; 57 (9): 1850-1858.  
12. McKinlay J, Piccolo R, Marceau L. An additional cause of health care disparities: the 
variable clinical decisions of primary care doctors. Journal of Evaluation in Clinical 
Practice. Aug 2013; 19 (4) 664-73.  
13. Piccolo RS, Araujo AB, Pearce, N, McKinlay JB. Cohort Profile: The Boston Area 
Community Health (BACH) Survey. International Journal of Epidemiology. Feb 2014; 43 
(1): 42-51. 
9.5 Papers in Progress 
An additional six papers are under review or in process. 
1. Piccolo RS, Subramanian SV, Pearce N, McKinlay JB. The Relative Contributions of 
Socioeconomic, Local Environmental, Psychosocial, Lifestyle/Behavioral, Biophysiologic, 
and Ancestral Factors to Racial/Ethnic Disparities in Type 2 Diabetes. To be submitted. 
2. Goonesekera SD, Yang MH, Hall SA, Fang SC, Piccolo RS, McKinlay JB. Racial ethnic 
differences in type II diabetes treatment patterns and glycemic control in the Boston 
Area Community Health Survey. BMJ Open. Under Revision. 
3. Lagisetty PA, Piccolo R, Yang M, Marceau LD, Grant R, Lopez L, Meigs JB, McKinlay JB. 
Food Environment, Diet Behavior and Weight Gain in a Multi-Ethnic Urban Cohort. 
Preventing Chronic Disease . Under Review. 
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4. Lopez L, Grant RW, Marceau LD, Piccolo RS, McKinlay JB, Meigs JB. Association of 
Accultration and Health Literacy with Prevalent Dysglycemia and Diabetes Control 
among Latinos in the Boston Area Community Health (BACH) Survey. Journal of 
Immigrant and Minority Health. Under Review. 
9.6 Abstracts/Presentations 
 
American Public Health Association (Boston, MA) November 2013 
 Does Genetic Ancestry Explain Racial/Ethnic Disparities in Diabetes? Results from a 
Longitudinal Study (Piccolo RS) 
 Racial/Ethnic Disparities in Type 2 Diabetes: The Role of Neighborhood (Piccolo RS) 
 
AcademyHealth (Baltimore, MD) June 2013 
 Are Racial/Ethnic Disparities in Diabetes Explained by Ancestry or by Socioeconomic 
Differences? Results from a Longitudinal Study (Piccolo RS) 
 The Role of Neighborhood Socioeconomic Status in Racial/Ethnic Disparities in Type 2 
Diabetes (Piccolo RS) 
 
American Diabetes Association (Chicago, IL) June 2013 
 The Role of Neighborhood Socioeconomic Status in Racial/Ethnic Disparities in Type 2 
Diabetes (Piccolo RS) 
 Is Genetic Ancestry Associated with Incident Type 2 Diabetes? (Piccolo RS) 
 
2013 Reducing Health Disparities in Type 2 Diabetes Mellitus Summit (Baltimore, MD) March 
2013 
 The Role of Neighborhood Socioeconomic Status in Racial/Ethnic Disparities in Type 2 
Diabetes (Piccolo RS) 
 
2012 Science of Eliminating Health Disparities Summit (Washington D.C.) December 2012 
 Does Limited Health Literacy Explain Racial/Ethnic Disparities in Diabetes Control? 
(Piccolo RS) 
 
Society for Social Medicine (London, UK) September 2012 
 A Profile of Undiagnosed Diabetics in the Community: Results from the Boston Area 
Community Health (BACH) Pre-Diabetes Survey (Piccolo RS) 
 
American Diabetes Association (Philadelphia, PA) June 2012 
 A Profile of Undiagnosed Diabetics in the Community: Results from the Boston Area 
Community Health (BACH) Pre-Diabetes Survey (Piccolo RS) 
 Does Limited Health Literacy Explain Racial/Ethnic Disparities in Diabetes Control? 
(Piccolo RS) 
 
AcademyHealth (Orlando, FL) June 2012 
 Does Limited Health Literacy Explain Racial/Ethnic Disparities in Diabetes Control? 
(Piccolo RS) 
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